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Abstract
Efflux pumps are an essential mechanism for bacteria that can account for antibiotic
resistance. If an efflux pump can expel an antibiotic so that its concentration within
the cell is below a killing threshold the bacteria can become resistant to the antibiotic.
Efflux pumps may be specific or they may pump various different substances and com-
pounds. The latter is one main reason that many efflux pumps are linked with multi
drug resistance (MDR). In particular overexpression of the AcrAB−TolC efflux pump
system is commonly linked with MDR in both Escherichia coli (E. coli) and Salmonella.
We look at the complex gene regulation network (GRN) central to controlling the efflux
pump genes acrAB and acrEF in Salmonella and their resulting effect on intracellular
antibiotic concentration. By using mathematical modelling, we first represent the gene
regulatory network solely, we present a model in the form of a system of ordinary differ-
ential equations (ODEs). Using time dependent asymptotic analysis, we can examine in
detail the behaviour of the efflux system on various different timescales before analysing
asymptotically approximated steady states. In our second model, we produce a spatial
model governing the diffusion and efflux of antibiotic in Salmonella, via the efflux pumps
AcrAB, AcrEF, MdsAB and MdtAB. Using parameter fitting techniques on experimental
data, we are able to establish the behaviour of multiple Salmonella strains, which enables
us to produce efflux profiles for each individual efflux pump system. In our final model,
by using insights from our asymptotic analysis we produce a multiscale model, combining
our ODE and PDE models. This model implements a feedback mechanism between the
intracellular antibiotic concentration and components of the GRN, enabling us to model
the behaviour of the bacteria in response to antibiotic. By performing parameter sensi-
tivity analysis, we are then able to look into various different methods to inhibit efflux
pumps, preventing expulsion of antibiotic to counter MDR.
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Antibiotics are a type of drug that are used to treat bacterial infections, by interfering
with the growth or an essential mechanism for survival of the bacteria. These essential
mechanisms can include maintaining the structure of the cell envelope, protein production
and DNA replication [86]. The World Health Organisation (WHO) has declared antibiotic
resistance a crisis that must be dealt with the utmost urgency. Antibiotic resistance is
reaching alarming levels, with treatment options for various infections becoming ineffective
[64, 65]. The use of antibiotics has been prevalent since the discovery of penicillin by
Alexander Fleming in the early twentieth century [23]. However, the widespread use of
antibiotics has exerted selection pressures on bacteria, causing mutant strains that are
antibiotic resistant. There are currently 17 classes of antibiotics, but for each of these a
mechanism for resistance has emerged [23]. Whilst the development of new antibiotics
is a possibility for treating these resistant bacteria, the discovery of new antibiotics has
massively slowed within the twenty first century, with the possibility of a post antibiotic
era in the coming years [2]. Thus, there is massive importance to look into alternative and
novel treatments for fighting bacterial infections. In February 2017, the WHO released a
priority list of antibiotic resistant bacteria in need of new antibiotics. Enterobacteriaceae,
which is a large family of Gram-Negative bacteria including Salmonella and Escherichia
1
coli (E. coli) were marked in the first priority group, labelling their carbapenem and
cephalosporin resistant strains as a critical priority for new antibiotics to be sought.
Salmonella resistant to fluoroquinolone was marked as a high priority in the second group
[100].
1.2 Gram-Negative bacteria including Salmonella
Gram-negative bacteria are a group of bacteria that are defined by the Gram staining
method of differentiating bacteria. The Gram staining method determines whether a
bacteria is Gram-positive or Gram-negative by detecting peptidoglycan in the bacteria’s
cell wall. Gram-negative bacteria’s cell walls are much thinner meaning they contain
much less peptidoglycan [7]. This is not the only difference, as Gram-positive and Gram-
negative bacteria vary in many of their structures between the plasma membrane and the
capsule as shown in Figure 1.1. The main noticeable difference is the inclusion of the
outer membrane in Gram-negative bacteria.
Salmonella is a genus of rod shaped pathogenic bacteria that is Gram-negative. There
are two species in this genus, Salmonella enterica and Salmonella bongori [1]. This type
of bacteria is one of the main causes of intestinal infections from food, most commonly
from poultry products. In most cases of infection, antibiotics are not needed, however for
Salmonella typhi which causes Typhoid fever, antibiotics are necessary [80]. Salmonella
typhi can transmit from human to human by the fecal to oral route, and hence bad
sanitation is a leading cause of transmission [81]. Salmonella typhi not only infects the
intestines, but has developed to grow in tissues of other organs. Due to overuse of many
different types of antibiotics, multi drug resistant (MDR) strains have developed, most
prominently in South Asia and Africa. Large mortality rates are highly prominent in
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Figure 1.1: The differences in structure between Gram-negative and Gram-positive bacte-
ria between the plasma membrane and the capsule. On the left we exhibit Gram-Negative
with its double membrane structure, whereas on the right we have the Gram-Positive sin-
gular membrane structure. Recreated from [7].
1.3 Efflux pumps
Efflux pumps are an essential mechanism for bacteria that can account for antibiotic resis-
tance. However, they are not exclusive to bacteria as they are found in all three domains
of life: Eukaryota, Bacteria and Archaea [82]. Efflux pumps are transport proteins found
on the cell membrane that expel substances into the external surrounding environment.
If an efflux pump can expel an antibiotic so that its concentration within the cell is below
a killing threshold the bacteria can become resistant to the antibiotic. Efflux pumps may
be specific or they may pump various different substances and compounds. The latter
is one main reason that many efflux pumps are linked with MDR. Many bacteria that
confer MDR exhibit overexpression of efflux pumps. Overexpression is often caused by
mutations of local gene repressors or changes to transcriptional regulators that affect the
production of proteins associated with efflux [97].
3
Many efflux pumps that exhibit MDR are part of the resistance nodulation division
(RND) family [32]. This family of efflux pumps found in Gram-Negative bacteria, span
both membranes meaning they can expel a substance straight from the cell’s cytoplasm to
the outside of the cell. In particular, a member of this family is the AcrAB-TolC system
which is common between both E. coli and Salmonella. We exhibit this system in Figure
1.2. The AcrAB-TolC system is tripartite, composed of the transporter protein AcrB, the
accessory protein AcrA and an outer membrane protein TolC [26]. The efflux of drugs
and other substances through the AcrAB-TolC system is induced by proton motive force.
Proton motive force is caused by hydrogen ions moving from the bacteria’s periplasm to
the cytoplasm, this movement causes an electrochemical gradient that drives transport
of the drug through the efflux pump, expelling the drug or other undesired substances
from the bacteria [68]. From genomic analysis, it has been shown that Salmonella strains
contain five RND efflux pump systems, AcrAB, AcrAD, AcrEF, MdsAB and MdtAB [41].
Of special note is the efflux pump system AcrEF-TolC, which is highly homologous to
the AcrAB-TolC system. Various studies have shown that strains deficient in AcrAB









Figure 1.2: The AcrAB-TolC system common in E. coli and Salmonella, exhibiting proton
motive force. Reproduced from [70].
4
1.4 Gene regulatory networks
In response to environmental stimuli, bacteria are able to control expression of certain
genes via gene regulatory networks (GRNs) [34]. This includes altering the expression of
efflux pump genes in response to a certain antibiotic. In order for a gene to be expressed, it
must undergo the processes of transcription (messenger ribonucleic acid [mRNA] synthesis
from a deoxyribonucleic acid [DNA] template) and translation (protein synthesis from
mRNA by ribosomes). In bacteria, translation in most cases takes place as soon as
transcription of mRNA occurs. This is due to the lack of a nuclear membrane and the high
instability and degradation of mRNA molecules. In addition, one strand of mRNA can be
translated multiple times before it is degraded. For these reasons it means that bacteria
can quickly adapt to changes in environmental stimuli [71]. Certain genes however cannot
simply be expressed as they may be part of a regulatory network, where they need to be
activated by another gene’s activator protein or repression by a repressor protein must
be removed for transcription to occur. Repressor proteins bind to an operator site of a
certain gene, which blocks transcription, whereas activator proteins bind to the promoter
site of a certain gene, which promotes the initiation of gene transcription. We exhibit
these processes in Figure 1.3. All bacteria have complicated networks of genes controlling
gene expression, which enable the bacteria to change their behaviour depending on which






Figure 1.3: Processes of gene regulation and protein synthesis. We exhibit here a gene
in the DNA (blue helix) being transcribed to mRNA (red strand), the mRNA is then
translated to create a protein (orange chain). Here both mRNA and protein undergo
degradation. We also exhibit by the dashed lines the potential activation or inhibition
from a protein within the system upon the transcription and translation processes.
Gram-negative bacteria express a significant number of efflux pumps on their cell mem-
branes. This causes them to be naturally resistant to various antibiotics. Overexpression
of these efflux pumps often confers MDR. However, regulation of efflux pump expression
is complicated and it is therefore important to understand the processes governing it. In
Figure 1.4, we look at the regulation of AcrAB, these are two of the proteins that form
the AcrAB-TolC system. In our first chapter, we use mathematical modelling techniques
to represent this GRN with a system of ordinary differential equations (ODEs). This will
further our understanding of the regulation of these genes and hence the AcrAB-TolC
system, enabling us to look into inhibition to counter MDR.
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Figure 1.4: The GRN governing the expression of acrAB in Salmonella. We represent
activator genes in green, repressor genes are coloured red and the efflux genes in blue.
The shapes along the lines with text in italics are the genes themselves, with shapes
under the top line being lesser underlying regulators. The other shapes without text are
the proteins produced by the genes. If a protein is on the same line before a gene, it
is either activating or repressing the gene’s transcription. We note the yellow enzyme
Lon Protease, this enzyme degrades RamA protein. Finally, the dashed lines show the
processes that are limited when the triangular protein RamR is bound. This network has
been reproduced from [10].
1.5 Antibiotic adjuvants
Due to the emergence of MDR pathogens and lack of new antibiotic discovery, novel
treatment methods have been sought. Antibiotic adjuvants are molecular compounds
that are used in combination with antibiotics, to enhance the activity of the antibiotic
against the pathogen [102]. There are many forms of adjuvants that include anti-virulence
and anti-resistance drugs. Anti-virulence drugs operate by disarming certain mechanisms
of the bacteria, rather than killing them [6]. In addition, anti-virulence drugs do not
directly prevent bacterial growth. These factors are thought to put less evolutionary
pressure on the bacteria and thus have a low chance of contributing to the emergence
of new resistant strains [72]. There are various different anti-virulence drug strategies,
including reducing bacterial adhesion to host cells, inhibiting toxins, and disrupting gene
regulation conferring determinants of virulence [73]. Virulence is defined as the ability of
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a pathogen to infect and cause damage to its host [16]. There are many determinants of
virulence in bacteria including: quantity of bacteria, entry route to the host, virulence
factors (gene products that enhance virulence potential) and host defence mechanisms
[67]. Notably, it has been shown that AcrB defective mutant Salmonella showed reduced
virulence as a result of the lack of efflux pump activity [95]. For a comprehensive study
linking various efflux pumps and virulence see [3, 68].
Anti-resistance drugs are also used to enhance the activity of an antibiotic against the
pathogen, however, they operate by targeting the pathogen’s mechanisms of resistance
[102]. Examples of anti-resistance drugs include β-lactamase inhibitors, drugs that affect
membrane permeability and efflux pump inhibitors (EPIs) [53]. Notably, EPIs inhibit
the action of efflux pumps, they can target efflux pumps directly (efflux inhibitors), or
can be used indirectly to target gene expression (efflux modulators) [35]. Their main
purpose is to increase the intracellular concentration of antibiotic, such that the bacteria
is unable to survive [84]. The development of novel EPIs is considered a promising strategy
with the ability to make a bacterium more sensitive to antibiotics and reverse MDR [87],
particularly the development of EPIs to treat Gram-negative infections [13].
1.6 Previous mathematical models of efflux pumps
and gene regulatory networks
Firstly, it must be noted that there are no known mathematical models that consider
wider GRNs that control efflux pump expression. Current models only consider the efflux
pump gene with a maximum of two regulatory genes. Thus, in this section we will look
to models of GRNs that control expression of different mechanisms, as well as looking
into models of efflux pump function. We begin by discussing general efflux pump models,
moving onto larger scale models that include efflux and finally, discussing various different
methods of modelling GRNs.
Michelson and Slate [57] present a model of the p-glycoprotein pump, associated with
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MDR in cancer patients. This pump is energy dependent, meaning it relies on the process
of dephosphorylation of adenosine triphosphate (ATP) to adenosine diphosphate (ADP)
to function. This is different to the proton motive force driving the AcrAB efflux pump.
They formulate a combined partial differential equation (PDE) and ODE model for the
concentration of drug within the system, relating it to the concentrations of ATP and
ADP using Michaelis-Menten Kinetics. They run simulations of the model, with different
initial conditions of ATP and ADP. Their findings show that the pump is much more
effective at pumping the drug out of the system from an initial state that contains ATP
and ADP than an initial state of ATP depletion. However, they also showed that depleting
a cell completely of ATP would not be enough to be an effective method for blocking drug
efflux.
Michelson and Slate [58] also expand on their previous model of the p-glycoprotein
pump, in this case including the presence of an inhibitor that prevents the drug from
binding to the pump. Three situations, competitive inhibition (multiple molecules are able
to bind to the efflux pump binding site), non-competitive inhibition (only the inhibitor
is able to bind to the efflux pump binding site) with inhibitor efflux and non-competitive
inhibition without inhibitor efflux were modelled. In the competitive case it was shown
that by decreasing the size of the dissociation constant of this inhibitor binding to the
pump, there was increased overall drug exposure. There were larger differences in drug
exposure with a larger initial concentration of drug, with little differences in drug exposure
for smaller initial concentration of drug. For the non-competitive cases, firstly with efflux
of the inhibitor, the drug exposure is slightly more than the competitive case. For the
case with no efflux of the inhibitor the drug exposure is further increased for inhibitors
that have a high affinity to bind. Thus, this shows that a non competitive inhibitor that
cannot be effluxed itself would be the most effective treatment method for blocking drug
efflux.
Yi et al. [103] develop a single cell model that encompasses drug delivery and efflux
simultaneously to look into MDR of cancer cells. In this model a cell is impaled with
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a diffusional microburet which can deliver a drug into the cell by controlled diffusion.
Efflux is modelled through active transport using Michaelis-Menten equations, building
from Michelson and Slate [57, 58]. Efflux is also modelled through passive transport,
simulations of this model show that passive transport can have a large effect on the cells’
intracellular concentration of the drug at steady state.
Perez et al. [66] use an ODE model efflux in E. coli by TetB, a member of the major
facilitator superfamily of efflux pumps. This type of efflux pump spans one membrane
and is responsible for resistance to tetracycline antibiotics. In this model, we have dif-
fusion through two membranes of the antibiotic into the cytoplasm, with efflux from the
cytoplasm to the periplasm. By finding the steady states of the model, binding constants
for the pump were found as well constants relating to the pump efficiency.
Diao et al. [25] produce an ODE model of a yeast efflux pump found in Saccharomyces
cerevisiae. They model the negative feedback loop of a regulator, efflux pump and inducer
(a substrate of the efflux pump). Charlebois et al. [18] also produce an ODE model of
the efflux pump in Saccharomyces cerevisiae. Here a more complex model is produced,
consisting of three genes that are part of a drug resistance network involved with efflux
pump expression.
Nagano and Nikaido [60] present an ODE model of antibiotic efflux in E. coli, from the
AcrAB-TolC efflux pump system. This model includes the enzyme β-lactamase located in
the periplasm, which breaks down the antibiotic. They assume efflux transport undergoes
Michaelis-Menten kinetics, with diffusion into the cell given by Fick’s law. By using
parameter fitting techniques, they are able to find various binding coefficients for various
antibiotics with AcrB. Lim and Nikaido [51] continue this work, extending the study to
find binding coefficients for various different penicillins.
The AcrAB-TolC efflux pump system and genes that govern the system’s expression
have been the topic of other mathematical models. Rossi et al. [79] experimentally ma-
nipulated the degradation of MarA (a known activator of acrAB expression) in E. coli, to
see the resulting effects on downstream genes. A generic mathematical model was formu-
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lated consisting of three genes: an activator and two downstream genes. This ODE model
showed that activators with a long half life had an advantage by increasing the coordina-
tion of the downstream genes. The analytical results were replicated experimentally with
marA and downstream genes inaA and acrAB.
Langevin and Dunlop [48] exhibit an ODE population model of E. coli undergoing
stress from two diverse chemicals, the antibiotic chloramphenicol and the jet biofuel pre-
cursor pinene. Both of these chemicals can be effluxed by the AcrAB-TolC system. Ex-
periments are taken on different strains of bacteria (wild-type and acrAB knock outs),
introducing chemical stressors as step functions at different rates. The experiments look
into the cost of efflux pumps, and show that at certain low levels of antibiotic the bacteria
without efflux pumps is more likely to survive. The mathematical model created has
two species competing against each other consuming a substrate. By parameter fitting
techniques the model is able to show agreement to the experimental data. Conclusions
were then able to be made to find the conditions where expressing the AcrAB-TolC efflux
pump would be more beneficial. It is shown that the benefit of efflux pumps is highly
dependent on the rate of stress introduction.
None of the above models, take into account the wider system of genes governing the
regulation of the proteins that make up these efflux pumps. Thus, they do not have
the potential to ascertain the complete switch dynamics of the cell in response to the
antibiotic. To fully model this behaviour, we would need to include the wider GRN
governing these pumps. We now look into various methods of modelling GRNs. We
include a selection to showcase a variety of techniques but our review is by no means
exhaustive. See also [44], for example, for a more complete overview and review of some
of these methods.
Glass and Kauffman [36] were the first to present a Boolean model of GRNs. Here,
they propose modelling genes as switches of expression where they can be active (1) or
inactive (0). All genes in the network undergo regulation functions which change their
value depending on whether a gene is an activator or repressor and the current state of
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expression. Although this type of modelling is limited due to the level of the detail, it
was found useful for proving the existence of steady states. If a steady state is found for a
discrete model, then a corresponding steady state should be approached by a homologous
continuous model. In addition, oscillatory behaviour in a homologous continuous model,
will have a closed cyclic path in the discrete model.
Shmulevich et al. [85] expand on the work of Glauss and Kauffman to produce a
probabilistic Boolean model of GRNs. In this model, genes can have multiple regulation
functions, with the choice of regulation function being probabilistic. This type of model
has been proven useful when not enough is biologically known about the GRN and how
certain genes interact with each other. One of the downsides of these Boolean models
is that experiments on GRNs do not produce discrete valued measurements and do not
have discontinuous jumps between states at certain time steps. Thus discrete models lose
detail and accuracy when data is discretised to fit them. An alternative is to model these
networks continuously.
Weaver et al. [96] present a linear model of GRNs. In this model, each gene’s ex-
pression level depends on a summation of the levels of its regulators. In this model this
summation is scaled in order to limit the concentration to be between 0 and 1. This
squashed function is then multiplied by maximal expression levels from data to provide a
realistic fit. One of the issues of this model is the low level of detail and little information
that can be extracted from it, including analysis of the processes in the network.
Nachman et al. [59] increase the level of detail in their model of GRNs by delving
deeper into transcription, including transcriptional factors that can bind to the promoter
site of a gene. They start by modelling one singular gene, deriving equations that model
the effects of having one or multiple regulators. They construct a differential equation
governing mRNA concentration, including transcriptional and degradation terms. By
applying and fitting this to data, they show that transcriptional rate parameters can be
gained. One issue with this model is transcriptional factors are likely to be proteins also
in the system, and equations governing their behaviour have not been defined.
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Li et al. [50] model the GRN governing the cell division cycle in the bacterium
Caulobacter crescentus. This bacterium can be divided into types, a mobile swarmer
cell or an immobile stalked cell. The stalked cell is able to replicate the division cycle
and it is on this that the model focuses. The process is centred around the expression
of three proteins CtrA, GcrA, and DnaA. To model this process, a system of 16 ODEs
were derived to model a simplified version of the cycle. These ODEs contain 44 parame-
ters, however in this model the size of these were determined by trial and error. Despite
this, the model has proved to be very accurate, matching up to experimental data of the
wild-type strain and 16 mutant strains.
Tian and Burrage [89] develop a general technique for producing stochastic models of
GRNs. This technique involves introducing Poisson random variables into ODE models.
Their method showed that they are able to include stochastic elements into robust ODE
models, without deriving equations from first principles. They applied this technique to
various existing ODE models of GRNs and ran simulations of the models. From this, they
were able to demonstrate the effect of noise on these networks.
Davidson et al. [22] model the regulatory network governing extra-cellular protease
(exoprotease) production in the Gram-positive bacterium Bacillus subtilis. They investi-
gate the role of the two regulators DegU and Spo0A, however the model itself is centered
on the auto-regulation of DegU, which includes phosphorylation processes. An ODE sys-
tem consisting of 6 differential equations and 14 parameters is produced to determine the
dynamics of exoprotease expression. Steady state analysis was implemented on the model
which revealed three different zones of responses from the system.
Finally, Jabbari et al. [42] produce a model of the agr operon that governs quorum
sensing in Staphylococcus aureus. They produce a system of 12 ODEs with 17 parame-
ters. However as data upon these parameter sizes were not yet available at the time, they
nondimensionalised their model. This took away the dependence on specific parameter
values, resulting in 11 parameter groupings where approximate sizes could be given de-
pendent on the size of certain reactions in relation to each other. They perform a series
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of time dependent asymptotic analyses upon the nondimensionalised system. Doing this
provided insights to the behaviour of the system on various different timescales. This
enabled them to produce a step by step breakdown of the dominant processes that govern
the GRN that control the quorum sensing process.
These GRN models are only a small sample of possible GRN models in bacteria, there
are even more GRN models that we have not considered in Eukaryota. Here, we have
covered a large range of mathematical models from literature and we will use ideas from
these papers in our methodology. In Chapter 2, we formulate a mathematical model of
the GRN governing the AcrAB-TolC system, using ODEs to provide a sufficient amount
of detail and insights into the network. We could have instead opted for a PDE model,
however as there is little data on the spatial dynamics of the gene products within the
GRN, we use ODEs to reduce the number of unknown parameters in the model. We
ran simulations of the ODE model, using parameters from the biology of the network
and consultations with the Piddock Laboratory (University Of Birmingham) to produce
realistic results. In Chapter 3, we nondimensionalise our model to reduce the dependency
on specific parameter values. We are then able to complete a set of time dependent
asymptotic analyses to simplify our model into a step by step breakdown of the GRN.
In chapters 4 and 5, we formulate a PDE model to model the effect of various efflux
pumps in Salmonella (including AcrAB-TolC) on expelling a substrate ethidium bromide.
We implement parameter fitting techniques on the model using experimental data in
order to ascertain efflux profiles of each efflux pump system. Finally in Chapter 6, we
produce a multiscale model by combining our GRN and substrate models. This enables
us to make predictions on manipulating the GRN, displaying the resulting effects on
the spatial dynamics of the substrate. By producing this final model, we are able to
target and highlight areas of the GRN that the intracellular substrate concentration is
most sensitive. We are then able to hypothesise new treatment methods that keep the




2.1 Model schematic & reactions
To formulate our model of the GRN governing acrAB expression, we must first delve into
the processes governing the GRN. We exhibit a detailed schematic of the GRN in Figure
2.1. We note that in this network, we also include the homologue of acrAB, acrEF. Ex-
perimentally, this efflux pump gene expression has been shown to become more prevalent
when there is less production of AcrAB or the acrAB genes are deleted, inactivated, or
when the protein is produced, but non-functional [95].
We will consider two strains of Salmonella Typhimurium (S. Typhimurium) in this
model. Firstly a wild-type strain, this is a typical strain of S. Typhimurium that we
would expect to encounter in a natural population. Secondly, we consider the strain
S. Typhimurium (SL1344), this strain displays MDR as a consequence of a ramR::aph
mutation in the ramR gene, resulting in production of a non-functional RamR protein
[77]. For simplicity, we will refer to this strain as the RamR variant or mutant strain.
To consider as much of the GRN around efflux as possible, we assume that the strains
are subject to stress, e.g. antibiotic or oxidative stress. We detail the steps involved in
acrAB and acrEF regulation shown in Figure 2.1 below, exhibiting the processes involved
in the wild-type case before explaining the differences in processes of the MDR-associated
RamR variant [10, 98].
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Wild-type strain:
• Expression of ramR results in the production of the RamR protein, which can bind
to the ramA operator site, the network’s main transcriptional activator [77].
• Expression of the ramA gene is repressed by bound RamR protein, less RamA is
produced compared to the variant below.
• We assume that the cell is stressed and thus secondary transcriptional activators
soxS, marA and rob are expressed constitutively resulting in production of SoxS,
MarA and Rob protein [63].
• We assume that the gene envR/acrS (which for simplicity, we will refer to as envR
for the rest of this thesis) is expressed constitutively, resulting in production of
EnvR.
• EnvR protein binds to the operator region of acrEF inhibiting its expression [38].
• The acrR gene is expressed resulting in production of AcrR protein which shares
the same site as EnvR protein in binding to the inhibitor region of the acrAB gene,
both inhibiting its expression [52].
• RamA protein shares the same site with SoxS to bind to the acrAB promoter region,
activating its expression.
• Post transcription of acrAB, the RNA protein CsrA acts as a stabiliser of translation
of acrAB mRNA into AcrAB protein [75].
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RamR variant (mutant) strain:
• Mutations in ramR cause a conformational change to RamR protein meaning it is
unable to bind to the ramA operator site. Therefore inhibition of ramA expression
is lost in this mutant.
• The ramA gene is expressed more highly than in the wild-type resulting in higher
concentrations of RamA protein.
• RamA is regulated post-translationally through degradation by the enzyme Lon
Protease [76].
• RamA binds to its own promoter site and activates its transcription.
• A high concentration of RamA protein (compared to the wild-type) shares the same
site with SoxS to bind to the acrAB promoter region, activating its expression.
• Transcription of the acrAB gene occurs at a high rate compared to the wild-type
case, due to the high RamA protein concentration compared to the wild-type.
We note that whilst the processes upon ramA regulation are only listed in the RamR
mutant strain, they may still occur in the wild-type strain. However we expect the effect
from these processes to be minimal due to the lower concentration of RamA in the strain.
Furthermore, mathematically each of the secondary transcriptional activators (secondary
TAs) soxS, marA and rob would have equivalent representations. Thus for simplicity,
we group these activators together and refer to them as soxS or secondary TAs for the
remainder of the work.
It has been shown experimentally that with decreased acrAB expression, greater
expression of the homologue efflux pump gene acrEF occurs (which operates similarly
to acrAB) [12]. This may be through known mechanisms in the network, for example
through the repressor envR. However, since these mechanisms have not yet been fully elu-
cidated, we capture this behaviour in the model by a simple direct link between AcrAB
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levels and expression of acrEF, noting that this is an area where extra detail can be in-
corporated in future work. Finally, we note that RamA protein is believed to be capable
of binding at the acrR gene, however no effect on acrR transcription has yet been demon-
strated. We nevertheless include this in our model under the assumption that RamA




















































































































































































































































































































































































































































































































































2.2 Modelling activation and inhibition of gene tran-
scription
In order to model our biological system mathematically, we must look into the kinetics
of how activator proteins activate or repressor proteins inhibit a gene by binding to an
operator site. In the following subsections, we model all situations that are present in our
GRN.
2.2.1 One protein and one binding site
The first situation that we model is one protein and one binding site that the protein
can reversibly bind to. We show this in Figure 2.2. In order to model this and further
situations, we look into the proportion of time that a protein is bound or unbound to a
binding site. Our aim is to obtain equations for these time proportions in terms of the
protein concentrations and their binding and unbinding rates. To be able to do this, we
introduce the following notation:
Φ: Proportion of time that the binding site is empty (all proteins are unbound),
ΦX: Proportion of time that the binding site is occupied by protein X (protein X is
bound).
We could also alternatively consider these proportions of time as probabilities. Since
we are dealing with proportions, it follows that all proportions of time must add up to
unity




Figure 2.2: One protein with one binding site. Here we exhibit the protein X binding to
the site at rate α1 and unbinding from the site at rate β1.
Using the law of mass action which states that “The rate of a chemical reaction is
directly proportional to the product of the concentration or active masses of the reacting
substances” [83], we can construct ordinary differential equations (ODEs) for each pro-
portion of time. In this case we are interested in the change of the proportion of time
that protein X is bound:
dΦX
dt
= α1XΦ− β1ΦX . (2.2)
By assuming that there is enough protein in the system that all proportions of time are
at quasi-steady state (QSS) [14], and by using equation (2.1) we obtain
0 = α1X(1− ΦX)− β1ΦX . (2.3)











is the dissociation constant for protein X. We comment that the behaviour
of these constants are such that as KX → 0, Φ→ 0 and ΦX → 1, conversely as KX →∞,
Φ → 1 and ΦX → 0. We must now apply these equations to an ODE for the rate of
change of an arbitrary gene’s mRNA, which we denote as Gm. Note that mRNA will
undergo degradation at some rate, which we include in the following equations as δm.
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Protein X is an activator protein binding to a promoter site.
In this case, we assume that there is a high level of transcription of the gene’s mRNA when
the activator protein is bound. It is often the case that there is a small basal transcription
rate (kb) regardless of whether protein X is bound. It is particularly useful to include this
basal rate when a gene is self activating: by including this rate we reduce the risk that
the gene quickly reaches steady state at zero. Thus the equation we achieve is as follows
dGm
dt




+ kb − δmGm. (2.6)
Protein X is a repressor protein binding to an operator site.
In this case, we assume that if a repressor is bound, there will be no transcription. This
means we must look at when there is no protein bound for transcription to occur. Thus
in this case the equation we achieve is as follows
dGm
dt





2.2.2 Two proteins with one binding site each
In this situation, we model two proteins with one binding site each that the protein can
reversibly bind to, we show this in Figure 2.3. As there is an extra protein and an extra
binding site in this case, we must introduce some new notation:
ΦX: Proportion of time that the binding site is occupied by protein X (protein X is
bound),
ΦY : Proportion of time that the binding site is occupied by protein Y (protein Y is
bound),
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Figure 2.3: Two proteins with two distinct binding sites. Here we exhibit the protein
X binding to a site at rate α1 and unbinding from the site at rate β1. We also have a
different shape protein Y binding to a different binding site at rate α2 and unbinding from
the site at rate β2.
Using the the law of mass action, we can find equations for the rate of change of all
proportions of time that proteins are bound to any of the binding sites
dΦX
dt
= α1XΦ + β2ΦXY − β1ΦX − α2Y ΦX , (2.9)
dΦY
dt
= α2Y Φ + β1ΦXY − β2ΦY − α1XΦY , (2.10)
dΦXY
dt
= α1XΦY + α2Y ΦX − β1ΦXY − β2ΦXY . (2.11)
By assuming that there is enough protein in the system that all proportions of time are




= 0 and dΦXY
dt
= 0), and by using a similar equation
to (2.1) that all time proportions must add to unity, we obtain:
0 = α1X(1− ΦX − ΦY − ΦXY ) + β2ΦXY − β1ΦX − α2Y ΦX , (2.12)
0 = α2Y (1− ΦX − ΦY − ΦXY ) + β1ΦXY − β2ΦY − α1XΦY , (2.13)
0 = α1XΦY + α2Y ΦX − β1ΦXY − β2ΦXY . (2.14)
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We now have a simultaneous system of equations which we can solve for to achieve
Φ =
KXKY




















are dissociation constants for proteins X and Y respectively.
Protein X is an activator protein binding to a promoter site and protein Y is
a repressor protein binding to an operator site.
In this case, we assume that there is no transcription if the repressor protein Y is bound
to the site. We also have a higher transcription rate when only protein X is bound. In
addition we could include a basal transcription rate that is active regardless of whether
protein X is bound. Thus the equation we achieve is as follows
dGm
dt
= k1ΦX + kb − δmGm, (2.19)
= k1
KYX
(KX +X)(KY + Y )
+GC − δmGm. (2.20)
2.2.3 Two sets of two proteins binding to one binding site for
each set
In this situation, we model two sets each consisting of two proteins and one binding site.
Within each set, the proteins share the same binding site that they can reversibly bind.
We display this in Figure 2.4. As there are two extra proteins in this case, we introduce
some new notation:
ΦW : Proportion of time that the binding site is occupied by protein W (protein W is
bound),
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ΦX: Proportion of time that the binding site is occupied by protein X (protein X is
bound),
ΦY : Proportion of time that the binding site is occupied by protein Y (protein Y is
bound),
ΦZ: Proportion of time that the binding site is occupied by protein Z (protein Z is bound),
ΦWY : Proportion of time that the binding sites are both occupied (proteins W and Y are
bound),
ΦWZ: Proportion of time that the binding sites are both occupied (proteins W and Z are
bound).
ΦXY : Proportion of time that the binding sites are both occupied (proteins X and Y are
bound).
ΦXZ: Proportion of time that the binding sites are both occupied (proteins X and Z are
bound).
Using the the law of mass action, we can find equations for the rate of change of all
proportions of time that proteins are bound to any of the binding sites
dΦW
dt
= α1WΦ + β3ΦWY + β4ΦWZ − β1ΦW − α3Y ΦW − α4ZΦW , (2.21)
dΦX
dt
= α2XΦ + β3ΦXY + β4ΦWZ − β2ΦX − α3Y ΦX − α4ZΦX , (2.22)
dΦY
dt
= α1Y Φ + β1ΦWY + β2ΦXY − β3ΦY − α1WΦY − α2XΦY , (2.23)
dΦZ
dt
= α2ZΦ + β1ΦWZ + β2ΦXZ − β4ΦZ − α1WΦZ − α2XΦZ , (2.24)
dΦWY
dt
= α1WΦY + α3Y ΦW − β1ΦWY − β3ΦWY , (2.25)
dΦWZ
dt
= α1WΦZ + α4ZΦW − β1ΦWZ − β4ΦWZ , (2.26)
dΦXY
dt
= α2XΦY + α3Y ΦX − β2ΦXY − β3ΦXY , (2.27)
dΦXZ
dt








Figure 2.4: Two sets of two proteins binding to one binding site for each set. Here we
exhibit the protein W binding to a site at rate α1 and unbinding from the site at rate
β1. This protein is in competition to bind for the same site as protein X which binds to
the site at rate α2 and unbinds from the site at rate β2. We also have a different shape
protein Y binding to a different binding site at rate α3 and unbinding from the site at
rate β3. This protein is in competition to bind for the same site as protein Z which binds
to the site at rate α4 and unbinds from the site at rate β4.
By assuming that there is enough protein in the system that all proportions of time
are at quasi-steady state and by using a similar equation to (2.1) (now Φ = 1 − ΦW −
ΦX −ΦY −ΦZ −ΦWY −ΦWZ −ΦXY −ΦXZ) we have a simultaneous system of equations
that can be solved to obtain
Φ =
KWKXKYKZ















































are dissociation constants for
proteins W, X, Y and Z respectively.
Protein W and X are activator proteins binding to a promoter site and proteins
Y and Z are repressor proteins binding to an operator site.
In this case, we assume that there is no transcription if either of the repressor proteins Y
or Z is bound to the site. We also have a higher transcription rate when either W or X
is bound. In addition we could include a basal transcription rate that is active regardless
of whether protein W or X is bound. Thus the equation we achieve is as follows
dGm
dt
= k1(ΦW + ΦX) + kb − δmGm, (2.38)
= k1
KYKZ(XKW +WKX)
(KXW +KWX +KXKW )(Y KZ + ZKY +KZKY )
+ kb − δmGm. (2.39)
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2.3 Ordinary differential equation models
In this section we produce a model of the GRN in Figure 2.1. In section 1.6 we compared
various different modelling techniques for GRNs. We choose to use a system of ordinary
differential equations (ODEs) to provide a sufficient level of detail and insights into the
network. For GRNs, the principal processes affecting mRNA and proteins are transcrip-
tion, translation and degradation. We exhibit this in equation (2.40). Here Gm and G
represent mRNA and protein respectively associated with an arbitrary gene. We note
that transcription and translation terms may be affected by the concentrations of other





















The equations for the GRN model are as follows:
dRm
dt





















= k5 − δmSm, (2.45)
dEm
dt









= µ(m1Rm − δpR), (2.48)
dA
dt
= m2Am − δpA− d1LA, (2.49)
dC
dt







m4Bm − δpB, (2.51)
dS
dt
= m5Sm − δpS, (2.52)
dE
dt







We note that all of the differential equations have linear terms regarding degradation,
which we group as the same rate for mRNAs and proteins respectively (δm and δp). RamA,
SoxS and MarA are the only proteins that we know of that undergo enzyme degradation
in the GRN, all degraded by Lon Protease. The secondary TA Rob however does not
experience this degradation [30]. Since we have grouped together SoxS, MarA and Rob
together, we opt not to include this additional enzyme degradation, instead only including
enzyme degradation for RamA in equation (2.49).
In the case of transcription and translation, the terms are not so straightforward. In
equation (2.42), we exhibit the activation of ramA transcription by its own protein, whilst
being repressed by RamR protein at the ramA operator site, derived from (2.20). In equa-
tion (2.43), we have the potential repression of transcription of acrR mRNA transcription
by RamR protein, derived from (2.8). In equation (2.44), we see the effect of the activator
protein RamA and the underlying activators Rob, SoxS and MarA (which we group as
one variable S) binding to a promoter site to activate transcription of acrAB mRNA,
whilst the proteins AcrR and EnvR bind to an operator site to repress acrAB mRNA
transcription, derived from (2.20). In equation (2.47), we have the repression of tran-
scription of acrEF mRNA transcription by EnvR protein, derived from (2.8). In equation
(2.51), we see the activation effect from CsrA in the translation terms for AcrAB, derived
from (2.6). Furthermore in equation (2.54), by including AcrAB in the translation term,
we are able to include the link between AcrAB and AcrEF concentrations, derived from
(2.8). Finally, we incorporate the RamR variant via a mutant coefficient (µ) in equation
(2.48). By setting this value to zero, we can replicate the case of mutated RamR as this
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results in no translation of ramR mRNA. Conversely by setting this value to one we have
full translation, but also degradation of RamR protein.
We denote all of the variables and parameters used to run simulations of our GRN
model in Table 2.1 and Table 2.2. We note that our model does not contain a signal (such
as an antibiotic or toxic substrate) that activates the GRN. Instead, we have chosen our
model to focus solely on the GRN to first greater understand the processes within the
network, leaving the introduction of an explicit signal for later work in Chapters 4-6. For
our simulations, we have chosen initial conditions of all mRNA and protein variables to be
very small (0.01nM), such that the system starts from a down-regulated state. Here, we
are making the assumption that there is at least a low concentration of mRNA and protein
of all genes at all times in the system. Whilst a down-regulated initial state may not be
the case in all scenarios (genes also involved with other cellular processes may already be
up regulated), we have chosen these initial conditions in order to show a greater potential
of processes within the GRN. We exhibit the notation for these conditions in (2.55) for
the mRNA and protein of an arbitrary gene:
Gm(0) = Gm0, G(0) = G0. (2.55)
2.3.1 Simulations
By using estimated parameter values shown in Table 2.2, we produce numerical simu-
lations of the GRN model for both wild-type and RamR mutant strains using ode45 in
MATLAB, exhibited in Figure 2.5. Where possible we have been guided by data in the
experimental literature for parameter values. Remaining parameters are chosen to give
biologically plausible results. We note that between strains, we have identical simulations
of both mRNA and protein for soxS and envR. This is expected as the expression of these
genes are constitutive in both strains. We see sizeable differences in the concentrations
of RamR (Figure 2.5(h)) between both strains due to the mutation of this protein in the
RamR mutant strain. We see resulting increased expression of ramA, producing larger
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Variables Description Units
Rm Concentration of ramR mRNA nM
R Concentration of RamR nM
Am Concentration of ramA mRNA nM
A Concentration of RamA nM
Cm Concentration of acrR mRNA nM
C Concentration of AcrR nM
Bm Concentration of acrAB mRNA nM
B Concentration of AcrAB nM
Sm Concentration of rob, soxS and marA mRNA nM
S Concentration of Rob, SoxS and MarA nM
Em Concentration of envR mRNA nM
E Concentration of EnvR nM
Fm Concentration of acrEF mRNA nM
F Concentration of AcrEF nM
Table 2.1: Variables used in our GRN model along with their respective units.
Parameter Description Estimate Units Reference
k1 Transcription Rate of ramR mRNA 30 nM min
−1
m1 Translation Rate of RamR 1 min
−1 [93]
k2 Transcription Rate of ramA mRNA 1 nM min
−1
m2 Translation Rate of RamA 1 min
−1 [93]
k3 Transcription Rate of acrR mRNA 10 nM min
−1
m3 Translation Rate of AcrR 1 min
−1 [93]
k4 Transcription Rate of acrAB mRNA 1 nM min
−1
m4 Translation Rate of AcrAB 1 min
−1 [93]
k5 Transcription Rate of rob, soxS and marA mRNA 1 nM min
−1
m5 Translation Rate of Rob, SoxS and MarA 1 min
−1 [93]
k6 Transcription Rate of envR mRNA 10 nM min
−1
m6 Translation Rate of EnvR 1 min
−1 [93]
k7 Transcription Rate of acrEF mRNA 0.1 nM min
−1
m7 Translation Rate of AcrEF 1 min
−1 [93]
k′2 Lower Transcriptional Rate of RamA 0.01 nM min
−1
δm Degradation Rate of mRNA 1 min
−1 [74]
δp Degradation Rate of proteins 0.02 min
−1 [40]
d1L Degradation caused by Lon Protease 0.37 min
−1 [76]
KR Dissociation Constant of RamR 65.8 nM [8]
KA1 Dissociation Constant of RamA with ramA and acrAB 2 nM
KA2 Dissociation Constant of RamA with acrR 2 nM
KC Dissociation Constant of AcrR 20.2 nM [8]
KE1 Dissociation Constant of EnvR with acrEF 20.2 nM
KE2 Dissociation Constant of EnvR with acrAB 20.2 nM
KS Dissociation Constant of rob, soxS and marA 200 nM
KTC Dissociation Constant of CsrA 0.02 nM
KB Chemical Signals Constant of AcrAB 1 nM
TC Concentration of CsrA 1 nM
µ Mutation Coefficient 0 or 1 N/A
Table 2.2: A table of parameters used in our GRN model and their estimated values.
Those with estimates gained from references are noted in the reference column. The
remainder have been chosen through investigation and discussion with the Piddock labo-
ratory (University Of Birmingham) to give biologically plausible results.
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concentrations of mRNA and protein (Figures 2.5(b) and (i)) in the RamR mutant strain.
Since we have a higher concentration of RamA in the RamR variant, we see inhibition of
acrR expression, resulting in lower concentrations of mRNA and protein (Figures 2.5(c)
and (j)) in the RamR variant strain. We see a resulting larger concentration of acrAB
mRNA and protein (Figures 2.5(d) and (k)) in the RamR variant strain with a lower
concentration of the homologue efflux pump protein AcrEF (Figure 2.5(n)) compared to
the wild-type. These simulations clearly exhibit the potential of the RamR mutant strain
to display MDR, with the steady state concentration for AcrAB (Figure 2.5(k)), the main
efflux pump in the GRN, being over four times larger in the mutant strain than the wild-
type. This results in the combined efflux of both AcrAB and AcrEF concentrations being
much larger in the RamR mutant strain, even with the increased concentration of AcrEF












































































































































































































































































































































































































In this chapter, we have formulated an ODE model of the GRN. We started our model
formulation by listing the processes governing the expression of the efflux pump genes
acrAB and acrEF. In order to assist detailing the processes within the network, we
introduced two strains of Salmonella, namely a wild-type and a RamR variant. By first
listing the processes of the wild-type strain, we displayed the differences in the RamR
variant, highlighting areas of the network that causes the RamR variant strain to confer
MDR.
We have then exhibited our method for deriving our ODEs. By modelling the propor-
tion of time that a protein is bound to a gene binding site, we can formulate equations
of gene expression based on whether the binding protein is an activator or repressor. We
have detailed our derivations for all binding processes that feature within the GRN. By
using these derivations, we have then detailed our ODE model for the GRN, consisting
of fourteen differential equations and twenty nine parameters.
Finally, we have run numerical simulations of our model, using a combination of
parameter values from data as well as estimates drawn from investigation and discussion
with the Piddock laboratory (University Of Birmingham). This has enabled us to view the
behaviour of the network and an overview of how the genes within the network interact,
starting from basal initial conditions of concentration.
This model does however have limitations. One downside of the model is that it is too
complex to yield analytically tractable solutions. In addition, results are dependent on
parameter values, making it difficult to draw strong conclusions from the model. In the
next chapter, we will use asymptotic techniques to break the full solution into separate
timescales. This analysis should reduce the dependency on precise parameter values and
give us analytical solutions for various different timescales, enabling us to draw stronger





As shown in the previous chapter, the GRN we are modelling is complex and thus in
order to look into effective inhibition techniques to combat efflux pump expression, the
processes within the system need to be fully analysed. With our previous model, we do
not have a full set of analytically solvable solutions or steady states. Thus we are limited
in the analysis we can conduct on the model without using numerical simulations.
In this chapter, we will use a series of asymptotic analyses to approximate these steady
state values and gain analytical solutions for the variables on intermediate timescales. This
analysis will enable us to show the effect upon variables at different timescales by varying
parameters in the GRN. We will conduct two full asymptotic analyses for the wild-type
and mutant strains, separate analysis for each strain is needed as the steps involved to
reach each timescale will differ. By discovering the behaviour on each timescale, we are
able to see the dominant processes involved in the GRN between both strains. By deriving
the asymptotically approximated steady states, we will also be able to compare different
strategies to inhibit efflux expression that will be most effective for individual strains.
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3.2 Nondimensional model








































here the asterisks denote nondimensional variables. We have chosen these scalings in or-
der to simplify our system of equations and create nondimensional parameters over which
we have insight into their relative sizes. We note that these have the added effect of sim-
plifying the somewhat complex transcription and translation terms. Substituting these








(A+ 1) (R + 1)
















= 1− Sm, (3.6)
dEm
dT









= µρRm − µ∆R (3.9)
dA
dT
= θ Am −∆A− υ A, (3.10)
dC
dT
= γ Cm −∆C, (3.11)
dB
dT
= β Bm −∆B, (3.12)
dS
dT
= σ Sm −∆S, (3.13)
dE
dT
















































We assume that all mRNAs and proteins are initially present at a low concentration
to monitor how the system upregulates. Thus, we choose low value generic dimensionless
initial conditions as follows
Rm(0) = Am(0) = Cm(0) = Bm(0) = Sm(0) = Em(0) = Fm(0) = 0.01,
R(0) = A(0) = C(0) = B(0) = S(0) = E(0) = F (0) = 0.01. (3.16)
From here on we will refer to these initial conditions with the following notation (similar
to the previous chapter). For any gene G, we will refer to the mRNA initial condition as
Gm0 and the protein initial condition as G0.
3.3 Parameter grouping sizes
By using information about the size of certain parameters compared to others, we can esti-
mate relative parameter sizes within the nondimensional groupings. We start by choosing





The grouping α is the ratio of a low basal rate of transcription to the higher transcription
rate of ramA mRNA. We now assign the remaining parameter groupings an order of
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i.e. mRNA degradation occurs at a much faster rate than the degradation of proteins. We
do not know all of the exact degradation rates for the mRNAs and proteins of genes within
the network. However, in a similar Gram-negative bacteria E. coli it was observed that
80% of 4,288 mRNAs had half-lives between 3 and 8 minutes [9], whereas for proteins, the
vast majority have half-lives of between 5 and 20 hours [54]. In Salmonella, on a study
of 870 proteins, the calculated median half-life was 99.30 minutes [94]. For individual
proteins within the GRN, it has been shown for RamA in a mutant strain with no Lon
Protease, there was very little observable degradation within 10 minutes, indicating that
the protein is highly stable [76]. Finally, in E. coli it has also been observed that AcrA
and AcrB lasted for approximately six days [17].
At O(ε
1











Having υ = O(ε
1
2 ) follows from (3.18), as the rate of degradation of RamA by Lon protease
(d1L) is larger than the natural rate of protein degradation (δp) [76]. Thus, we expect
this grouping to be a larger order of magnitude than ∆. For σ, as the secondary TAs
are all underlying activators, we expect that the dissociation constant is relatively large,
(furthermore by setting this grouping to this size we obtain the most realistic behaviour).
Finally, for ξ the transcription and translation rates for EnvR should be small as this is a
repressor of the homologue efflux pump system AcrEF, and thus we expect this grouping
to be the same size as σ which governs similar underlying genes.
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For λ, the dissociation constants that make up this grouping correspond to the same
proteins, but binding to different binding sites. With no evidence to the contrary, we
make the assumption that the constants are roughly equal. For η, there is contradictory
evidence in the literature over whether EnvR preferentially binds acrAB, acrEF or both
equally [38, 37]. As a result, we also assume these dissociation constants are roughly equal
and explore variations to this choice in the parameter sensitivity section. As for ω, we
know very little about the chemical signals that cause activation of AcrEF, and hence we












δm (TC +KTC )
. (3.21)
The groupings in (3.21) correspond to the expression of RamA, RamR, AcrR and AcrAB
respectively. These four proteins constitute the primary TAs and the central pathway
for the GRN, and thus it is not unreasonable to assume that expression of their genes
is relatively high and the respective dissociation constants are likely to be smaller. It
has also been shown experimentally in a wild-type Salmonella strain, that expression of
ramA and acrAB was higher than soxS, marA and acrEF [99]. Therefore, we expect these
groupings to be the largest in order. Testing more subtle differences in size did not bring
significant variations to the behaviour of the model. In Table 3.1, we summarise all of the
above parameter grouping sizes, chosen for definiteness. We could alternatively choose
another size for the intermediate scaling between O(ε) and O(1), however in the following
analysis soxS (σ) and envR (ξ) translation appear together independently on the same
timescale. Therefore, whilst the time scaling to reach this timescale may change, we do
not expect change in the order of the following processes in the analysis. In addition,
the remaining parameter refers to RamA degradation (υ) which will primarily affect the
39
steady states of variables, the dependence on this parameter scaling is therefore covered
in the sensitivity analysis in Section 3.8. The parameters below are therefore scaled as
follows
∆ =ε∆′, θ =θ′, σ =ε
1
2σ′,
ρ =ρ′, υ =ε
1
2υ′, η =η′, (3.22)
α =εα′, γ =γ′, λ =λ′,
β =β′, ξ =ε1/2ξ′, ω =ω′,
where the parameters with primes are taken to be O(1). By substituting these into our
nondimensional model and dropping primes, we obtain the following system of equations,








(A+ 1) (R + 1)
















= 1− Sm, (3.27)
dEm
dT









= µρRm − µε∆R, (3.30)
dA
dT
= θ Am − ε∆A− ε1/2υ A, (3.31)
dC
dT
= γ Cm − ε∆C, (3.32)
dB
dT
= β Bm − ε∆B, (3.33)
dS
dT
= ε1/2σ Sm − ε∆S, (3.34)
dE
dT







with initial conditions (3.16). We will follow some numerical simulations of the model
with a time-dependent asymptotic analysis in order to extract the dominant behaviours





υ, σ, ξ O(ε
1
2 )
ρ, θ, γ, β, η, λ, ω O(1)
Table 3.1: Nondimensionalised parameter groupings and their orders of magnitude.
3.4 Numerical simulation
We exhibit a numerical simulation of (3.16) and (3.23)-(3.36) in Figure 3.1 showing both
the wild-type and RamR variant cases. For both cases, we see the rapid production of
mRNA (a)-(g), reaching steady state very quickly for most variables. The efflux genes’
mRNAs (d) and (g) reach steady state more slowly due to being affected by regulatory
protein concentrations. All proteins (h)-(n) reach steady state at a later timescale than
the mRNA. These simulations enable us to exhibit the differences between mutant and
wild-type strains, caused by the mutation to RamR protein (h). This mutation causes
overexpression of ramA mRNA (b) and protein (i) which in turn causes lower concentra-
tions of acrR mRNA (c) and protein (j). These concentrations combined result in a higher
concentration of acrAB mRNA (d) and protein (k), which itself causes lower expression
of AcrEF (n). We note that the steady state concentration of AcrAB is significantly
higher in the mutant case than the wild-type case. Unless otherwise stated, these are the





























































































































































































































































































































































3.5 Asymptotic analysis for ε→ 0
We now exploit asymptotic analyses to break down the full solution into smaller timescales
to investigate how the system evolves over time. For an insight into various asymptotic
techniques and methods, some used in this section, see [45]. Variable scalings on each
timescale are obtained by first finding the long-term behaviour of each variable on the
previous timescale. Once this long-term or near blow up behaviour is found, we can
identify the scalings based on how each variable behaves compared to our time variable
T . For example if a nondimensionalised variable G behaves on the previous timescale as
follows
G ∼ T as T →∞,
then to move to the next timescale we must scale G in the same way that we do for T .
The scalings to reach each timescale mathematically appear in a set sequence, where new
behaviour entering the leading order balance determines the scaling for T . These scalings
could also be revealed by analysing the correction terms for the asymptotic approximations
on each timescale. In Section 3.6.1, we exhibit both methods of revealing the scalings
to reach the next timescale. Throughout the next sections, we will draw comparisons
between the numerical solutions and asymptotic approximations. In all figures asymptotic
approximations will be shown in circles, whereas the numerical simulations will be shown
as solid lines. We take ε = 0.01 unless otherwise stated.
3.6 Asymptotic analysis of the wild-type dynamics
We begin with the wild-type case where RamR protein is not mutated (i.e µ = 1). We
denote the variable scalings for each timescale in Table 3.2. Here the scalings are given






























































































































































































































































































































































































































































































































































































































































































































































3.6.1 Timescale 1: mRNA transcription
On this initial timescale all variables must be scaled to O(ε) to reflect their initial condi-
tions. We thus take the following scalings
T = εT̂ , Rm = εR̂m, Am = εÂm, Cm = εĈm, Bm = εB̂m,
Sm = εŜm, Em = εÊm, Fm = εF̂m, R = εR̂, A = εÂ,
C = εĈ, B = εB̂, S = εŜ, E = εÊ, F = εF̂ . (3.37)




































= µρ εR̂m − ε2µ∆R̂,
dÂ
dT̂





= γ εĈm − ε2∆Ĉ,
dB̂
dT̂
= β εB̂m − ε2∆B̂,
dŜ
dT̂
= ε3/2σ Ŝm − ε2∆Ŝ,
dÊ
dT̂






− ε2∆F̂ . (3.38)












































The ODE system has now been reduced and we can extract the dominant behaviour
on this timescale. Solving the reduced model subject to the initial conditions gives the
following asymptotic approximations on this timescale:
R̂m = T̂ +Rm0, R̂ = R0, Âm = Am0, Â = A0,
Ĉm = T̂ + Cm0, Ĉ = C0, B̂m = Bm0, B̂ = B0,
Ŝm = T̂ + Sm0, Ŝ = S0, Êm = T̂ + Em0, Ê = E0,
F̂m = T̂ + Fm0, F̂ = F0. (3.40)
We plot the asymptotic approximations of all variables on this timescale against the nu-
merical solutions in Figure 3.2. As expected, we see the transcription of various gene’s
mRNA occurring first with protein levels remaining at their initial value. The transcrip-
tion of ramA and acrAB mRNA are currently not active due to there being insufficient
levels of activator protein bound to their promoter sites to achieve any level of transcrip-
tion at leading order. We have now analysed this first timescale and must determine the
scalings necessary to reach the next timescale. We now demonstrate two possible methods
for revealing these scalings.
Method 1: Analysing the leading order balance
In this method, we determine the scalings for each variable by first analysing their long
term behaviour on the current timescale. We can then look at which new terms will first
enter the leading order balance on the next timescale to reveal the exact scaling. For this
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timescale, as T̂ →∞ we have
R̂m, Ĉm, Ŝm, Êm, F̂m ∼ T̂ , (3.41)
with every other variable still constant at their initial condition. We now propose a new
time scaling to reach the next timescale:
T̂ = δ(ε)Ť , (3.42)
where δ(ε) is a function of ε. Since we are scaling forwards in time, we must have that
δ(ε) > 1. Substituting this scaling (3.42) into the solutions (3.40) for our variables that
evolve on this timescale . We have
R̂m = δ(ε)Ť +Rm0, Ĉm = δ(ε)Ť + Cm0, Ŝm = δ(ε)Ť + Sm0,
Êm = δ(ε)Ť + Em0, F̂m = δ(ε)Ť + Fm0. (3.43)
Notably, we have terms of O(δ(ε)) > O(1), in order for these terms to be O(1) on the
subsequent timescale, we must then take the following variable scalings
R̂m = δ(ε)Řm, Ĉm = δ(ε)Čm, Ŝm = δ(ε)Šm, Êm = δ(ε)Ěm, F̂m = δ(ε)F̌m. (3.44)


















































































− ε2∆F̂ . (3.47)
We can see from this system of equations that the smallest scaling δ(ε) that brings
in a new term to the leading order balance is δ(ε) = ε−
1
2 . This scaling brings in RamR,
AcrR and AcrEF translation in equations (3.45), (3.46) and (3.47) respectively.
Method 2: Analysing the correction term
In this method, we look at the behaviour of the correction terms on the current timescale
to determine the time scaling to reach the subsequent timescale. For all 14 of our variables
we take the following asymptotic expansions, with notation for a gene mRNA Gm and
protein G.
Gm = gm0 + ε
1
2 gm1 + εgm2 + ..., G = g0 + ε
1
2 g1 + εg2 + ... . (3.48)
In addition to the leading order system of equations (3.39) and solutions (3.40), the first
















































Solving this system of equations we have:










µρT̂ 2 + µρRm0T̂
)
,
Âm ∼ Am0 + ε
(
(A0 + α− Am0)T̂
)





















γT̂ 2 + γCm0T̂
)
,
B̂m ∼ Bm0 + ε
(
(A0 + S0 −Bm0)T̂
)









T̂ 2 − Sm0T̂
)






σT̂ 2 + σSm0T̂
)
,




T̂ 2 − Em0T̂
)






ξT̂ 2 + ξEm0T̂
)
,
















T̂ 2 + Fm0T̂
)
. (3.50)
For the variables that have not evolved at leading order, we can see that the correction
terms for R̂, Ĉ and F̂ become O(1) when T̂ = O(ε−
1
2 ). Since this is the smallest possible
time scaling to bring in correction terms, this gives us our time scaling T̂ = ε−
1
2 Ť to
reach the next timescale. The variables Ŝ and Ê become leading order at T̂ = O(ε−
3
4 )
whilst the variables Âm, Â, B̂m and B̂ become leading order at T̂ = O(ε
−1), which gives us
insight into potential scalings for future timescales past the subsequent timescale. For the
variables that have evolved at leading order, applying the scaling T̂ = ε−
1
2 Ť , the leading
order terms become O(ε−
1
2 ). For these terms to be O(1) on the subsequent timescale we
must also apply the following variable scalings
R̂m = ε
− 1
2 Řm, Ĉm = ε
− 1
2 Čm, Ŝm = ε
− 1
2 Šm, Êm = ε
− 1
2 Ěm, F̂m = ε
− 1
2 F̌m. (3.51)
Notably, both methods return the same scalings as they are mathematically set in sequence



































































































































































































































































































































































































































































































































3.6.2 Timescale 2: Protein translation
We move onto the second timescale, here protein translation occurs for RamR, AcrR and
AcrEF in equations (3.53)-(3.55). We take the following scalings based on the variables
on the previous timescale’s long-term behaviour
T̂ = ε−
1
2 Ť , R̂m = ε
− 1





2 Šm, Êm = ε
− 1
2 Ěm, F̂m = ε
− 1
2 F̌m. (3.52)





































































































2 ∆F̂ . (3.55)












































Solving this reduced system of ODEs and matching to the long-term dominant be-
haviour on the previous timescale gives the following asymptotic approximations
Řm = Ť , R̂ =
µρ
2
Ť 2 +R0 Âm = Am0, Â = A0,
Čm = Ť , Ĉ =
γ
2
Ť 2 + C0, B̂m = Bm0, B̂ = B0,
Šm = Ť , Ŝ = S0, Ěm = Ť , Ê = E0,
F̌m = Ť , F̂ =
1
2
Ť 2 + F0. (3.57)
We plot these asymptotic approximations against the numerical solutions in Figure 3.3.
We see the translation of some of the genes transcribed on the previous timescale appear-
ing at leading order on this timescale. This is expected as bacteria have fast translation
processes, such that translation occurs as soon as the gene is transcribed. The transla-
tion is not present for EnvR and the underlying activators which agrees with what we
might expect from biological intuition as these are a homologue gene and secondary TAs






























































































































































































































































































































































































































































































3.6.3 Timescale 3: SoxS and EnvR translation
On this third timescale protein translation occurs at leading order for the rest of the
proteins for which transcription of their corresponding mRNA occurred on timescale 1 in
equations (3.59)-(3.60). We take the following scalings:
Ť = ε−
1
4 T̄ , Řm = ε
− 1





4 S̄m, Ěm = ε
− 1





2 R̄, Ĉ = ε−
1
2 C̄, F̂ = ε−
1
2 F̄ . (3.58)




















































































































































Taking this leading order balance, solving and matching to the long-term dominant
behaviour on the previous timescale gives the following asymptotic approximations
R̄m = T̄ , R̄ =
µρ
2
T̄ 2, Âm = Am0, Â = A0,
C̄m = T̄ , C̄ =
γ
2
T̄ 2, B̂m = Bm0, B̂ = B0,
S̄m = T̄ , Ŝ =
σ
2
T̄ 2 + S0, Ēm = T̄ , Ê =
ξ
2
T̄ 2 + E0,




We plot these asymptotic approximations against the numerical solutions in Figure 3.4.
On this timescale, we see the translation of all mRNAs that were previously transcribed on
the earlier timescales. This makes logical sense as we expect rapid translation in response
































































































































































































































































































































































































































































































3.6.4 Timescale 4: acrAB mRNA transcription
For this timescale, transcription of the efflux pump gene acrAB emerges in equation
(3.64). We take the following scalings:
T̄ = ε−
1
12 T̃ , R̄m = ε
− 1
12 R̃m, C̄m = ε
− 1





12 Ẽm, F̄m = ε
− 1
12 F̃m, R̄ = ε
− 1





6 S̃, Ê = ε−
1
6 Ẽ, F̄ = ε−
1
6 F̃ . (3.63)




































6 S̃ + εÂ)(1 + ε
5



















































































































Solving this leading order system of ODEs and matching to the dominant behaviour
on the previous timescale gives us
R̃m = T̃ , R̃ =
µρ
2
T̃ 2, Âm = Am0, Â = A0,
C̃m = T̃ , C̃ =
γ
2
T̃ 2, B̂m =
σ
6
T̃ 3 +Bm0, B̂ = B0,
S̃m = T̃ , S̃ =
σ
2








We plot these asymptotic approximations against the full solution in Figure 3.5. This
is the first timescale on which the efflux gene acrAB is transcribed. We notice that this





















































































































































































































































































































































































































































3.6.5 Timescale 5: AcrAB translation
We move onto the fifth timescale, here the translation term for AcrAB appears in the
leading order balance in equation (3.68). We take the following scalings based on the
variables on the previous timescale’s long-term behaviour
T̄ = ε−
1
24T ′, R̄m = ε
− 1
24R′m, C̄m = ε
− 1





24E ′m, F̄m = ε
− 1
24F ′m, R̄ = ε
− 1





12S ′, Ê = ε−
1
12E ′, F̄ = ε−
1
12F ′, B̂m = ε
− 1
8B′m. (3.67)

































4 Â+ S ′
(1 + ε
3
4S ′ + εÂ)(1 + ε
3















































= β B′m − ε
9
8 ∆ B̂, (3.68)
dS ′
dT ′



























































= F ′m. (3.69)
Solving this leading order system and matching to the long-term dominant behaviour





T ′2, Âm = Am0, Â = A0,
C ′m = T
′, C ′ =
γ
2
T ′2, B′m =
σ
6




S ′m = T
′, S ′ =
σ
2
T ′2, E ′m = T




F ′m = T




The above asymptotic approximations are plotted against the full solution in Figure
3.6. In this timescale, we have translation of AcrAB at the leading order, we note that
this is being driven here by the secondary TA. We note there is disparity between the
approximations and numerics. We could eliminate this by matching to additional orders
of behaviour on the previous timescale, however for simplicity in solutions for the latter






























































































































































































































































































































































































3.6.6 Timescale 6: mRNA degradation and full protein transla-
tion
For this timescale, mRNA degradation and expression of ramA enters the leading order
balance in all mRNA equations and (3.72). We take the following variable scalings
T ′ = ε−
1




















4R†, C ′ = ε−
1
4C†, S ′ = ε−
1
4S†, E ′ = ε−
1
4E†,
F ′ = ε−
1
4F †, B′m = ε
− 3
8B†m, B̂ = ε
− 1
2B†. (3.71)












































= µρR†m − εµ∆R†,
dÂ
dT †
= θ Âm − ε
1
2υ Â− ε∆Â, (3.72)
dC †
dT †
= γ C†m − ε∆C†,
dB †
dT †
= β B†m − ε∆B†,
dS †
dT †
= σ S†m − ε∆S†,
dE †
dT †


























































= F †m. (3.73)
Solving and matching to the long-term dominant behaviour on the previous timescale
gives the following asymptotic approximations
R†m = 1− e−T
†
, R† = µρ(T † − e−T † − 1), C†m = 1− e−T
†
, C† = γ(T † − e−T † − 1),
B†m =
σT †









, S†m = 1− e−T
†
, S† = σ(T † − e−T † − 1),
E†m = 1− e−T
†
, E† = ξ(T † − e−T † − 1), F †m = 1− e−T
†
, F † = T † − e−T † − 1,
(3.74)
while the behaviour for both ramA mRNA (Âm) and RamA protein (Â) depends on the
relationship between the parameters µ,θ and ρ. If
θ
µρ
6= 1 we have
Âm =









(µρ− θ)(µρT † + 1)
,
Â =


















> 1, detailed below. For the case where
θ
µρ
= 1 we have
Âm = α ln
(
T † + 1
)








T † + 1
)
. (3.76)
Here we have taken the case where θ = 1, µ = 1, ρ = 1 for simplicity of displaying the
solutions.
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We can see that we have three cases of long-term behaviour for both ramA mRNA
(Âm) and RamA protein (Â). We exhibit the relation between this long-term behaviour



















T †, for θ
µρ
< 1,









where here CA is a constant. We note that the parameter θ relates to RamA production,
whilst ρ relates to RamR production. Since RamR is a repressor of ramA expression, we
might expect its rate of production to dominate, thus we note that the case
θ
µρ
< 1 is the
most biologically plausible and use the resulting behaviour to move to the next timescale.
For all future numerical simulations, we set θ = 0.5 to satisfy this inequality.
We plot these asymptotic approximations against the full solution in Figure 3.7. This
is the first timescale where the ramA gene is expressed at leading order, this is due to
there being little RamA protein in the system to activate its own expression. We note we
have transcription of ramA mRNA and translation of RamR coming into this timescale.
In addition to this we have degradation terms for all mRNAs, this is causing the mRNAs
to level off and reach steady state. In addition to this, the local repressor of acrAB (AcrR)
is bound to the operator site of acrAB which is in effect limiting the transcription of this
gene. For acrAB mRNA we have a slight mismatch of the approximation to the solution,
we could prevent this by matching to lower orders of behaviour on the previous timescale
(or reduce the discrepancy with a smaller value of ε). However, we have chosen not to do







































































































































































































































































































































































































































3.6.7 Timescale 7: Degradation of RamA, inhibition of acrAB
and acrEF
For this timescale, we have a change of the terms involved in transcription of acrAB and
acrEF, with new terms emerging at leading order in equations (3.80) and (3.81). We also
have RamA degradation entering the leading order balance in equation (3.82). We take
the following variable scalings:
T † = ε−
1
2T ‡, R† = ε−
1
2R‡, C† = ε−
1





2S‡, E† = ε−
1
2E‡, F † = ε−
1
2F ‡, Â = ε−
1
2A‡. (3.79)








































(1 + S‡ + ε
1



























− F †m, (3.81)
dR‡
dT ‡















































































Solving the leading order balance and matching to the long-term dominant behaviour
on the previous timescale gives the following asymptotic approximations
R†m = 1, R
‡ = µρT ‡, Âm =
αυµρT ‡
υµρT ‡ − θ
, A‡ =
θαµρT ‡
υµρT ‡ − θ
,
C†m = 1, C
‡ = γT ‡, B†m =
σ
γ(σT ‡ + 1)
, S†m = 1,
S‡ = σT ‡, E†m = 1, E
‡ = ξT ‡, F †m =
η





ln(σT ‡ + 1), F ‡ =
ηγ
βωξ
ln(βω ln(ξT ‡ + η) + γ). (3.84)
We plot asymptotic approximations of those variables that evolve on this timescale against
the numerical solutions in Figure 3.8. On this timescale, we have repressor proteins dom-
inating the transcription terms for acrAB and acrEF. With lower levels of transcription,
degradation dominates and the concentrations of the mRNAs lower. We note that in this
wild-type case RamA production occurs late compared to other proteins (starting on the
previous timescale) and is quickly degraded to achieve only low levels in comparison to
other proteins in the system. On this timescale, all other mRNAs have reached steady
state and AcrAB and AcrEF grow logarithmically. With logarithmic behaviour for both
B‡ and F ‡, we must justify the scalings we take to the next timescale. Suppose we scale
68
our variable as T ‡ = ε−αT  then
B‡ ∼ ln(T ‡), (3.85)
∼ ln(ε−αT ),
∼ α ln(1/ε) + ln(T ),
∼ ln(1/ε) + ln(T ).
This means that moving to the next timescale, we should scale B‡ by ln(1/ε). We can
apply a similar process again supposing we scale our variable as T ‡ = ε−αT  then
F ‡ ∼ ln(ln(T ‡)), (3.86)
∼ ln(ln(ε−αT )),
∼ ln(α ln(1/ε) + ln(T )),












∼ ln(ln(1/ε)) + ln(ln(T )).


































































































































































































































































































































































































































3.6.8 Timescale 8: AcrEF degradation
On this timescale, degradation of AcrEF emerges in equation (3.88). We take the following
scalings:
T ‡ = ε−
1










2 ln(1/ε)−1 ln(ln(1/ε))−1E, B†m = ε
1
2 ln(1/ε) ln(ln(1/ε))Bm,
F †m = ε
1
2 ln(1/ε) ln(ln(1/ε))F m, B
‡ = ln(1/ε)B,
F ‡ = ln(ln(1/ε))F . (3.87)
For simplicity in presentation, we choose to express the log functions as φ = ln(1/ε)−1
























































































= σS†m − φδ∆S,
dE 
dT 


















































To be able to match to the logarithmic behaviour on the previous timescale, we
must go to second order for B and F . By taking the expansions B = b0 + φb1... and









−∆f 0 . (3.91)
Solving and matching to the long-term dominant behaviour on the previous timescale
gives the following asymptotic approximations
R†m = 1, R




, C†m = 1, C
 = γT ,
S†m = 1, S
 = σT , E†m = 1,




2φ−1δ−1 + σT )





























ln(φδ) + γ). (3.92)
72
We plot these asymptotic approximations against the full solution in Figure 3.9. We
include the second order terms to show the logarithmic behaviour of AcrAB and AcrEF.
We note there is disparity in fit for the plots of AcrAB and AcrEF, therefore we include
additional plots (Figure 3.9 (o) and (p)) with a smaller value of ε to prove the accuracy






















































































































































































































































































































































































































































































































































































































































3.6.9 Timescale 9: final timescale, protein degradation
We move onto the final timescale, here degradation for all proteins that were not already
at steady state emerge in the leading order balance. We take the following final scalings
based on the variables of the previous timescale’s long-term behaviour
T  = ln(1/ε) ln(ln(1/ε))T+, R = ln(1/ε) ln(ln(1/ε))R+,
C = ln(1/ε) ln(ln(1/ε))C+, S = ln(1/ε) ln(ln(1/ε))S+,
E = ln(1/ε) ln(ln(1/ε))E+, Bm = ln(1/ε)
−1 ln(ln(1/ε))−1B+m,
F m = ln(1/ε)
−1 ln(ln(1/ε))−1F+m . (3.93)
















































































= σ S†m −∆S+,
dE +
dT +








Here, the terms φ = ln(1/ε)−1 and δ = ln(ln(1/ε))−1 have emerged from logarithmic
behaviour on previous timescales. With the value of ε = 0.01, these terms are effectively
O(1), so we include them in the leading order balance. Matching to the long-term domi-








































This system of ODEs can be solved, matching to the long-term dominant behaviour
on the previous timescale gives the following asymptotic approximations







































On this final timescale, we see all proteins reaching a steady state as their degradation
terms appear at leading order. We note that the approximated steady states match closely
to the numerics. Thus we should be able to draw strong conclusions by performing steady
































































































































































































































































































































































































































































































In Figure 3.11 we exhibit the leading order processes in timescale order from our asymp-
totic analysis for the wild-type case. We detail the order of dominant processes shown in
the schematics. As predicted by the analysis:
• Genes that are not highly regulated by proteins are expressed, resulting in their
mRNA transcription and protein translation.
• If produced subject to the relevant stress, SoxS (the secondary TAs) does not signif-
icantly increase acrAB expression but the asymptotic analysis reveals that it may
effect the timescale on which expression of acrAB first occurs.
• When produced, RamR inhibits ramA expression, preventing RamA from achieving
activation of acrAB at leading order. AcrR also lowers (but does not shut off
entirely) transcription of acrAB.
• EnvR binds to the promoter site of acrEF repressing its transcription.
• Degradation of all proteins brings the system to a steady state. The system would
remain at this state with efflux proteins present until the relevant stress is removed
from the cells, at which point the system would revert to a state of basal efflux.
We note that at steady state, the local repressors of the efflux pumps (acrR and envR)
have been expressed to a large enough concentration that they are dominant in the leading
order processes and are the only gene products impacting efflux pump expression. We can
see at this point the system is reduced to four genes affecting efflux pump expression, and
thus at steady state for this case we should focus on these genes as potential inhibition
targets. This concludes the wild-type asymptotic analysis. We have broken down the










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.7 Asymptotic analysis of the mutant dynamics
In this section we take the case where RamR protein is mutated (i.e µ = 0). We remind
ourselves that this mutation results in a strain that displays MDR. Therefore, we expect
the dynamics to be different to the wild-type case. In order to gain further insight into
the behaviour of this strain, we must consequently undertake a new series of asymptotic
analysis. We denote the scalings we must take in order to reach each timescale in Table
3.3.
3.7.1 Timescale 1: mRNA transcription
As with the wild-type case, on this first initial timescale we address the issue of the
systems initial conditions of all variables being O(ε). We must take the following scalings
T = εT̂ , Rm = εR̂m, Am = εÂm, Cm = εĈm, Bm = εB̂m,
Sm = εŜm, Em = εÊm, Fm = εF̂m, R = εR̂, A = εÂ,
C = εĈ, B = εB̂, S = εŜ, E = εÊ, F = εF̂ . (3.97)












































= γ εĈm − ε2∆Ĉ,
dB̂
dT̂
= β εB̂m − ε2∆B̂,
dŜ
dT̂
= ε3/2σ Ŝm − ε2∆Ŝ,
dÊ
dT̂






− ε2∆F̂ . (3.98)
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This system of ODEs can be solved analytically and as there is no previous timescale,
we match these solutions to our initial conditions to give the following asymptotic ap-
proximations
R̂m = T̂ +Rm0, R̂ = R0, Âm = Am0, Â = A0,
Ĉm = T̂ + Cm0, Ĉ = C0, B̂m = Bm0, B̂ = B0,
Ŝm = T̂ + Sm0, Ŝ = S0, Êm = T̂ + Em0, Ê = E0,
F̂m = T̂ + Fm0, F̂ = F0. (3.100)
We plot these asymptotic approximations against the numerical solutions in Figure 3.12.
As expected, we see the transcription of various gene’s mRNA occurring first. The tran-
scription of ramA and acrAB mRNA are currently not active due to there being very
little activator protein bound to their promoter sites to get a high level of transcription.
As there is no translation of RamR protein, we see our asymptotic approximation already
encompasses the full behaviour of this protein. We note that the behaviour of almost
all variables on this timescale are almost identical to the wild-type timescale 1 (Section

































































































































































































































































































































































































































































































































3.7.2 Timescale 2: protein translation
For this timescale, we take the following scalings:
T̂ = ε−
1
2 Ť , R̂m = ε
− 1





2 Šm, Êm = ε
− 1
2 Ěm, F̂m = ε
− 1
2 F̌m. (3.101)
These scalings result in the translation terms for AcrR and AcrEF entering the leading
order balance in equations (3.102)-(3.103). We note that this timescale has the same time




































































































2 ∆F̂ . (3.103)












































Solving this reduced system of ODEs and matching to the long-term dominant be-
haviour on the previous timescale gives the following asymptotic approximations
Řm = Ť , R̂ = R0 Âm = Am0, Â = A0,
Čm = Ť , Ĉ =
γ
2
Ť 2 + C0, B̂m = Bm0, B̂ = B0,
Šm = Ť , Ŝ = S0, Ěm = Ť , Ê = E0,
F̌m = Ť , F̂ =
1
2
Ť 2 + F0. (3.105)
We plot these asymptotic approximations against the numerical solutions in Figure 3.13.
As expected, we see the fast translation of the genes transcribed on the previous timescale.
However, as RamR protein is mutated and is not produced in a form that affects any other
gene in the network, we see no translation from ramR mRNA. The translation is not
present for EnvR and the secondary TAs as these are a homologue gene and underlying

























































































































































































































































































































































































































































































3.7.3 Timescale 3: SoxS and EnvR translation
We move onto the third timescale, we take the following scalings based on the variables
on the previous timescale’s long term behaviour
Ť = ε−
1
4 T̄ , Řm = ε
− 1





4 S̄m, Ěm = ε
− 1





2 C̄, F̂ = ε−
1
2 F̄ . (3.106)
These scalings result in the rest of the translation terms for all mRNAs that are under-
going transcription entering the leading order balance in equations (3.107)-(3.108). We
note that this timescale coincides with timescale 3 on the wild-type asymptotic analysis.


















































































































































We solve the leading order system of ODEs and match to the long term dominant
behaviour on the previous timescale, giving us the following asymptotic approximations
R̄m = T̄ , R̂ = R0, Âm = Am0, Â = A0,
C̄m = T̄ , C̄ =
γ
2
T̄ 2, B̂m = Bm0, B̂ = B0,
S̄m = T̄ , Ŝ =
σ
2
T̄ 2 + S0, Ēm = T̄ , Ê =
ξ
2
T̄ 2 + E0,




We plot these asymptotic approximations against the numerical solutions in Figure
3.14. Following from the previous timescale, here we introduce the fast translation of the




























































































































































































































































































































































































































































































3.7.4 Timescale 4: acrAB mRNA transcription
For this timescale, we have transcription of acrAB mRNA entering the leading order
balance in equation (3.112). We take the following scalings:
T̄ = ε−
1
12 T̃ , R̄m = ε
− 1
12 R̃m, C̄m = ε
− 1





12 Ẽm, F̄m = ε
− 1
12 F̃m, C̄ = ε
− 1





6 Ẽ, F̄ = ε−
1
6 F̃ . (3.111)
This timescale occurs at the same time as timescale 4 on the wild-type analysis. After




































6 S̃ + εÂ)(1 + ε
5

















































































































Taking this leading order balance, solving and matching to the long-term dominant
behaviour on the previous timescale gives the following asymptotic approximations
R̃m = T̃ , R̂ = R0, Âm = Am0, Â = A0,
C̃m = T̃ , C̃ =
γ
2
T̃ 2, B̂m =
σ
6
T̃ 3 +Bm0, B̂ = B0,
S̃m = T̃ , S̃ =
σ
2








We plot these asymptotic approximations against the full solution in Figure 3.15. This
is the first timescale where our efflux gene acrAB is transcribed. We notice that this is

































































































































































































































































































































































































































































3.7.5 Timescale 5: AcrAB translation
For this timescale, we take the following scalings based on the variables on the previous
timescale’s long term behaviour
T̄ = ε−
1
24T ′, R̄m = ε
− 1
24R′m, C̄m = ε
− 1





24E ′m, F̄m = ε
− 1
24F ′m, C̄ = ε
− 1





12E ′, F̄ = ε−
1
12F ′, B̂m = ε
− 1
8B′m (3.115)
These scaling result in AcrAB translation terms entering the leading order balance in
equation (3.116). We note that this timescale matches the same time scaling as timescale


































4 Â+ S ′
(1 + ε
3
4S ′ + εÂ)(1 + ε
3













































= β B′m − ε
9
8 ∆ B̂, (3.116)
dS ′
dT ′



























































= F ′m. (3.117)
This system of ODEs can be solved, matching to the long term dominant behaviour
on the previous timescale gives the following asymptotic approximations
R′m = T
′, R̂ = R0, Âm = Am0, Â = A0,
C ′m = T
′, C ′ =
γ
2
T ′2, B′m =
σ
6




S ′m = T
′, S ′ =
σ
2
T ′2, E ′m = T




F ′m = T




We plot these asymptotic approximations against the full solution in Figure 3.16. In
this timescale, we have translation of AcrAB, we note that this is still being driven by
the underlying regulators Rob, SoxS and MarA. We note that this is the last timescale
that displays almost identical behaviour (apart from RamR protein) to the respective










































































































































































































































































































































































































3.7.6 Timescale 6: mRNA degradation and full protein transla-
tion
We move onto the sixth timescale, here mRNA degradation and expression of ramA appear
at leading order in all mRNA equations and (3.120). We take the following variable
scalings
T ′ = ε−
1




















4C†, S ′ = ε−
1
4S†, E ′ = ε−
1





8B†m, B̂ = ε
− 1
2B†. (3.119)
This is the last timescale that matches on time scalings compared to the corresponding
number timescale on the wild-type analysis. Using these scalings, our system of equations
















































= θ Âm − ε
1
2υ Â− ε∆Â, (3.120)
dC †
dT †
= γ C†m − ε∆C†,
dB †
dT †
= β B†m − ε∆B†,
dS †
dT †
= σ S†m − ε∆S†,
dE †
dT †























































= F †m. (3.121)
Solving and matching to the long term dominant behaviour on the previous timescale
gives the following asymptotic approximations
R†m = 1− e−T
†
, R̂ = R0, C
†
m = 1− e−T
†
, C† = γ(T † − e−T † − 1),
B†m =
σT †









, S†m = 1− e−T
†
, S† = σ(T † − e−T † − 1),
E†m = 1− e−T
†
, E† = ξ(T † − e−T † − 1), F †m = 1− e−T
†
, F † = T † − e−T † − 1,
Âm =
(√
1 + 4 θα +
√
























1 + 4 θ
. (3.122)
We plot asymptotic approximations of those variables that evolve on this timescale against
the numerical solutions in Figure 3.17. In this timescale, we have most of the mRNAs’
asymptotic approximations reaching near steady state as their degradation takes effect.
The only mRNA not reaching steady state is ramA mRNA, which is exhibiting exponential
growth. There is the same exponential growth for RamA protein, both of these growth
behaviours are caused by the positive feedback loop with the ramA gene upon itself. In
contrast to the wild-type system, without any presence of RamR protein to repress this

































































































































































































































































































































































































































3.7.7 Timescale 7: activation of acrAB by RamA





resulting from the logarithmic and exponential behaviour on the previous timescale re-
spectively. Activation of acrAB mRNA transcription via RamA protein now appears in




ln(1/ε) + T ‡, Âm = ε
− 1
2A‡m, Â = ε
− 1
2A‡, C† = ln(1/ε)C‡,
B† = ln(1/ε)B‡, S† = ln(1/ε)S‡, E† = ln(1/ε)E‡, F † = ln(1/ε)F ‡. (3.123)
This timescale takes place between timescale 6 and timescale 7 (Sections 3.6.6-3.6.7)
























































= θ A‡m − ε
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= φF †m. (3.125)
We solve the leading order system of ODEs and match to the long term dominant
behaviour on the previous timescale, giving us the following asymptotic approximations
R†m = 1− e−T
‡
, R̂ = R0, C
†








θT ‡ + φ−1σT ‡
φ−1γT ‡ + 1





T ‡ − e−T ‡ − 1
)
, E†m = 1− e−T
‡





T ‡ − e−T ‡ − 1
)

















































− β φσ ln (Tγ φ θ + φ θ)
γ2
. (3.126)
Notably here we have the function Ei that represents the exponential integral func-
tion. In order to move to the next timescale we must determine the long term dominant
behaviour in terms of elementary functions by taking their series expansions at infinity.












We plot asymptotic approximations of those variables that evolve on this timescale
against the numerical solutions in Figure 3.18. In this timescale we still have exponential
100
growth of ramA mRNA and RamA protein caused by the positive feedback of the ramA
gene. This growth has resulted in activation of acrAB mRNA which now exhibits long
term exponential growth. This is being translated to AcrAB protein which now also ex-
hibits long term exponential growth. This behaviour varies from the wild-type analysis,
where there is no direct activation of acrAB mRNA from RamA on any timescale. Com-












































































































































































































































































































































































































3.7.8 Timescale 8: ramA mRNA reaching steady state
For this timescale, the limitation of ramA activating its own expression enters the leading
order balance in equation (3.129). We take the following scalings based on the variables













‡ = ln(1/ε)C, S‡ = ln(1/ε)S,
B‡ = ε−
1
2 ln(1/ε)−1B E‡ = ln(1/ε)E, F ‡ = ln(1/ε)F . (3.128)
Comparatively, this timescale takes place between timescale 6 and timescale 7 (Sec-
tions 3.6.6-3.6.7) of the wild-type asymptotic analysis. The system of equations rescaled
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= γ C†m − εφ−2∆C,
dB
dT 








































































Taking this leading order balance, solving and matching to the long-term dominant
behaviour on the previous timescale gives the following asymptotic approximations
R†m = 1− e−T

, R̂ = R0, C
†
m = 1− e−T

C =
φ2γ λ ln (θ T  + λ)
θ
, F †m = 1− e−T






T  − e−T  − 1
)
, E†m = 1− e−T

, E = φ2ξ
(
































































ln2(θT  + λ) +
1
λ
ln(θT  + λ)
)
. (3.131)
Notably here we have the functions W that represents the Lambert W function. In
order to move to the next timescale we must determine the long term dominant behaviour
in terms of elementary functions by taking their series expansions at infinity. For the
Lambert W function as z →∞ we have [19]
W(z) = ln(z) +O(ln(ln(z))). (3.132)
We plot asymptotic approximations of those variables that evolve on this timescale
against the numerical solutions in Figure 3.19. In this timescale the ramA gene’s positive
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feedback has been limited, causing at long term the gene’s mRNA to approach steady state
and the gene’s protein to have linear growth. This change of behaviour of RamA from
exponential growth causes acrAB mRNA and protein to no longer display exponential
behaviour. Notably this behaviour is not present in the wild-type analysis as the ramA
gene positive feedback loop is not present at leading order on any timescale. We note
that we have disparity of fit for both acrAB mRNA and protein. Therefore, we include
additional plots (Figure 3.19 (o) and (p)) with a smaller value of ε (ε = 0.0001) to prove
the accuracy of the asymptotic approximations. Disparities in other simulations could




























































































































































































































































































































































































































































































3.7.9 Timescale 9: degradation of RamA protein
We move onto the ninth timescale, here degradation of RamA protein caused by Lon
Protease enters the leading order balance as well as EnvR repression of acrEF in equations
(3.134)-(3.135). We take the following scalings based on the variables on the previous
timescale’s long term behaviour
T  = ε−
1
2T+, A = ε−
1













 = ln(1/ε)C+, F  = ln(1/ε)2F+. (3.133)
In relation to the wild-type asymptotic analysis, this timescale transpires between
timescale 8 and timescale 9 (Sections 3.6.8-3.6.9) . The system of equations rescaled for
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Solving and matching to the long term dominant behaviour on the previous timescale















φ2(1 + ξT+ + γλυ
θ
T+)
, E†m = 1, E





β φ2θ ln ((φ3γ λ υ + φ3θ ξ)T+ + φ3θ)




ln(φ3 ln(T+ + 1)).
(3.137)
We plot asymptotic approximations of those variables that evolve on this timescale against
the numerical solutions in Figure 3.20. In this timescale we have RamA protein reach-
ing steady state from degradation via Lon Protease. With this, we have acrR mRNA
also reaching steady state. With less RamA protein due to degradation, the repressors
dominate expression of acrAB, causing its inhibition. We also have EnvR protein causing
inhibition of acrEF mRNA. This inhibition of mRNAs causes logarithmic behaviour for
both AcrAB and AcrEF. Comparatively to the wild-type analysis, for both strains we
see the emergence of repressor proteins on the latter timescales. Interestingly though





























































































































































































































































































































































































































3.7.10 Timescale 10: full protein degradation, with all proteins
reaching steady state
For this timescale, we use δ = ln(ln(1/ε))−1, emerging from the logarithmic behaviour on
the previous timescale. On this timescale protein degradation emerges for the rest of our
proteins. We take the following variable scalings:
T+ = ε−
1
2 T̆ , C+ = ε−
1












B+ = ln(1/ε)B̆, F+ = ln(ln(1/ε))F̆ . (3.138)
Comparatively, this timescale takes place after timescale 9 (Section 3.6.9) of the wild-
























































































= γ C+m − φ−3∆C̆,
dB̆
dT̆






























































This system of ODEs can be solved, matching to the long term dominant behaviour
on the previous timescale gives the following asymptotic approximations.






, C̆ = φ3
γλυ
∆θ


















(1− e−∆T̆ ), Ĕ = φ2 ξ
∆







φ4δη (γ λ υ + θξ)
ξωβθ
(1− e−∆T̆ ). (3.141)
We plot asymptotic approximations of those variables that evolve on this timescale against
the numerical solutions in Figure 3.21. In this timescale we have all variables reaching
steady state. We note that compared to the wild-type analysis, the steady state values
for RamA and AcrAB are much larger in the mutant strain. Due to disparity in the
asymptotic approximations of some variables, we have included the second order terms in
the asymptotic approximations (we could instead use a smaller value for ε) obtained via












































































































































































































































































































































































































































In Figure 3.22 we exhibit the leading order processes in timescale order from our asymp-
totic analysis for the mutant case. We note that the schematics are not on identical
timescales to the wild-type case as the scalings to reach each of the timescales are dif-
ferent. Here we detail the differences in the order of dominant processes shown in the
schematics compared to the wild-type case. As predicted by the analysis:
• In this case, functional RamR is not produced. This allows the positive feedback
loop on ramA expression to dominate at leading order, resulting in high production
of RamA and activation of acrAB expression.
• Any activation by secondary TAs (that may occur under the appropriate stress) is
overshadowed by RamA and relegated to lower order behaviour. RamA also lowers
AcrR levels, yielding higher expression of acrAB in the analysis.
• RamA is regulated by degradation through the Lon protease, allowing AcrR and
EnvR to dominate acrAB expression.
• Degradation of all proteins brings the system to a steady state.
At steady state, as expected this mutant strain also has RamA dominating the be-
haviour (in addition to those considered in the wild type strain). The analysis therefore
identifies ramA, acrR, envR, acrAB and acrEF as the most likely potential targets for
efflux pump inhibition. In regards to the other timescales, this breakdown highlights the
importance of the positive feedback loop of ramA. With the release of ramA expression
in this mutant case, various different interactions between genes and proteins become
dominant. In particular, we see direct and indirect activation of acrAB, with the latter
as a result of its local repressor, acrR, itself being inhibited (by RamA). It is interesting
to note that the direct activation from RamA only dominates at leading order prior to
steady state and without undergoing our time-dependent analysis we may have not iden-
tified this key mechanism in the activation of the efflux pump genes under this parameter
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set. Reducing the activation from RamA may be enough to minimise early expression of
acrAB, enabling the antibiotic to kill bacteria before its efflux pumps are overexpressed.
For example, an efflux inhibiting adjuvant targeting RamA may be more successful if ad-
ministered with or before antibiotic. It is also important to note that in the wild-type case
we see no leading order activation processes caused by RamA (though this will be present
at lower orders). Thus whilst choosing ramA as an inhibition target seems plausible, this
may only revert the GRN to the wild-type case rather than knocking out efflux expres-
sion entirely. This concludes the mutant asymptotic analysis. We have broken down the














































































































































































































































































































































































































































































































































































































3.8 Steady State Analysis
Upon reaching the final timescale, all of our variables attain a steady state. For the full
nondimensionalised model it is not possible to derive a set of analytically solvable steady
states. However, in both wild-type and mutant cases we can achieve analytical expressions
for the asymptotic approximation of the steady states. We know from our GRN that
reducing the concentration of the main efflux pump protein AcrAB results in increased
concentration of the homologue efflux pump protein AcrEF. Thus we must consider both
efflux pump protein concentrations simultaneously. We perform a sensitivity analysis
of the sum of the asymptotic approximations of the steady states of AcrAB (including
second order terms) and AcrEF, the proteins that form the efflux pump complexes (i.e.
this reflects the total efflux “power” of the bacteria). By conducting this analysis we hope
to identify potential targets for efflux inhibition. Here, we use relative sensitivity in order
to draw comparisons on how much individually changing a parameter affects the overall
efflux. We define our equation for the relative sensitivity as
ς =
d(B̄ + F̄ )
dP
, (3.142)
where d(B̄ + F̄ ) represents the change of the efflux pump genes steady state and dP
represents the change of the nondimensional parameter being varied.
To conduct our sensitivity analysis, we vary all our nondimensional parameters in a
bounded parameter space. For both wild-type and mutant strains, the space is bounded




5 to maintain consistency with the parameter sizes used in the
asymptotic analysis. By using a Latin hypercube method of sampling, we choose 10000
points in the parameter space for each parameter and find the relative sensitivity for each
point. The resulting relative sensitivities are then plotted on box plots in order for us to













Figure 3.23: Box plots showing the relative sensitivity of nondimensional parameters on
the combined asymptotic approximated steady states of AcrAB and AcrEF. In (a) we
denote the sensitivity in the wild-type case whereas in (b) we denote the mutant case.
For (b), mutations to RamR protein results in more parameters involved in our steady
state approximation.
We can see from the wild-type case (a), that the parameter to which efflux is most
sensitive is η, here all points correspond to the same value as this grouping only affects
AcrEF and does so linearly. Our next most sensitive parameter is ξ, which also has the
largest spread of sensitivity of all parameters in this case. We note that our most sensitive
parameter groupings η and ξ relate to the binding coefficients of EnvR to the two efflux
pump genes, and the expression of envR respectively. Since both of these parameters
involve envR mRNA or protein, the analysis suggests that this gene could be a possible
target for inhibition of efflux in this case. Our next most sensitive parameter is ω relating
to the link between the concentration of AcrAB and activation/repression of acrEF the
homologue efflux pump gene. Unfortunately as we do not know the full mechanisms
involved causing this link, this does not provide a realistic target for inhibition. However,
this does lead us to believe that with more biological knowledge of this link there could
be a potential inhibition target worth pursuing. Finally with similar sensitivities are
117
γ (acrR expression) and β (acrAB expression). Since the former of these parameters
has a relatively low sensitivity compared to other parameters, the analysis predicts that
this may not be a target worth pursuing. The latter is an expected target, relating to
direct expression of one of the efflux pump genes. It is interesting to note that some
parameters in the system (that do not affect the efflux pump genes directly) provide a
greater sensitivity than β, that is directly related to AcrAB concentration.
In the mutant case (b), it comes to note that we have double the amount of parameters
that affect the efflux pump steady states compared to the wild-type case. This is partially
due to including second order terms, however it is only the parameters ∆ and σ that do
not appear at leading order. With only one change in the GRN (to RamR protein),
the change in the amount of parameters demonstrates the unpredictability and sensitive
nature of this network. We note that here, the parameter to which the steady state of
efflux proteins is most sensitive is ξ (envR expression). Additionally we also see high
sensitivity to the parameter η (EnvR binding affinity). This similarity with the wild-
type system further highlights the case for targeting the gene envR for inhibiting efflux.
Our next most sensitive parameter is β (acrAB expression) which differs from the wild-
type case where it was one of the least sensitive parameters. This could be due to the
overexpression of acrAB in this mutant case. The parameters λ (RamA binding affinity),
θ (ramA expression), υ (RamA degradation from Lon Protease), γ (acrR expression) and
ω (AcrAB and acrEF link) all show a degree of sensitivity, meaning that any of these
parameters could prove to be a realistic target to inhibit efflux. However it is interesting
to note that parameters associated with ramA, which is over expressed in this mutant
case, is not the most sensitive target for inhibiting efflux. The rest of the parameters
∆ (degradation of mRNA and proteins) and σ (soxS mRNA expression) have a low
sensitivity in this case, which we should expect as these parameters are only prevalent
in the second order terms. Thus the analysis suggests that these parameters may not be
realistic targets for inhibiting efflux.
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3.9 Discussion
Antimicrobial resistance is a topic with ever increasing importance. With the threat to
human health worsening as more bacteria evolve resistance to antibiotics, it is clear we
must urgently seek novel treatment methods in order to combat antibiotic resistance.
By delving into GRNs governing resistance mechanisms, it is possible to identify certain
targets to potentially prevent resistance in bacteria. We believe that our asymptotic
analysis has given us useful insights into the network governing efflux pump expression.
We first nondimensionalised our model, resulting in nondimensional parameter group-
ings. By using information from the biology of the network and consultations with the
Piddock Laboratory (University Of Birmingham), we were able to estimate sizes for these
parameter groupings and focus on relative parameter sizes rather than absolute parame-
ter values. We performed two independent series of time dependent asymptotic analyses,
modelling the dynamics of the wild-type and mutant strains. This enabled us to break
down our nondimensional model (which does not have a full set of analytical solutions)
onto various timescales, exhibiting the order of dominant processes within the network. In
both cases on the early timescales, genes that are not highly regulated are transcribed and
quickly translated. On the middle timescales we see translated proteins inhibiting and
activating expression of other genes within the network. Finally on the later timescales
we have degradation of proteins bringing the system to a steady state. We noted that
for the mutant strain, as non-functional RamR is produced, the expression of ramA and
resulting reactions feature heavily in the dominant processes within the network. This
ultimately results in a steady state where more genes are active at leading order than
the wild-type case. Notably RamA only directly affected acrAB expression on the middle
timescales, whereas on the later timescales acrAB expression was affected indirectly. This
leads us to believe that if we were to choose ramA as an inhibition target, the timing of
an adjuvant in relation to antibiotic administration could be crucial.
After achieving asymptotically approximated steady states for the system in both
strains. We have performed parameter sensitivity analysis upon the steady state values.
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This enabled us to determine which parameter groupings the strains are most sensitive
to for inhibiting efflux. We saw that amongst both strains, the most sensitive parameters
were linked to the gene envR. This closely aligned with the biology of the network as
the gene’s protein is capable of directly inhibiting both acrAB and acrEF expression.
Many other parameter groupings displayed reasonable sensitivity and hence showed us
multiple inhibitory targets. It was interesting to note the sensitivity of the link between
the concentration of AcrAB and the activation / repression of acrEF. Although we do
not know the full biology behind this mechanism, this sensitivity gives us strong reason
to further delve into the processes causing this link.
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CHAPTER 4
A SPATIAL MODEL OF SUBSTRATE EFFLUX
4.1 Motivation
The Resistance-Nodulation-Division (RND) family of transporters are common to extrude
a range of antibiotics and can account for multi drug resistance (MDR) [69]. From genomic
analysis, it has been shown that Salmonella strains contain five RND efflux pump systems.
Various antibiotics have been shown to be substrates of multiple of these efflux pump
systems [61]. Thus inhibition of one of the efflux pump systems could mean that substrate
extrusion will be picked up by another efflux pump system.
In the previous chapters we have modelled and analysed the GRN governing expression
of two members of the RND family of transporters. This model has given us useful insights
into potential inhibitory targets for the aforementioned efflux pumps. However, our model
does not consider the link between efflux pump gene expression and the resulting effects
on substrate concentration. In this chapter we will consider a cellular model of substrate
efflux governed by multiple members of the RND family, with the aim of linking this model
to our gene regulatory model in further chapters. We will attempt to parametrise this
model in order for us to replicate the experimental data. By successfully parametrising our
model, we will then be able to conduct analysis into the role of efflux upon the bacterial
cell and its environment.
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4.2 Experimental Protocol
We base our mathematical model upon experiments completed by the Blair laboratory,
based at the University of Birmingham [56]. Cultures of Salmonella are adjusted to an
optical density (measured at a wavelength of 600nm, OD600) of the value 0.2 and are
placed into standard 96 well plates. Salmonella are rod shaped bacteria and generally
range between 2-5µm long and 0.5-1.5µm wide [4]. Individual cultures are loaded with
high concentrations of ethidium bromide (a substrate of multiple RND efflux pumps).
At this stage, an efflux inhibitor is present which prevents proton motive force of the
RND efflux pumps, resulting in substrate accumulation. Ethidium bromide is a DNA-
intercalating agent that fluoresces when it is bound to DNA [28]. Due to this fluorescing,
the concentration of ethidium bromide within a culture can be approximated. Once the
cells are washed to remove extracellular substrate the fluorescence is measured. The
cells are then re energized so that the efflux pumps begin to extrude the substrate. The
fluorescence is then monitored and measured over various time points [11]. Experiments
have taken place on various different cultures of Salmonella, including a wild-type case
and various cases with efflux gene knock outs. By comparing multiple experiments, we
are able to see the effects of the efflux pump systems. For these experiments four RND
efflux pumps have been considered: AcrAB, AcrEF, MdsAB and MdtAB. All of these
efflux pump proteins share the same outer membrane protein TolC, with MdtAB having
the ability to also form a system with the outer membrane protein MdtC [61].
4.3 Cell model formulation
We choose to model these experiments using partial differential equations (PDEs). Whilst
currently the spatial effects may not have a huge bearing on the results, by choosing PDEs
it gives us the potential to apply the model to situations where spatial effects could be more
important, such as in vivo experiments. To formulate our model, we assume that each
cell in a population acts identically. We also assume that the concentration of ethidium
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bromide is evenly distributed in the population such that every cell has an identical initial
concentration of ethidium bromide. We assume this distributed concentration of ethidium
bromide is independent to each cell, meaning that if the substrate has been expelled into
the extracellular space, it can only diffuse back into the original cell. Since we do not
know the correlation between fluorescence of ethidium bromide and the concentration of
ethidium bromide within the culture, we assume a directly proportional relation between
the two. By making these assumptions, we are able to model the full culture population
via a single cell model where that cell displays the typical behaviour of all cells in the
population. We exhibit a schematic of our single cell model in Figure 4.1. To model the
cell, we follow a similar method to Carr and Pontrelli [15]. We use spherical coordinates to
model an axisymmetric spherical cell with radius RM surrounded by extracellular (outside
of a cell) space with an outer boundary of radius RB. At the cell radius (RM), we have
a thin permeable membrane which contains all of the efflux pump systems that expel
substrate from the intracellular (inside of a cell) space to the extracellular space. This
limit to the amount of extracellular space is represented by the outer boundary radius



























Here we have split the ethidium bromide into two concentrations for intracellular (cI) and
extracellular (cE) concentration under the assumption that the ethidium bromide diffuses
at a different rate within the intracellular space (with coefficient DI) to the extracellular
space (with coefficient DE) [20].
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Figure 4.1: A schematic of the single cell efflux model. The solid circle denotes our
membrane boundary at the distance from the centre RM , whilst the dotted line denotes
our outer boundary at distance RB. We place our model equations in the intracellular
and extracellular regions where they apply.
4.3.1 Boundary Conditions







Here we assume axisymmetric properties of the cell for the intracellular concentration.
Our secondary boundary condition is at the membrane RM , which we demonstrate in
Figure 4.2. We choose to model our membrane with small but finite thickness δ, with the
fictitious points R−M and R
+
M being the intracellular and extracellular membrane points
respectively. We can see that we have both diffusion and efflux through the membrane
and thus the total flux through the membrane will be a combination of both diffusive
flux and advective flux (via efflux). Via Fick’s law [33], we can calculate the diffusive flux
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through the membrane:
JD = −DM∇c(RM , T ), (4.3)
= −DM
c(R+M , T )− c(R
−










(cI(RM , T )− cE(RM , T )).
Here DM denotes the diffusion coefficient inside the membrane. In regards to the advective
flux, this is proportional to the concentration times the volume flow from efflux X [46]
JA = X c(R
−
M , T ), (4.4)
= X cI(RM , T ).
Therefore the total flux through the membrane is
J = JD + JA, (4.5)




is a mass transfer coefficient related to the permeability of the mem-
brane. Finally, we require continuity of flux at the membrane and therefore the boundary











= (P +X) cI(RM , t)− P cE(RM , t). (4.6)
In summation, this condition encompasses flux continuity between the intracellular and
extracellular space, with interface conditions that characterise the properties of the mem-
brane which we assume are constant for the full duration of our simulations [21]. If we set
X = 0 such that there is no efflux, we can see that as P → 0 this condition becomes a no
flux boundary condition (which is expected with no membrane permeability), in contrast
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as P →∞ we approach cI(RM , t) = cE(RM , t) which models the case with no membrane.
In addition to the above boundary conditions, we have the outer boundary condition (at
r = RB). There are two methods by which we choose to model this:
1. We assume that the culture is surrounded by enough extracellular space that the
substrate dissipates. Here we set the outer boundary to be at the far field where
the concentration is always zero,
cE(RB, t)→ 0 as RB →∞. (4.7)
2. We assume that the extracellular space is limited, such that substrate expelled out
of the cell will always be within range to diffuse back in. Here we set the outer







Whilst we expect the extracellular space to be limited meaning our secondary boundary
condition would be more relevant to the experiments, we do not know the extent of
the extracellular space in comparison to the individual cell and thus our first boundary
condition would provide a simpler model for numerical simulations in the case of a large
extracellular space [31].
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Figure 4.2: A schematic showing the processes involved at the membrane RM with small
finite thickness δ. We show fictitious points R−M and R
+
M that are part of the intracellular
and extracellular space respectively. We show the process of efflux of substrate from the
intracellular space direct to the extracellular space through the RND efflux pumps. In
addition we exhibit diffusion of substrate in both directions through each membrane from
the intracellular and extracellular spaces into the periplasm.
4.3.2 Initial Conditions
As the cultures are washed to remove extracellular substrate before the initial fluorescence
is measured, we assume that there is no substrate in the extracellular space initially. In
regards to the intracellular space, we assume that all substrate fluoresces. The initial
conditions for the model are therefore
cI(r, 0) = C0 cE(r, 0) = 0, (4.9)
where here C0 denotes a constant for the initial intracellular concentration of substrate.
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4.3.3 Model Solution
We adopt the method of separation of variables to obtain a solution to this PDE model,
adopting an approach that has been used to solve similar spherical models [43]. By







































= −λ2i , (4.12)















, GE(t) = e
−DEλ2Et. (4.14)




λI , the boundary conditions (4.2)-(4.8)
(using the no flux outer boundary condition) become:
F ′I(0) = 0, (4.15)
−DIF ′I(RM) = (P +X)FI(RM)− P FE(RM), (4.16)
−DEF ′E(RM) = (P +X)FI(RM)− P FE(RM), (4.17)
F ′E(RB) = 0. (4.18)
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The remaining boundary conditions (4.16)-(4.18) leave us with a system of equations with
unknown constants k2, k3, k4. To find a non trivial solution of this system of equations we
require the determinant of a coefficient matrix of system to be non zero. We can use this
condition to determine an infinite set of eigenvalues λI,n (n = 1, 2, ...) with the following




















GI,n(t) = GE,n(t) = e
−DIλ2I,nt. (4.22)






Here i = I, E and the constants ai,n are Fourier coefficients that are determined by the
initial conditions (4.9). Notably this solution is only valid if the parameters P and X
are constant. In Section 5, we introduce variable efflux X and thus this general solution
will not be valid for the models presented in the section. Furthermore, to solve the
determinant matrix to find the unknown coefficients and eigenvalues we must employ the
use of numerical methods. In this thesis we have instead opted to use finite difference
numerical methods to produce numerical simulations of the model, which can be utilised
on both models in this section as well as Section 5.
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4.4 Numerical Method
In order to produce numerical simulations of the model, we use a combination of finite
difference methods [49, 92]. We discretise both time and space into a finite grid with
spacing ∆t and ∆r respectively, resulting in the coordinates ri = i∆r and tn = n∆t
for i = 0, 1, ..., R (where R =
RB
∆r
) and for n = 0, 1, ..., T . We then use forwards time




























Here cnI,i and c
n
E,i denote the intracellular and extracellular concentrations respectively.






























































These discretisations will apply to all spatial points not at the boundaries, which
we must incorporate using different approximations. For the point r0 = 0, we need to
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We now discretise the no flux boundary condition using central difference, involving a




achieving cnI,−1 = c
n
I,1. We can then substitute this into (4.29) to achieve the discretisation
for this boundary point





For our outer boundary condition (the coordinate rR = RB) we have two possibilities of
boundary condition, a far field boundary condition and a no flux boundary condition.
The far field condition is simply a perfect sink condition
cnE,R = 0. (4.32)
For the no flux boundary condition, we follow a similar method to the boundary at r0,




obtaining cnE,R+1 = c
n
E,R−1, which substituting into (4.26) simplifies to






Finally we have our membrane boundary condition which we define to be at the point








= (P +X)cnI,M − PcnE,M . (4.35)
By solving this condition as a system of simultaneous equations, we are able to find
equations for the ghost points of each of the concentrations cnI,M+1 and c
n
E,M−1. These are























= −λEcnE,M + ηEcnI,M + cnE,M+1, (4.37)















Now that we have these equations, we can apply them to our finite difference method by
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substituting into equations (4.26)













cnI,M + 2 θI c
n
I,M−1,
















Thus by collating our approximations our full finite difference method to approximate
our model is represented in equation (4.41). We implement this method in MATLAB
to produce various different simulations of our model. Unless otherwise stated we set
our spatial step ∆r = 0.1µm, with membrane at radius 2µm. Furthermore in order to
maintain stability of our finite difference method we set ∆t =
∆r2
4DMAX
, where DMAX =
max(DI , DE) [78]. The model has also been tested at different resolutions using smaller
values for ∆r, the size of ∆r here provides a sufficient degree of accuracy whilst not taking









































































































































































































As we are modelling the Salmonella cells as spheres rather than rods, we choose a cell
radius (2µm) that yields a similar spherical volume and surface area to the maximum
cylindrical volume and surface area of Salmonella’s typical rod shaped dimensions.
We exhibit simulations of the single cell model with a zero far field outer boundary in
Figure 4.3. Here we have set the far field boundary (at 10µm) to be far enough from the
membrane (at 2µm). We also set the initial intracellular concentration to be 1 mol/µm3.
For simplicity, we have set the diffusivity coefficients of the intracellular and extracellular
substrate to be identical (0.1µm2s−1).
In Figure 4.3 (a), we can see the results of an impermeable membrane with no efflux.
We see no transfer of substrate from the intracellular space, with a uniform distribu-
tion throughout for all time. In (b), we see the introduction of a permeable membrane.
Here we can immediately see that substrate is able to diffuse across the membrane. This
results in a decrease in the intracellular concentration. The rate of expulsion from the
intracellular space slows as time gets larger, as the membrane surrounding extracellular
concentrations become similar to the intracellular concentration. In (c), we see an im-
permeable membrane with active efflux pumps. Whilst being similar to the simulations
in (b), we note that substrate is not free to diffuse back into the intracellular space once
being expelled. This results in almost all substrate being expelled from the intracellular
space, even with higher extracellular concentrations surrounding the membrane. In (d)
we exhibit a permeable membrane with active efflux pumps. In this simulation, we see
a combination of the characteristics of simulations (b) and (c). Whilst the efflux pumps
expel a large concentration of substrate, some substrate is able to diffuse back into the
intracellular space through the permeable membrane. We note that in the latter sim-
ulations (b), (c) and (d) the extracellular concentration dissipates due to the zero far
field boundary condition. Thus the system will only reach steady state once there is zero
concentration in all regions.
We exhibit simulations of the single cell model with a no flux outer boundary in
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Figure 4.4. Here we have set the outer boundary (at 4µm) to be close to the membrane
(at 2µm). We note that the simulations in each case are similar to those in Figure 4.3.
We see however with the introduction of a no flux boundary, the simulations approach
steady state as time grows. In Figure 4.4 (b) the substrate is free to diffuse across the
membrane. However as the extracellular space is limited and is not depleting, we see
the intracellular and extracellular concentrations approaching steady state at the same
concentration. In (c) we see the impermeable membrane with active efflux; here the
extracellular concentration approaches a steady state but is unable to diffuse back into
the cell. Thus we see the intracellular concentration being completely expelled via the
cell’s efflux pumps. Finally in (d) we see the mixture of diffusion and expulsion via efflux
pumps, with a steady state being approached for both intracellular and extracellular
concentrations. However, we note that the intracellular concentration steady state is
higher than the intracellular concentration in (c), due to the membrane permeability
enabling substrate to diffuse back in from the extracellular to the intracellular space.
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Figure 4.3: Simulations of the cell model with a zero far field outer boundary condition,
with RM = 2µm and RB = 10µm. We exhibit the distribution profiles on the left,
with resulting averaged intracellular concentrations on the right. In simulation (a) P =
0µm,X = 0µm, (b) P = 0.1µm,X = 0µm, (c) P = 0µm,X = 0.1µm and (d) P =
0.1µm,X = 0.1µm. 137
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Figure 4.4: Simulations of the cell model with a no flux outer boundary condition with
RM = 2µm and RB = 4µm. We exhibit the distribution profiles on the left, with resulting
averaged intracellular concentrations on the right. In simulation (a) P = 0µm,X = 0µm,
(b) P = 0.1µm,X = 0µm, (c) P = 0µm,X = 0.1µm and (d) P = 0.1µm,X = 0.1µm.
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4.5 Parametrisation Data
Experiments have taken place on various different cultures of Salmonella, with various
efflux pump knockouts as described in Section 4.2. We detail the strains used in the
experiments as:
• Wild-type strain; in this strain we have all four efflux pump systems active.
• AcrAB knockout strain (A Knockout); in this strain we have only AcrEF, MdsAB
and MdtAB active.
• AcrEF knockout strain (E Knockout); in this strain we have only AcrAB, MdsAB
and MdtAB active.
• MdsAB knockout strain (S Knockout); in this strain we have only AcrAB, AcrEF
and MdtAB active.
• MdtAB knockout strain (T Knockout); in this strain we have only AcrAB, AcrEF
and MdsAB active.
• AcrAB and AcrEF knockout strain (AE Knockout); in this strain we have only
MdsAB and MdtAB active.
• Full RND knockout strain (AEST Knockout); in this strain we have none of our
four efflux pumps active. Thus the only transfer of substrate will be through the
cell membrane or through other lesser efflux pump systems.
We summarise all of these strains and their corresponding efflux parameters in Table
4.1. In regards to efflux parameter notation, we list the efflux pumps that are still active
in the subscript (e.g. A knockout would be noted by XEST ). We include each strain’s
efflux parameter in the following parameter fitting exercises by modifying the membrane











= (P +XI)cI(RM , t)− PcE(RM , t), (4.42)
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Strain Name Active Efflux Pumps Efflux Constant
Wild-type AcrAB, AcrEF, MdsAB, MdtAB XAEST
A Knockout AcrEF, MdsAB, MdtAB XEST
E Knockout AcrAB, MdsAB, MdtAB XAST
S Knockout AcrAB, AcrEF, MdtAB XAET
T Knockout AcrAB, AcrEF, MdsAB XAES
AE Knockout MdsAB, MdtAB XST
AEST Knockout N/A N/A
Table 4.1: A summary of the strains involved in the experiments. We list each strain’s
active efflux pumps as well as their corresponding efflux rate constant.
here XI denotes the efflux for the strain of which the pump(s) I are active. This enables
us to find the corresponding efflux value for each strain through multiple parameter fitting
exercises.
For each experiment with a given strain, we have multiple assays (biological repeats).
Within these individual assays, we have technical repeats for each strain. The mean and
standard deviations are found of these technical repeats and we plot these in Figures 4.5-
4.11. Under advice from the Blair laboratory, we have taken each assay’s initial data point
to be the start of the final peak of fluorescence. This is due to unknown experimental
errors upon measuring fluorescence on very early time points. Fluorescence for each assay
is measured in arbitrary units. In order to combine the data from all assays we normalise
our data by dividing the fluorescence over time by the peak initial fluorescence. In Figures
4.12 and 4.13, we show the results of normalising our data. As not all assays run for the
same length of time, we split our combinations into three time periods (short, medium and
long time). Whilst the short time plots include data of all assays, the medium and long

























































































Figure 4.5: Experiments taken upon the wild-type strain consisting of 18 assays. In each
individual assay we have plotted the mean (solid line) and standard deviation (shaded






















































































Figure 4.6: Experiments taken upon the A knockout strain consisting of 19 assays. In each
individual assay we have plotted the mean (solid line) and standard deviation (shaded





























Figure 4.7: Experiments taken upon the E knockout strain consisting of 6 assays. In each
individual assay we have plotted the mean (solid line) and standard deviation (shaded




























Figure 4.8: Experiments taken upon the S knockout strain consisting of 6 assays. In each
individual assay we have plotted the mean (solid line) and standard deviation (shaded





























Figure 4.9: Experiments taken upon the T knockout strain consisting of 6 assays. In each
individual assay we have plotted the mean (solid line) and standard deviation (shaded


























Figure 4.10: Experiments taken upon the AE knockout strain consisting of 6 assays.
In each individual assay we have plotted the mean (solid line) and standard deviation


















































































Figure 4.11: Experiments taken upon the AEST knockout strain consisting of 17 assays.
In each individual assay we have plotted the mean (solid line) and standard deviation































































Figure 4.12: Normalised efflux assay data, for each plot we have the mean of the assays
(solid line) and standard deviation (shaded error bar). We have combined (a) Wild-type,
(b) A Knockout and (c) AEST knockout. We have split the data of each strain into three
time regions, only including the assays that reach the maximum time point.
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Figure 4.13: Normalised efflux assay data, for each plot we have the mean of the assays
(solid line) and standard deviation (shaded error bar). We have combined (a) E knockout,
(b) S knockout, (c) T knockout and (d) ST knockout. For (d) we have split the data for
the strain into two time regions, only including the assays that reach the maximum time
point.
4.6 Parametrisation Methods
We employ the use of the function fminsearch in MATLAB to obtain our parameter
estimates. The function uses the Nelder-Mead simplex method (described in [47]) to
minimize a given objective function starting from initial parameter guesses. In order to
obtain these parameter guesses, we use a latin hypercube method of sampling as described
by McKay in [55]. By establishing realistic upper and lower parameter bounds, we create
a parameter space from which a range of initial parameter guesses are chosen. We use
this sampling method in order to choose a well-spread distribution of initial parameter
guesses (something that is not guaranteed from using a random method of sampling).
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r2 cI(r, t) dr.
Here y denotes the experimental data, I denotes the averaged intracellular concentration
of substrate, RM denotes the distance from the cell centre to the cell membrane and tmax is
the maximum time for the simulations. We have opted to divide our objective function by
the amount of data points in the corresponding assay to which we are fitting. This gives
us a comparison point between the accuracy of fits to different strains that differ in assay
length. In addition we have applied a constraint to our parameters to be non-negative,
we have included this by ensuring that the absolute value of each parameter is taken
through every iteration of finding the objective function. We note that our data values are
measured in relative fluorescence and our model in concentration. However, as we have
assumed a directly proportional relationship between the fluorescence and intracellular
concentration of substrate, we choose to model in terms of relative concentration so we
can directly fit the model to the data. Finally, we list all parameters used in this model,
noting the parameters being varied in Table 4.2. For simplicity in presentation, we will
omit the units of each fitted parameter in our following optimal parameter sets.
4.7 Results
As in our numerical simulations in section 4.4, for the following we set the cell to have
a radius of 2µm. Since we do not know the link between fluorescence and concentration
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Parameter Description Value Units
RM Membrane Radius 2 µm
RB Outer Boundary Radius Not Set µm
P Permeability Mass Transfer Coefficient Not Set µmmin−1
XAEST Efflux Conversion Constant For Wild-type Case Not Set µmmin
−1
XEST Efflux Conversion Constant For A Knockout Case Not Set µmmin
−1
XAST Efflux Conversion Constant For E Knockout Case Not Set µmmin
−1
XAST Efflux Conversion Constant For S Knockout Case Not Set µmmin
−1
XAES Efflux Conversion Constant For T Knockout Case Not Set µmmin
−1
XST Efflux Conversion Constant For AE Knockout Case Not Set µmmin
−1
DI Diffusion Coefficient Of Intracellular Substrate Not Set µm
2min−1
DE Diffusion Coefficient Of Extracellular Substrate Not Set µm
2min−1
Table 4.2: All parameters used in our single cell model and their respective units. If we
vary a parameter we will list it as “Not Set” in the “Value” column, otherwise if the
parameter is not varied we list its fixed value.
of substrate, we assume that the fluorescence is directly proportional to the averaged
internal concentration of ethidium bromide such that the relative fluorescence and relative
concentration of substrate is equivalent. By modelling in terms of relative concentration,
we can then produce a fit to the relative fluorescence. For the parameter fitting exercises in
this chapter, unless otherwise stated we have taken 1000 sets of initial parameter guesses,
finding the local minimum objective function and corresponding optimised parameters
for each parameter set. By then comparing the resulting objective functions, we have
been able to deduce the optimal set of fitted parameters. We have taken the step sizing
∆r = 0.25 and ∆t =
∆r2
4DMAX
for efficiency to reduce the time taken to run parameter
fits of all of the samples whilst maintaining small enough step sizes to produce accurate
simulations. For all parameter fits, we fit to the long time data only, withholding the
short time and medium time assays for testing of the accuracy of the fit.
4.7.1 Zero far field boundary condition
We first run exercises upon our model with a zero far field boundary condition. For the




In order to start fitting our model to the data, we initially fit to the data where no RND
efflux pumps are active in the strain. Whilst there is the possibility of less significant efflux
pump systems being active in this case, we choose to assume that the efflux contributed
from these pumps will be negligible compared to the efflux caused by the RND efflux
pumps and membrane permeability. Thus by initially fitting to this data we can construct
a base for the diffusion parameters and membrane permeability as these should not vary
between experiments. We plot the optimal parameter fit in Figure 4.14 which corresponds
with the following parameters:
[DI , DE, P ] = [2.45× 10−2, 1.01× 10−2, 2.72× 10−2], (4.44)
given to three significant figures and resulting in an objective function of 8.07× 10−4. We
note that in general the fit for long time is reasonable, with the model residing within
the standard deviation error bars for the majority of long time. We do however note
that whilst the data appears to be reaching some kind of steady state, the model does
not encapsulate this and by the end of the simulation the concentration appears to be
decreasing faster than in the data. When comparing to the (b) medium time and (c)
short time assays, we can see that the early time behaviour is missing. Quite prominently
the data suggests a delay in the decreasing of concentration, however there is no delay in
the model as the concentration clearly undershoots this.
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Figure 4.14: Parameter fitting results of the model with a zero far field boundary condition
to the AEST knockout data. In (a) we show the fit to the assays that reach long time,
(b) the assays that reach medium time and (c) all assays shown upon short time.
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Individual efflux knockouts
By fixing our optimal parameters from the AEST knockout case, we can continue to find
the remaining efflux parameters from the other strains. As a reminder for efflux parameter
notation, we list the efflux pumps that are active in the subscript. For the following fits,
we include the individual pump knockouts, meaning in each strain three other RND efflux
pumps will be active. We exhibit the optimal fits in Figure 4.15 with the corresponding
parameters:
[XEST , XAST , XAET , XAES] = [2.50× 10−2, 6.68, 0.729, 0.718], (4.45)
given to 3 significant figures and a combined objective function of 2.16× 10−2. We note
that whilst the fit for the A knockout is similar to the data, the E, S and T knockouts are
not reasonable fits and exhibit largely different dynamics to the data. As the A knockout
corresponds to the strain containing a knockout of the most dominant efflux pump AcrAB-
TolC, we expect this case to be the closest to the AEST knockout in that we expect little
efflux, which could explain the closeness of fit. Whilst this case does provide the most
realistic fit, the key dynamics are missing, with the model not approaching a steady state
at long time and no delay of decrease of concentration in the early time.
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Figure 4.15: Parameter fitting results of the model with a zero far field boundary condition
to the individual knockout strains after fixing AEST parameters (4.44). We exhibit the
A knockout strain in (a) long time, (b) medium time and (c) short time. The rest of the
strains are exhibited as (d) E knockout, (e) S knockout and (f) T knockout.
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Wild-type strain
Since we have estimated parameters for efflux of the individual knockouts, if we assume
that all efflux is additive, we can use simultaneous equations to find efflux parameters for
the individual pumps. From these individual parameters, we can produce an approxima-
tion for the efflux parameter for the wild-type strain. If we assume that
XE +XS +XT = XEST , (4.46)
XA +XS +XT = XAST , (4.47)
XA +XE +XT = XAET , (4.48)
XA +XE +XS = XAES, (4.49)
XA +XE +XS +XT = XAEST , (4.50)
















(XEST +XAST +XAET − 2XAES). (4.54)
Using the optimal parameters from our individual knockouts strains (XEST , XAST , XAET , XAES)
we are able to find the efflux values of our individual efflux pumps (XA, XE, XS, XT ) and
combine them to estimate the efflux in the wild-type case:
[XA, XE, XS, XT , XAEST ] = [2.69,−3.96, 1.99, 2.00, 2.72], (4.55)
given to three significant figures. We plot our model with the estimated wild-type param-
eter in Figure 4.16. It is clear to note that in the long time the simulated efflux is larger
than measured in the data, with the concentration reaching null values at long time. We
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also note that the individual efflux value for XE is negative, this leads us to believe that
in this model efflux from each individual pump is not additive as negative efflux is not
possible.





















Figure 4.16: Comparison of the estimated wild-type efflux constant (4.55) applied to our
model with a zero far field boundary condition to the wild-type data after fixing AEST
parameters (4.44). In (a) we show the fit to the assays that reach long time, (b) the assays
that reach medium time and (c) all assays in the short time.
Since our estimated efflux parameter does not provide a realistic fit, we run a parameter
fit for the wild-type efflux parameter. We plot this in Figure 4.17 with the corresponding
parameter:
[XAEST ] = [0.247], (4.56)
given to three significant figures and an objective function of 4.50×10−3. Here we note that
the fit at long time is better than our previous estimated parameter, with the concentration
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not reaching null values. However, again like the individual knockouts the dynamics of
the data is missing, especially shown against the short time assays. Finally, we note that
the efflux parameter is less than those fitted of the individual knockouts. We believe this
to be because we are fitting to a longer time region in this wild-type data compared to
the individual knockout data. In addition compared to the individual efflux knockouts
in Figure 4.15, we see that at longer time the individual knockout fits would likely hit
null values quicker than the wild-type case, which should not be possible as the wild-type
case is where efflux should be at a maximum compared to other strains as all pumps are
active.





















Figure 4.17: Parameter fitting results of the model with a zero far field boundary condition
to the wild-type data after fixing our AEST parameters (4.44) and using a parameter fitted
efflux rate constant (4.56). In (a) we show the fit to the assays that reach long time, (b)
the assays that reach medium time and (c) all assays in the short time.
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4.7.2 No-flux boundary condition
Whilst the fit for the zero far field boundary condition model was reasonable in the AEST
knockout case, the model failed to capture the dynamics of all cases with efflux. Given
that one element of this was the model’s failure to reach a steady state (guided by our
results of section 4.7.1) we now fit our model with a no-flux outer boundary condition.
For the following fits we also vary the position of the extracellular boundary (RB), by
using 125 initial parameter guesses into fminsearch for each integer between 3µm and
10µm inclusive, resulting in 1000 sets of optimal parameters.
AEST knockout
As with the zero far field boundary model, we set our baseline parameters in the AEST
knockout case where we assume that efflux is not active. We plot the optimal fit in Figure
4.18, with corresponding parameters:
[RB, DI , DE, P ] = [4, 0.102, 7.00× 10−2, 9.42× 10−3], (4.57)
given to 3 significant figures and an objective function of 7.2 × 10−4. We note that in
regards to the objective function, the fit here is better than the previous model for this
strain in Section 4.7.1. However we note that the fit is still very similar and is notably
still missing the early and mid time dynamics, with only a small improvement to the long
term dynamics.
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Figure 4.18: Parameter fitting results of the model with a no flux outer boundary condition
to the AEST knockout data. In (a) we show the fit to the assays that reach long time,
(b) the assays that reach medium time and (c) all assays in the short time.
Individual efflux knockouts
For the individual efflux knockouts, we again follow the method used in Section 4.7.1. By
fixing our parameters gained from the AEST knockout case, we are able to find the efflux
parameters for our individual efflux knockout strains. We plot these fits in Figure 4.19
and the corresponding parameters are:
[XEST , XAST , XAET , XAES] = [6.54× 10−3, 4.94× 10−2, 4.10× 10−2 4.07× 10−2], (4.58)
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given to 3 significant figures and a combined objective function of 1.56× 10−2. We note
that the combined objective function is immediately improved compared to the zero far
field boundary model. Our fit for the A knockout model in (a) still undershoots the data
in the long term, however it is closer to reaching a steady state than the previous model.
Again we note that the early dynamics are missing in the short and medium time. The
fits for the E, S and T knockouts (d)-(f) are also improved compared to section 4.7.1, with
the model approaching a steady state that fits within the standard error of the data.
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Figure 4.19: Parameter fitting results of the model with a no flux outer boundary condition
to the individual knockout strains having fixed our AEST parameters (4.57). We exhibit
the A knockout strain in (a) long time, (b) medium time and (c) short time. The rest of
the strains are exhibited as such (d) E knockout, (e) S knockout and (f) T knockout.
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Wild-type strain
By following the method in Section 4.7.1, we are able to estimate the efflux parameters
for each of the individual efflux pumps. We plot our estimated wild-type efflux in Figure
4.20, with the following corresponding parameters
[XA, XE, XS, XT , XAEST ] = [3.94×10−2,−3.54×10−3, 4.90×10−3, 5.18×10−3, 4.59×10−2],
(4.59)
given to three significant figures. We note that the estimated wild-type parameter (XAEST )
causes the model to undershoot the data, however the model does approach a steady state
as the experimental data suggests. Again early dynamics are missing as there is no delay
in concentration decreasing and past this delay the decrease in concentration is not fast
enough to encapsulate the behaviour shown by the data. In addition, as for the individual
efflux values, our parameter for efflux by AcrEF (XE) is again negative. This again leads
us to believe that for our current model the individual efflux parameters are not additive
and may differ from strain to strain. Since our estimated efflux parameter again does not
provide a realistic fit, we run a parameter fit for the wild-type efflux parameter in Figure
4.21 with the corresponding parameter:
[XAEST ] = [3.57× 10−2], (4.60)
given to three significant figures and an objective function of 3.48×10−3. This parameter
is similar to our estimated wild-type efflux parameter and the resulting model has similar
dynamics. Whilst in the long time the model reaches a steady state, the early dynamics
exhibited by the data are still missing.
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Figure 4.20: Comparing our estimated wild-type efflux constant (4.59) in our model with
a no flux outer boundary condition to the wild-type data with fixed AEST parameters
(4.57). In (a) we show the fit to the assays that reach long time, (b) the assays that reach
medium time and (c) all assays in the short time.
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Figure 4.21: Parameter fitting results of the model with a no flux outer boundary condition
to the wild-type data using using (4.57) having fixed our AEST parameters (4.57). In (a)
we show the fit to the assays that reach long time, (b) the assays that reach medium time
and (c) all assays in the short time.
4.8 Discussion
We have formulated a spatial model that encapsulates the behaviour of substrate concen-
tration of a single cell, demonstrating the physical effects of efflux pump activity upon
substrate concentration. By making assumptions on the far field boundary conditions
for this model, we have created a single cell model that can potentially encapsulate the
behaviour of a Salmonella culture.
By using finite difference methods, we have discretised our domain and produced
numerical solutions for our model. These simulations have presented insights into the
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behaviour of the mass transfer coefficients, showing clear differences between the coeffi-
cient related to efflux and the coefficient related to permeability. By producing likewise
simulations for the model with differing outer boundary conditions (zero far field and
no flux), we have been able to show the effects these give to our model. With the zero
far field boundary condition, we see the intracellular concentration more likely to fully
deplete. In the long term, the model with this boundary condition would achieve a steady
state of fully depleted concentration in all space, unless we have no transfer of substrate
through the membrane. This would physically represent a Salmonella population that
has plentiful extracellular space, such that once substrate is expelled from the cells it
disperses and does not diffuse back into the population. With the no flux condition, the
system may reach a non zero steady state. Since there is no depletion at the far field, at
long time both intracellular and extracellular concentrations will reach steady state. This
represents physically a Salmonella population that has limited extracellular space, such
that we see diffusion of expelled substrate back into the cell.
We have implemented parameter fitting techniques for the efflux model to experimental
data consisting of various different strains with different efflux pumps active. By varying
the extracellular boundary condition, we have been able to fit two versions of the model
to the data. Whilst the zero far field boundary model provided a reasonable fit to the
AEST knockout data, the flaws in the model were realised upon adding efflux. Not only
were efflux dynamics missing upon early time, upon long time the model concentration
would keep on decreasing when the data suggests an approach to a steady state. In
regards to the no flux boundary model, we saw better fits across all strains, shown by the
objective functions of each of the fits. Whilst again, short time dynamics were missing
upon our fits, the long time fits were improved in all strains. The model in all fits appeared
to reach or be approaching a steady state at long time. Whilst the fits would give a
reasonable approximation to modelling the experimental data, it is clear that our model
needs adaptation to encapsulate the data better and primarily the short and medium time
dynamics. In the next chapter, we will attempt to adapt our existing model to greater
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In the previous chapter we have modelled our efflux data via a single cell model, including
variations upon the model’s extracellular boundary condition. However, when attempting
to fit the model to data, flaws were exhibited. Early time and medium time dynamics
in particular did not correspond with the data. It is clear that our current model is
oversimplified and needs adaptation.
As stated in the previous model, ethidium bromide is a DNA-intercalating agent that
fluoresces when it is bound to DNA. Due to this fluorescing, the concentration of ethidium
bromide within a culture can be approximated. However in our previous model, we have
made assumptions that the fluorescence is directly proportional to the concentration of
ethidium bromide. In reality, we will have two states of ethidium bromide; bound ethidium
bromide that is fluorescing and unbound ethidium bromide that is not fluorescing. In
addition, as we know from our gene regulatory model the expression of efflux pump genes
is not constant. In our previous model, we have taken efflux to be constant and to be fully
expressed from the start of the assay, when in reality this may not be the case. This may
be a reason for the disparity in results for strains that included efflux. By considering
these aspects we adapt our previous model with the hope of finding a better fit to our
data.
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5.2 Bound ethidium bromide model formulation
We formulate our model in a manner similar to the previous model by again assuming
that each cell acts identically. We also assume that the concentration of ethidium bro-
mide is evenly distributed in the population such that every cell has an identical initial
concentration of ethidium bromide. We assume this distributed concentration of ethid-
ium bromide is independent to each cell, meaning that if the substrate has been expelled
into the extracellular space, it can only diffuse back into the original cell. In this model
however we consider ethidium bromide in two states. The first state is ethidium bromide
that fluoresces because it is bound to DNA, we will further refer to this state as bound
ethidium bromide. In this state the ethidium bromide cannot pass through the cell mem-
brane via efflux or diffusion. The second state is ethidium bromide that is not bound
to DNA. We will further refer to this state as unbound ethidium bromide. In this state,
ethidium bromide does not fluoresce but can move freely through the cell membrane via
efflux or diffusion. Since one state is bound, we assume that the two states will diffuse
at different rates and hence apply a different diffusion coefficient for each state. Again
similar to the previous model, we do not know the correlation between fluorescence of
ethidium bromide and the concentration of bound ethidium bromide within the culture,
we thus assume a directly proportional relation between the two.
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Figure 5.1: A schematic of the bound ethidium bromide model. The solid line represents
our cell membrane at radius RM , whereas the dashed line represents our outer boundary
at radius RB. We have placed our equations where they apply in the intracellular and
extracellular space.
We exhibit a schematic of our model in Figure 5.1. Again, we use spherical coordinates
to model an axisymmetric spherical cell with radius RM surrounded by extracellular space
with an outer boundary of radius RB. At the cell radius, we have a thin permeable
membrane which contains all of our efflux pump systems that expel unbound substrate




= DB∇2cB − αcB + βcI , (5.1)
∂cI
∂t




Here cB denotes the bound concentration of substrate, cI denotes the intracellular un-
bound concentration of substrate and cE denotes the extracellular unbound concentration
of substrate. The intracellular ethidium bromide undergoes DNA binding at rate β and
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unbinding at rate α. We assume that there is always a sufficient concentration of DNA
that is well mixed throughout the cell such that ethidium bromide is able to bind at all
times.
5.2.1 Boundary Conditions





























Similar to the previous model, we assume axisymmetry of the cell, resulting in two bound-
ary conditions at the cell centre for both bound and unbound ethidium bromide concentra-
tions. We also uphold flux continuity between the intracellular and extracellular space for
the unbound substrate. The bound ethidium bromide however, cannot pass through the
membrane via either efflux or diffusion, thus we introduce the no flux boundary condition
(5.6).
In addition to the above boundary conditions, we have the outer boundary condition.
After analysing parameter fitting results from the previous model we discount the zero
far field boundary condition. Thus we assume that the extracellular space is limited, such
that substrate expelled out of the cell will always be within range to diffuse back in. Here









As with the previous model, we assume that there is no substrate in the extracellular
space. In regards to the intracellular space, we do not know the ratio of unbound to bound
substrate, thus we introduce the parameter γ into our initial conditions that will define
the ratio of unbound to bound substrate. The initial conditions for each concentration
are as follows
cB(r, 0) = CB0, cI(r, 0) = γ CB0, cE(r, 0) = 0, (5.8)
where CB0 is the initial concentration of bound substrate.
5.2.3 Variable Efflux
In our previous model, we chose our rate of efflux to be constant. In reality we know that
the rate of efflux is not likely to be constant as expression of the proteins that constitute
the efflux pumps can vary. We model efflux as a simple efflux pump formation model with
the following equation and initial condition
dX
dt
= φ− δX, X(0) = X0, (5.9)
where φ is our efflux pump formation rate, δ is our efflux pump degradation rate and X0
is a constant determining the initial rate of efflux. In addition, the formation of efflux










where φI is the efflux pump formation rate dependent on substrate concentration and I
is the averaged intracellular concentration of substrate. We will consider both cases of
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efflux in our simulations, hoping to give us further insights into the dynamics of efflux
over the course of the experiments.
5.3 Numerical Method
We follow a similar method for discretisation as used on the previous model in Section 4.4.
In the interests of brevity, we omit most trivial steps, only exhibiting the main differences






















































In regards to our boundary conditions, we omit our conditions due to following similar
discretisation to the boundary conditions in Section 4.4. By collating our approximations
our full finite difference method to approximate our model is represented in equation
(5.15). We implement this method in MATLAB to produce various different simulations
of our model. Unless otherwise stated we set our spatial step ∆r = 0.1 with RM = 2µm.


















































































































































































































































































































































For the following simulations, we choose our cell radius to be 2µm, with a far field
boundary at 4µm. We set the diffusivity of unbound ethidium bromide to be equal
at DI , DE = 1µm
2 min−1, whilst we set the bound ethidium bromide to have diffusivity of
DB = 0.1µm
2 min−1. Finally, we set the initial intracellular concentrations of bound and
unbound ethidium bromide to be equal at 1 mol /m3. We exhibit various simulations of
our bound ethidium bromide model, exhibiting various features of the model’s dynamics
in Figures 5.2-5.4. In these simulations, we vary membrane permeability, efflux rate and
finally the binding and unbinding rates of the intracellular ethidium bromide.
In Figure 5.2 (a), we see the results of an impermeable membrane with no efflux
and equal binding and unbinding coefficients. We see no transfer of substrate from the
intracellular space, with a uniform distribution of both concentrations throughout for all
time due to equal rates of binding and unbinding. In (b), we maintain an impermeable
membrane, however here the unbinding rate dominates the binding rate. We see the
bound substrate concentration decrease over time and unbound substrate concentration
increase until both concentrations reach a steady state.
In Figure 5.3 (a), we maintain an impermeable membrane, however here the binding
rate dominates the unbinding rate. We see the opposite to the previous simulations, with
the bound substrate concentration increasing until reaching steady state. In (b), we set
the binding and unbinding rates to be equal but introduce a permeable membrane. We
can see here that the unbound substrate concentration quickly disperses into the extra-
cellular space until a steady state is reach between the unbound and bound substrate
concentrations. We note that on very early time the bound substrate concentration has
a delay upon unbinding, with the bound substrate concentration only reaching a max-
imum unbinding rate when the unbound intracellular concentration has decreased and
reached steady state. When the unbound substrate concentration has reached its lowest
point, we see the greatest decrease of bound substrate concentration, due to there being
the minimal intracellular unbound substrate concentration available to form bound sub-
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strate concentration. Finally at long time both concentrations reach a steady state as the
unbound substrate concentration has fully dispersed and unbound and bound substrate
concentrations have reached an equilibrium point.
In Figure 5.4 (a), we introduce efflux to the permeable membrane. We note that the
simulation is similar to Figure 5.3 (b), however with the efflux rate only expelling unbound
substrate concentration from the intracellular to extracellular space, the intracellular and
extracellular concentrations reach different steady states at long time. Due to introducing
efflux the unbound intracellular substrate concentration reaches a steady state lower than
achieved via diffusion through the membrane alone (i.e. Figure 5.3 (b)). This has a
resulting effect on the bound substrate concentration as we reach a lower concentration
and equilibrium point between both concentrations at long time. Finally in (b), we
maintain our efflux values but exhibit a case of the unbinding rate dominating the binding
rate. Again, we have similar dynamics to the previous simulation, however instead of the
intracellular and extracellular concentrations reaching an equilibrium at the same steady
state concentration, we see the bound substrate concentration continuing to unbind and
almost fully depleting at long time.
We can compare the dynamics of these simulations to the previous single cell model
(with no flux outer boundary condition) simulations in Section 4.4.1 by comparing the
intracellular bound concentration of substrate in this model against the concentration of
intracellular substrate of the single cell model. By comparing the cases with active efflux
(Figure 5.4 against Figure 4.4 (c) and (d)), it is notable that the long term dynamics
are very similar, with the concentration of substrate appearing to reach a steady state
in both models. However, the main differences are noted upon the early and mid time
dynamics, with the bound ethidium bromide model having a delay in decrease of substrate
concentration during early dynamics. A maximum decrease of substrate concentration is
then reached which then slows upon mid time. This is promising as our parameter fitting
results with the previous model showed that the long term dynamics matched, however
the model was not able to replicate the early and mid time dynamics of the data.
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Figure 5.2: Simulations of the bound ethidium bromide model with a no flux far field
outer boundary condition and RM = 2µm. We exhibit bound and unbound distribution
profiles, with averaged intracellular concentrations below. We vary permeability, efflux,
unbinding and binding rates. In (a) we have P,X = 0 and α, β = 0.1. In (b) we have
P,X = 0 and α = 0.1, β = 0.01. 175
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Figure 5.3: Further simulations of the bound ethidium bromide model with a no flux far
field outer boundary condition and RM = 2µm. In simulation (a) we have P,X = 0 and
α = 0.01, β = 0.1. In simulation (b) we have P = 1, X = 0 and α, β = 0.1.
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Figure 5.4: Final set of simulations of the bound ethidium bromide model with a no
flux far field outer boundary condition. In simulation (a) we have P = 1, X = 1 and
α, β = 0.1. In simulation (b) we have P = 1, X = 1 and α = 0.1, β = 0.01.
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5.4 Parametrisation Methods
We follow similar methods to our previous parameter fitting exercises in Section 4.6. We
again employ the use of the function fminsearch in MATLAB with a latin hypercube
method of sampling to produce initial parameter guesses, with the only difference being
our objective function. Our objective function that we are attempting to minimise for













r2 cB(r, t) dr.
Here y denotes the experimental data, I denotes the averaged intracellular concentration
of the bound substrate, RM denotes the distance from the cell centre to the cell membrane
and tmax is the maximum time for the simulations. Again, we note that our data values are
measured in relative fluorescence and our model in concentration. However, as we have
assumed a directly proportional relationship between the fluorescence and intracellular
bound concentration of substrate, we choose to model in terms of relative concentration
so we can directly fit the model to the data. We list all parameters used in this model,
noting the parameters being varied and their respective units in Table 5.1. For simplicity
in presentation, we will omit the units of each fitted parameter in our following optimal
parameter sets.
5.5 Results
As with our previous parameter fitting methods, we set the cell to have a radius of 2µm.
We have taken the step sizing ∆r = 0.25 and ∆t =
∆r2
4DMAX
. For most parameter fitting
exercises we have taken 1000 sets of initial parameter guesses, finding the optimal case,
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Parameter Description Value Units
RM Membrane Radius 2 µm
RB Outer Boundary Radius Not Set µm
P Permeability Mass Transfer Coefficient Not Set µmmin−1
XAEST Efflux Conversion Constant For Wild-type Case Not Set µmmin
−1
XEST Efflux Conversion Constant For A Knockout Case Not Set µmmin
−1
XAST Efflux Conversion Constant For E Knockout Case Not Set µmmin
−1
XAST Efflux Conversion Constant For S Knockout Case Not Set µmmin
−1
XAES Efflux Conversion Constant For T Knockout Case Not Set µmmin
−1
XST Efflux Conversion Constant For AE Knockout Case Not Set µmmin
−1
DB Diffusion Coefficient Of Bound Substrate 0 µm
2min−1
DI Diffusion Coefficient Of Unbound Intracellular Substrate Not Set µm
2min−1
DE Diffusion Coefficient Of Unbound Extracellular Substrate Not Set µm
2min−1
α Unbinding Rate Of Bound Substrate Not Set min−1
β Binding Rate Of Unbound Substrate Not Set min−1
γ Initial Ratio Of Unbound To Bound Substrate Concentrations Not Set N/A
Table 5.1: All parameters used in our bound ethidium bromide model and their respective
units. If we vary a parameter we will list it as “Not Set” in the “Value” column, otherwise
if the parameter is not varied we list its fixed value.
fitting to the long time data only. We withhold the short time and medium time assays for
testing of the accuracy of the fit. For simplicity of our parameter fitting exercises, we set
our bound ethidium bromide diffusion rate to be zero (DB = 0) reducing the number of
parameters in the following fits. This is under the assumption that the bound molecules
will be large compared to unbound molecules such that the diffusion will be negligible
compared to the unbound state. Initially, we will consider efflux to be constant for all
parameter fitting exercises in this section. We do this in order for us to gain more insights
firstly into the binding dynamics by drawing comparisons against the single cell model in
Chapter 4.
AEST knockout
We follow parameter fitting exercises to the AEST knockout strain with the previous
models in Sections 4.7.1 and 4.7.2 by continuing to assume that there is no efflux in this
case. We plot the optimal parameter fit in Figure 5.5 which has the following parameters:
[RB, DI , DE, P, α, β, γ] = [4, 5.26, 6.47× 10−3, 6.63, 9.15× 10−2, 2.38× 10−2, 39.4], (5.17)
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given to three significant figures and resulting in an objective function of 1.23× 10−4. We
note that in Figure 5.5 (a) the fit is near perfect, with almost all of the model fitting within
the standard error of the data. The model differs in very early time, where the bound
substrate concentration increases and peaks before decreasing. We can see from (d) and
(e) that with a high initial unbound substrate concentration (caused by the fitted ratio
γ), that the binding process dominates over unbinding. Over time the unbound substrate
concentration diffuses out of the cell into the extracellular space, resulting in a lower
intracellular unbound substrate concentration. At this point the unbinding processes
dominate as the unbound substrate cannot bind when it is situated in the extracellular
space. Finally, as the expulsion of intracellular unbound substrate concentration slows,
this means that both intracellular concentrations appear to reach an equilibrium with its
unbinding and binding processes. This results in a near steady state of bound substrate
concentration at the end of the simulation. Testing the fit including the medium and short
time assays in (b) and (c), shows improved results to the previous model in Section 4.7.2.
Whilst the model may not fit within the standard error of the data for both medium and
short time, the model closely mimics the dynamics of the data.
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Figure 5.5: Parameter fitting results of the bound ethidium bromide model to the AEST
knockout data. In (a) we show the fit to the assays that reach long time, (b) the assays
that reach medium time and (c) all assays in the short time. Finally in (d) and (e) we




Similar to the previous model, we fix our optimal parameters from the AEST knockout
case, as we assume these should not vary in each strain. Since our individual knockout
cases did not give insight into predicting the wild-type case in Chapter 4, we skip param-
eter fitting to the individual knockout cases instead immediately providing a parameter
fit to the wild-type case. We will instead use our individual knockout cases in later pa-
rameter fitting exercises to help ascertain estimates of individual efflux parameters. We
plot our optimal fit for the wild-type strain in Figure 5.6, with the corresponding optimal
parameter
[XAEST ] = [37.5], (5.18)
given to three significant figures and resulting in an objective function value of 3.65×10−3.
We note that although the earlier dynamics are improved, the overall objective function of
this fit is larger than the best fit to this wild-type strain of the previous model in Section
4.7.2. As with the AEST knockout case, a high initial unbound substrate concentration
causes a delay on early time in the decreasing of bound substrate concentration. The
efflux parameter is comparatively much larger than the permeability parameter, however
even with this large efflux rate, our bound substrate concentration cannot unbind quickly
enough to follow the dynamics of the data. We can see from the distribution profile in
(e) the intracellular concentration is expelled extremely rapidly such that there is a large
localised concentration in the extracellular space close to the membrane of the cell. The
bound intracellular concentration decreases until the bound and unbound intracellular
concentrations have reached an equilibrium point. We note that although the model’s
bound substrate concentration steady state does not fit in the standard error of the data
at long term in (a), the model still achieves a steady state. It is clear from this parameter
fit that the optimal parameters fixed from the AEST knockout case do not provide realistic
dynamics to the wild-type case.
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Figure 5.6: Parameter fitting results of the bound ethidium bromide model to the wild-
type strain data having fixed our AEST parameters (5.17). In (a) we show the fit to the
assays that reach long time, (b) the assays that reach medium time and (c) all assays in
the short time. Finally in (d) and (e) we demonstrate the distribution profiles for both
concentrations upon fitting to the long time data
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AEST knockout and wild-type strain
Since the previous optimal parameters for the AEST knockout case did not provide a
base for a realistic fit to the wild-type case, we now produce fits for both cases simultane-
ously. For this parameter fitting exercise, we minimise the combined sum of the objective
functions calculated for each data set. We plot the optimal parameter fits for the AEST
knockout in Figure 5.7 and wild-type strain in Figure 5.8 using the following parameters:
[RB, DI , DE, P, α, β, γ,XAEST ] = [4, 7.44, 1.65, 2.00× 10−2, 1.32, 0.86, 1.75, 5.70× 10−2],
(5.19)
given to three significant figures and resulting in a combined objective function of 2.58×
10−3. We can immediately see that the fit to the wild-type case (Figure 5.8) has much
improved, with the majority of the model fitting within the standard error of the data in
(a). In terms of parameters, the binding and unbinding rates are much faster enabling the
bound substrate concentration to unbind and therefore be expelled from the intracellular
space at a faster rate. We also have a lower initial concentration of unbound substrate
concentration (γ), which in turn results in smaller permeability (P ) and efflux activity
parameters XAEST . We thus now do not see a spike in the external unbound substrate
concentration at early time near the membrane. Whilst the fit for the wild-type case has
improved, further shown by comparing to the test data of short time and medium time
assays (b) and (c), we have compromised the fit for the AEST knockout (Figure 5.7).
In (a)-(c) we now have a large peak upon early time where the intracellular unbound
substrate concentration is still at high concentrations such that binding is dominating.
We also have reduced similarities in behaviour in the long term as (although the model
still fits within the region of standard error for the data) the model looks as though it
will hit a steady state much earlier than the data suggests and at a higher concentration.
184





















Figure 5.7: Parameter fitting results of the bound ethidium bromide model to both the
AEST knockout and wild-type data simultaneously, comparing against the AEST data. In
(a) we show the fit to the assays that reach long time, (b) the assays that reach medium
time and (c) all assays in the short time. Finally in (d) and (e) we demonstrate the
distribution profiles for both concentrations upon fitting to the long time data.
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Figure 5.8: Parameter fitting results of the model to both the AEST knockout and wild-
type data simultaneously, comparing against the wild-type data. In (a) we show the fit to
the assays that reach long time, (b) the assays that reach medium time and (c) all assays
in the short time. Finally in (d) and (e) we demonstrate the distribution profiles for both
concentrations upon fitting to the long time data
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5.6 Improving the wild-type fit
Whilst simultaneous parameter fits have improved our fit for modelling the dynamics of
the wild-type case, it is clear that the efflux knockout is compromised. Thus it is possible
that we are not encapsulating the effect of efflux with our constant efflux parameter. For
the next parameter fits, we look into improving the fits for the wild-type case upon the
model with no bound substrate diffusion and variable efflux.
5.6.1 Variable Efflux
AEST Optimal Parameters
Initially, as these parameters provided a realistic fit to the AEST case, we fix the following
parameters from the AEST knockout
[RB, DI , DE, P, α, β, γ] = [4, 5.26, 6.47× 10−3, 6.63, 9.15× 10−2, 2.38× 10−2, 39.4], (5.20)
given to three significant figures and resulting in an objective function of 1.23× 10−4. We
then fit our efflux parameters. Since we do not know the initial condition of efflux, we
include this in the parameter fit. Our following fitted parameters are:
[X0, φ, δ] = [149, 0.31, 0.085], (5.21)
given to three significant figures and resulting in an objective function of 7.58 × 10−4.
We plot the optimal fit in Figure 5.9. We note that here with variable efflux, the overall
objective function has significantly decreased. This is mainly due to the increased accuracy
of replicating the data’s steady state in (a). Whilst we note here the long term dynamics
are much improved, the short term dynamics are still not being encapsulated. The initial
condition of efflux is set to a very large value causing the model to undershoot the data.
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Figure 5.9: Parameter fitting results of the bound ethidium bromide model with variable
efflux to the wild-type strain data, fixing AEST parameters from (5.20). In (a) we show
the fit to the assays that reach long time, (c) the assays that reach medium time and (d)
all assays in the short time. In (b) we exhibit the resulting efflux profile, with (e) and (f)




Since the optimal AEST parameters did not produce a realistic fit for the wild-type case
upon early and mid time, we now produce fits for the wild-type case by considering each
of the top 100 sets of parameters for the fit to the AEST data. Then by combining their
objective functions, we choose a case that is optimal and realistic to both the AEST and
wild-type cases. The parameters we fix from the AEST data are
[RB, DI , DE, P, α, β, γ] = [4, 6.13× 10−2, 1.14× 10−2, 4.26× 10−2, 0.21, 3.44× 10−2, 6.15],
(5.22)
given to three significant figures and resulting in an objective function of 2.15 × 10−4.
This results in the following parameters when fitting to the wild-type case:
[X0, φ, δ] = [86.9, 9.17× 10−3, 0.34], (5.23)
given to three significant figures and resulting in an objective function of 4.55× 10−4. We
plot the fits for the AEST and wild-type case in Figures 5.10 and 5.11 respectively. We
note here, we have made barely any compromise to the fit to the AEST data but have
achieved a much more realistic fit for the wild-type case. For the wild-type (Figure 5.11),
the short time behaviour is much improved, with the model only just undershooting the
data. In regards to the efflux dynamics in (b) we note that the initial condition of efflux
is initially very large and greatly decreases over time.
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Figure 5.10: Parameter fitting results of the bound ethidium bromide model with variable
efflux using the top 100 fits to the AEST data and fitting to the wild-type data, shown
against the AEST knockout data. In (a) we show the fit to the assays that reach long time,
(b) the assays that reach medium time and (c) all assays in the short time. Finally in (d)
and (e) we demonstrate the distribution profiles for both concentrations upon fitting to
the long time data.
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Figure 5.11: Parameter fitting results of the bound ethidium bromide model with variable
efflux using the top 100 fits to the AEST data and fitting to the wild-type data, shown
against the wild-type data. In (a) we show the fit to the assays that reach long time, (c)
the assays that reach medium time and (d) all assays in the short time. In (b) we exhibit
the resulting efflux profile, with (e) and (f) demonstrating the distribution profiles for
both concentrations upon fitting to the long time data
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5.6.2 Substrate Dependent Efflux
Combined Optimal Parameters
It is clear from the previous fits that not only is efflux unlikely to be constant, the optimal
fits start with a high level of efflux that decreases over time. We note that the efflux rate
very closely matches the concentration of internal antibiotic, thus we produce a fit to a
model where the rate of efflux is dependent on the internal antibiotic concentration using
(5.10). As with the previous fit, we consider each of the 100 best sets of parameters for
the AEST case for the wild-type case, finding the minimal combined objective function.
The parameters we choose from the AEST data are
[RB, DI , DE, P, α, β, γ] = [4, 2.30, 1.01, 1.47× 10−2, 0.22, 8.89× 10−2, 2.59], (5.24)
given to three significant figures and resulting in an objective function of 2.44 × 10−4.
Fitting to the wild-type we achieve the parameters
[X0, φ, δ] = [4.00× 10−2, 7.99× 10−2, 0.60], (5.25)
given to three significant figures and resulting in an objective function of 3.76 × 10−4.
We plot the resulting parameter fits in Figures 5.12 and 5.13. We note again that there
is barely any compromise in regards to fitting to the AEST knockout data (Figure5.12).
However the fit to the wild-type case is much improved (Figure 5.13). We note that
the long term dynamics are well approximated in (a), whilst the short term dynamics
are further encapsulated with a small delay in the initial decrease of bound substrate
concentration. We can see that the time course of the efflux rate is very different in (b)
to previous fits. The initial condition of efflux is small, however there is a sharp increase
in efflux before decreasing to reach a steady state. We note that we have seen similar
behaviour to this when simulating the protein expression of these efflux pumps in our
GRN model in Chapter 2.
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Figure 5.12: Parameter fitting results of the bound ethidium bromide model with variable
efflux dependent on substrate using the top 100 fits to the AEST data and fitting to the
wild-type data, shown against the AEST data. In (a) we show the fit to the assays that
reach long time, (b) the assays that reach medium time and (c) all assays in the short time.
Finally in (d) and (e) we demonstrate the distribution profiles for both concentrations
upon fitting to the long time data.
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Figure 5.13: Parameter fitting results of the bound ethidium bromide model with variable
efflux dependent on substrate using the top 100 fits to the AEST data and fitting to the
wild-type data, shown against the wild-type data. In (a) we show the fit to the assays
that reach long time, (c) the assays that reach medium time and (d) all assays in the
short time. In (b) we exhibit the resulting efflux profile, with (e) and (f) demonstrating
the distribution profiles for both concentrations upon fitting to the long time data.
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Individual Efflux Knockouts
Since we have found parameters that encapsulate the behaviour of the two most extreme
cases (AEST knockout and wild-type) we fix the AEST parameters (5.24) and fit new
efflux parameters for each case of efflux knockouts. For notation, we list all fitted param-
eters as XG0, φG and δG together with their corresponding objective function θG, where
G represents the efflux pumps that are active in that case. The parameters we achieve
are
[XEST0, φEST , δEST , θEST ] = [8.99× 10−3, 4.89× 10−3, 0.26, 4.53× 10−4], (5.26)
[XAST0, φAST , δAST , θAST ] = [1.35× 10−2, 4.18× 10−2, 0.24, 6.15× 10−4], (5.27)
[XAET0, φAET , δAET , θAET ] = [7.01× 10−8, 4.30× 10−2, 0.32, 6.53× 10−4], (5.28)
[XAES0, φAES, δAES, θAES] = [7.87× 10−8, 3.42× 10−2, 0.25, 9.53× 10−4], (5.29)
[XST0, φST , δST , θST ] = [2.12× 10−4, 1.57× 10−4, 2.94× 10−2, 1.30× 10−3], (5.30)
given to three significant figures and resulting in a combined objective function of 3.98×
10−3. Notably we have very small values for XAET0 and XAES0 which could depend on
the resolution of the numerical method. These initial conditions however have been tested
these at value zero and have obtained similar results. We plot the resulting fits in Figures
5.14 and 5.15. We can immediately see that for each efflux knockout case, the dynamics
are closely matched with the majority of the model fitting within the standard error of the
data. It is also interesting to note that nearly all efflux profiles (barring the AE knockout)
start off at a low value, then rapidly increase before decreasing to a steady state value
(Figure 5.14 (d), (f), Figure 5.15 (b) and (d)). The efflux profile for the AE knockout in
Figure 5.15 (e) and (f) we note has a very different efflux profile to the other cases. This
could be due to the fact that in this case only the efflux pumps MdsAB and MdtAB are
active, these are both lesser efflux pumps compared to AcrAB and AcrEF and we should
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expect less efflux and hence a lesser or no initial peak of efflux caused by these pumps.






































Figure 5.14: Parameter fitting results of the bound ethidium bromide model to the data
of individual knockouts, having fixed AEST parameters (5.24). In (a), (b) and (c) we
show the model fitting to the A knockout, firstly to long time and then testing against
medium and short time data respectively. In (d) we show the resulting efflux variable. In
(e) we show the fit to the E knockout and resulting efflux parameter (f).
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Figure 5.15: Further parameter fitting results of the bound ethidium bromide model to
the data of individual knockouts, having fixed AEST parameters (5.24). In (a) we show
the S knockout with resulting efflux parameter in (b). In (c) we show the T knockout with
resulting efflux parameter in (d). Finally, in (e) we show the AE knockout with resulting
efflux parameter in (f).
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In Figure 5.16 (a) we show all of our fitted efflux profiles compiled onto one plot.
Similar to Section 4.7.1, we assume that efflux from each individual efflux pump is the
same from strain to strain (when said efflux pump is active) and is additive, we can find
the level of efflux from each efflux pump by solving a system of simultaneous equations.
In (b) we plot the individual efflux variables derived under this assumption.
(a)








Figure 5.16: Compiled efflux profiles from our parameter fitting results of the ethidium
bromide model with substrate dependent efflux. In (a) we show the profiles of our efflux
knockout strains, in (b) we show the profiles of our estimated individual efflux profiles.
We can see that this puts the value from the efflux pump AcrEF (XE) to be negative.
We know this is not possible and thus the assumption made above must not be correct.
However, we know from our GRN model that if AcrAB levels are high AcrEF levels are
low and there is a switch between these pumps. Thus we make another assumption that
there is no AcrEF (XE = 0) when AcrAB (XA) is active and also group MdsAB and
MdtAB as one pump (XS + XT = XST ), due to both pumps not being involved in our
GRN model. Thus our simultaneous equations to be solved are
XA +XST = XAST , (5.31)
XE +XST = XEST , (5.32)
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which results in the efflux values
XA = XAST −XST , (5.33)
XE = XEST −XST . (5.34)
We plot these values in Figure 5.17, showing the efflux profile for AcrEF only when
AcrAB is not active. All profiles are now positive which could possibly suggest that there
is interplay between the efflux pumps and that when a pump is knocked out, there is a
noticeable effect upon the other pumps in the cell. In addition the behaviour for the two
main efflux pumps is very similar, showing an early increase before rapidly decreasing to
reach a steady state. These factors could be due to many mechanisms, however our GRN-
model efflux proteins (AcrAB and AcrEF) do exhibit similar behaviour to these efflux
profiles. Therefore the interaction of genes that govern expression of the efflux pumps
could be prominent in determining the efflux profiles of the RND pumps. Thus the GRN
behaviour may provide a pivotal role in substrate efflux over long time and determining
the spatial distribution of substrate concentration within the Salmonella cells and their
environment.




Figure 5.17: Efflux profiles from our parameter fitting results of the ethidium bromide
model with substrate dependent efflux. Here we show the profiles of our estimated efflux
profiles for AcrAB and AcrEF, with strain results for ST (MdsAB and MdtAB).
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5.7 Compartmental Model
In the previous subsections, we have produced a PDE model and applied parameter fitting
techniques on the spatial average of the intracellular concentration to fit to experimental
data. An alternative approach however, could have been taken utilising compartmental
models using ODEs. In this section, we compartmentalise our model (5.1)-(5.3) and
compare the differences in simulations between the ODE and PDE models. In order to












r2 ci(r, t) dr, (5.35)












where i = B, I, E. If we take the volume integral of our equation for bound ethidium













r2 sin(θ) (DB∇2cB − αcB + βcI) dr dθ dφ,
(5.37)



























− αc̄B + βc̄I , (5.40)
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= −αc̄B + βc̄I . (5.41)
Next, we assume that all rates of diffusion are much faster compared to other reaction rates




= −αcB + βcI . (5.42)











− αc̄B + βc̄I , (5.43)
In this case, we substitute our membrane boundary condition for unbound intracellular






(−(P +X)cI(RM , t) + PcE(RM , t))− αc̄B + βc̄I , (5.44)
We again assume that the compartment concentrations are uniform (hence c̄i = ci and









cI + αcB − βcI , (5.45)





















In this case, we use our boundary conditions for the extracellular ethidium bromide. We
have a no flux boundary at r = RB (5.7), and the membrane condition at r = RM (5.5).
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We note that this model retains the majority of the parameters from the PDE model,
however there is no dependence on the diffusion coefficients DB, DI and DE. In Figure
5.18, we exhibit the simulations comparing the ODE and PDE models, using the optimal
parameters for the AEST and wild-type cases in Section 5.6.2. We can see from the
simulations that for the chosen parameters the ODE model encapsulates the behaviour
of the PDE model well, with little difference in their simulations. In Figure 5.19 however,
we exhibit the simulations with slower diffusion rates (by a factor of 100). We can see
that there are large differences between the model simulations, with the ODE model not
being able to encapsulate the changes in behaviour to the PDE model. In Figure 5.20, we
exhibit a parameter variation plot comparing the root mean square error (RMSE) of all
concentrations between ODE and PDE models, using the optimal wild-type parameters.
We can see that when either diffusion rate is small enough, the assumption of a uniform
concentration within the compartments fails and thus the behaviour in the ODE model
does not match up to the behaviour in the PDE model. Therefore, whilst for the optimal
parameters chosen the ODE model may be sufficient, if we were to model a different
substrate that diffuses differently we may not encapsulate the substrate’s full behaviour.
In addition if we were to introduce a synthetic molecule to try to combat substrate efflux
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the ODE model may not be sufficient i.e. a molecule that binds to the substrate affecting
its diffusion dynamics. For these reasons, we continue using the PDE model for the
remaining sections.












































Figure 5.18: Simulations comparing the compartmental ODE and spatial PDE model. In
(a) we exhibit simulations using the AEST optimal parameters, whilst in (b) we use the
optimal wild-type parameters.













































Figure 5.19: Simulations comparing the compartmental ODE and spatial PDE model
with slower substrate diffusion (by a factor of 100). In (a) we exhibit simulations using
the AEST optimal parameters, whilst in (b) we use the optimal wild-type parameters.
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(a)
















Figure 5.20: Parameter variation plots exhibiting the RMSE between the ODE and PDE
models for all concentrations, varying the log of diffusion parameters DI and DE to greater
show the differences in RMSE for small values of diffusion. In (a) we exhibit a 3D mesh
and (b) a contour plot.
5.8 Discussion
We have adapted our previous spatial model to greater encapsulate the dynamics of sub-
strate expulsion of a single cell by including the binding dynamics of ethidium bromide.
By using finite difference methods, we have discretised our domain and produced numeri-
cal solutions for both concentrations of bound and unbound ethidium bromide, including
the interplay between both concentrations. We have produced multiple simulations, vary-
ing parameters to best present insights into the model. Whilst the long term dynamics
are similar to the original model, it is shown that the short and medium term dynamics
have changed. By introducing two states of ethidium bromide we have caused the fluo-
rescing intracellular substrate concentration to decrease more slowly at early time, with
the depreciation depending on the binding and unbinding rates as well as the membrane
permeability and efflux parameters.
We have then implemented parameter fitting techniques using our more in depth
bound ethidium bromide model. Upon initial parameter fitting exercises, it was shown
that although the model fitted well to the AEST knockout data, it struggled to model
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the wild-type dynamics when including an efflux parameter. We have conducted joint
parameter fitting exercises, minimising a combined objective function for both data sets.
Whilst the fit for the wild-type case was much improved, the fit for the AEST knockout
was compromised, with a greater peak at initial concentration and the model appearing
to reach a steady state at a higher concentration than the data suggests.
It is clear that the efflux behaviour in the model was not fully accurate, with the
constant efflux parameter unable to fully replicate the dynamics of the drop in substrate
concentration seen in the data. By including efflux as a variable instead, we have been
able to improve our model fits for both cases of knockout and wild-type, with the model
demonstrating the difference in dynamics between both cases. By again fitting to both
cases simultaneously with a joint objective function, we have further been able to improve
our fits, with minimal compromise to the fit of the AEST case. Furthermore, we have
produced fits where efflux is dependent on the internal substrate. This has provided us
with our optimal fits and also interesting profiles for our efflux variables. We noted that
the efflux profiles are similar to simulations of the expression of genes in our GRN model,
leading us to believe that gene expression could be the cause of this efflux profile on this
time period. This suggests that combining our GRN model with our spatial model is an
appropriate next step and will enable us to make predictions about adaptations to the
GRN and how they could affect the antibiotic concentration within the cell. In addition,
we have compartmentalised our model, simplifying our existing PDE model into an ODE
model. Whilst the ODE model provided good simulations with our optimal parameters,
we have shown the limitations of the ODE model for modelling different substrates or
manipulations. Therefore in the following sections we opt to use our PDE model rather





In the previous chapters, we have constructed two independent models. The first in Chap-
ter 2, is a model of the GRN governing the expression of efflux proteins that constitute
the efflux pumps AcrAB and AcrEF for a Salmonella cell. The second model in Chapter
5, is a spatial model of substrate efflux from a Salmonella culture, exhibiting the efflux
caused by four RND efflux pumps AcrAB, AcrEF, MdsAB and MdtAB. Upon parameter
fitting of the spatial model, we were able to gain insights into the efflux dynamics over
time when a culture was subject to a stressor, namely Ethidium Bromide. From multiple
parameter fitting exercises, it was shown that these dynamics in the spatial model were
similar to the expression of efflux pump proteins in the GRN model. It was also shown
that substrate dependent efflux best captured the dynamics of the data, agreeing with
our knowledge that bacteria can react to their environment. One way that we already
know bacteria can do this is by varying expression of genes that control aspects of the
bacterial behaviour. In this chapter, we will combine the GRN model with the spatial
model, in order to create a multiscale model of the Salmonella population and its envi-
ronment. This model will enable us to draw hypotheses on manipulating aspects of the
GRN and the resulting effect upon substrate concentration in a culture. By creating this
multiscale model, we have a more realistic and complete model that should capture more
of the important aspects of the population’s behaviour than the previous models.
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6.2 GRN Model Adaptation
Following our asymptotic analysis in Chapter 3, we have identified the genes that dominate
processes within the network. Thus for simplicity, in this section we use this analysis
to create a simplified version of the GRN in Chapter 2. One change is to remove the
secondary TAs soxS, marA and rob. Our asymptotic analysis concluded that once ramA
is expressed, these secondary TAs did not produce a noticeable effect at long time on the
expression of the efflux pump genes. The second change to the network is to remove the
post transcriptional activator CsrA. Since this protein was not linked to other mechanisms
within the network, mathematically we can easily incorporate the effect of this protein
by altering the translation rate of acrAB mRNA. Thus for simplicity, we choose to omit
this protein from the network.
Since our initial construction of the GRN, the knowledge of the mechanisms within
the network has been broadened [27]. In order for our model to fully encapsulate the
new mechanisms within the network, we further adapt our GRN model. We exhibit our
updated network in Figure 6.1, with the following changes exhibited by dashed lines:
• RamA activates acrEF as well as acrAB [5].
• The link between the expression of acrAB and acrEF, is governed by heat-stable
nucleoid-structuring protein (H-NS) [62].
In regards to the first change, previously the expression of acrEF was only governed
by EnvR. Thus we should see new interesting dynamics to the network with acrEF now
also being dependent on the activator protein RamA to be transcribed. In regards to the
second change, we have replaced our theoretical link between both efflux pumps in our
previous GRN model with the molecule H-NS. We exhibit the interactions that involve
H-NS in Figure 6.2. When H-NS is active, it inhibits expression of both envR and acrEF
[12]. H-NS is believed to be involved in the experimentally observed switching dynamics
of the two efflux pumps, such that acrEF expression is activated when acrAB expression




























































































































































































































































































































































































AcrAB will activate the molecule H-NS, hence inhibiting the expression of both acrEF
and envR. To include this into our model we assume that the variable H-NS will vary
between 1 (when active) and 0 (when inactive). We represent the variable for H-NS




where kh is the activation rate of H-NS linked to AcrAB concentration and mh is the












Figure 6.2: A schematic of a section of the GRN model, demonstrating the interactions
that involve H-NS. This includes the proteins AcrAB and H-NS, and the genes envR and
acrEF.
From our parameter fitting exercises, we achieved the best results when efflux was
dependent upon the substrate concentration. To combine the two models, rather than
choosing the substrate concentration to have a direct effect upon the expression of both
efflux pumps, we choose to target the areas in the network that are most likely to be
affected by a stressor, backed up by consultations with the Blair group and Piddock
group at the University of Birmingham. We plot our updated GRN model that has
substrate concentration as a signal in Figure 6.1, with the following changes exhibited by
209
dot dashed lines:
• The internal substrate concentration inhibits expression of ramR [39].
• The internal substrate concentration inhibits the concentration of Lon Protease
within the cell [39].
In regards to the first change, ramR is the local repressor of ramA, the primary activator
of both efflux pumps. By targeting ramR, we should see an indirect effect upon ramA
expression. For the second change, by targeting Lon Protease concentration, we indirectly
affect RamA concentration by altering the protein’s degradation. In regards to the efflux
of the substrate, we assume that efflux will correspond with both translation of AcrAB
and AcrEF. We incorporate this by assuming that the efflux rate is proportional to the
combined concentrations of these efflux pump proteins. In addition, since both MdsAB
and MdtAB (which were both involved in the experiments) and their corresponding genes
are not involved in this GRN, we include their corresponding efflux rates from their
parameter fitted equations in the previous chapter. The equations for the combined GRN







































= µ(m1Rm − δpR), (6.9)
dA
dt










= m4Bm − δpB, (6.12)
dE
dt
= m5Em − δpE, (6.13)
dF
dt
= m6Fm − δpF, (6.14)
dXST
dt
= φST I − δSTXST , (6.15)
∂cB
∂t
= DB∇2cB − αcB + βcI , (6.16)
∂cI
∂t









r2 cB(r, t) dr. (6.19)
Here I denotes the averaged internal concentration of bound substrate. As the mRNAs
and proteins in the GRN only exist in the intracellular space, for simplicity of reducing
the number of unknown parameters we have opted to not include spatial effects on these
variables. In regards to our GRN equations, these have been modified compared to our
model equations in Chapter 2. Firstly by using insights into the asymptotic analysis we
have adapted equations (6.6) and (6.12). From the former we have removed activation
from SoxS (also removing soxS mRNA and SoxS entirely from the model) whilst the
latter we have removed CsrA from the translation terms of acrAB. By using updates from
further knowledge into the GRN, we have updated equations (6.7) and (6.8), including
the assumption that H-NS must not be active for mRNA transcription in both equations,
whilst including dependence on RamA concentration on the latter. In addition, we have
modified our basal ramA transcription rate in (6.4). Rather than including a standard
basal transcription rate regardless of whether a protein is bound to the promoter region
of ramA, we have chosen to only include transcription in the times where RamA or no
proteins are bound to the promoter region. Finally, we have included the GRN influence
from internal bound substrate by regulating ramR mRNA transcription in (6.3) and
regulating Lon Protease degradation in (6.10). Whilst MdsAB and MdtAB do not feature
within the GRN we include their rate of efflux in (6.15), this is in order for us to replicate
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the full dynamics of the spatial model shown from the parameter fitting results in Chapter









































The first set of boundary conditions (6.20) represent axisymmetry in both angular di-
mensions for bound and unbound substrate. The boundary condition (6.21) represents
our membrane boundary condition for unbound substrate. In this boundary condition
we set our efflux rate X =
B + F
XC
+ XST . We have included the efflux rate of MdsAB
and MdtAB directly as XST in this equation, however for AcrAB (B) and AcrEF (F)
we link their concentrations to their efflux rates by assuming a directly proportional re-
lationship, dividing both concentrations by an efflux rate constant XC . The final set of
boundary conditions (6.22) represents no flux boundary conditions, for bound substrate
at the membrane and unbound substrate at the outer boundary. The initial conditions
for each concentration are as follows
cB(r, 0) =

CB0, 0 ≤ r ≤ RM ,
0, RM < r ≤ RB,
cI(r, 0) =

γ CB0, 0 ≤ r ≤ RM ,
0, RM < r ≤ RB,
(6.23)
where CB0 is the initial concentration of bound substrate. These initial conditions denote
the concentrations for bound and unbound substrate. We express the initial condition
for the unbound substrate as a ratio of the bound substrate using γ. In regards to the
initial conditions for the GRN and efflux we have down-regulated initial conditions for the
mRNAs and proteins of all repressor genes (ramR, acrR and envR). For the mRNAs and
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proteins of the remaining genes (ramA, acrAB and acrEF ), we will estimate their initial
conditions in order to replicate the experiments. In the experiments, the cell has had a
short amount of time to react to the substrate before the first measurement is taken and
thus we should expect some activation of expression of the efflux genes and their activator
genes. This behaviour is also shown in the parameter fitted efflux dynamics, as the initial
conditions for the efflux rates of individual pumps are not fully down regulated. Finally,
the initial condition for the efflux rate of MdsAB and MdtAB follows from our fitted
initial condition in the previous chapter. The notation for the initial conditions are then
as follows:
Rm(0) = Cm(0) = Em(0) = Gm0, R(0) = C(0) = E(0) = G0, XST (0) = XST0, (6.24)
Am(0) = Am0, Bm(0) = Bm0, Fm(0) = Fm0, (6.25)
A(0) = A0, B(0) = B0, F (0) = F0. (6.26)
We will provide the exact values in the following section. We list all of the variables and
parameters used in our model in Tables 6.1 and 6.2. In all future simulations, we will be
using the finite difference method in Chapter 5 to approximate our model, using spatial
step ∆r = 0.25 and time step ∆t =
∆r2
4DMAX
, where DMAX = max(DI , DE, DB).
6.3 Numerical Simulations
In this section, we will exhibit numerical simulations of the multiscale model, attempting
to replicate similar results from fitting to the same data used in Chapter 5. As we have
assumed a directly proportional relationship between the fluorescence and intracellular
bound concentration of substrate, we again model our substrate in terms of relative con-
centration so we can compare the model directly against the data. Since we have data
for both wild-type and EST knockout strains, we compare the model against the data of
these strains using parameter values from Table 6.2. We have aimed to keep parameters
as similar as possible to those in the previous GRN model in Chapter 2 and have main-
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Variables Description Units
Rm Concentration of ramR mRNA nM
R Concentration of RamR nM
Am Concentration of ramA mRNA nM
A Concentration of RamA nM
Cm Concentration of acrR mRNA nM
C Concentration of AcrR nM
Bm Concentration of acrAB mRNA nM
B Concentration of AcrAB nM
Em Concentration of envR mRNA nM
E Concentration of EnvR nM
Fm Concentration of acrEF mRNA nM
F Concentration of AcrEF nM
X Combined efflux rate of all pumps µmmin−1
XST Efflux rate of MdsAB and MdtAB µmmin
−1
cB Relative concentration of bound substrate N/A
cI Relative concentration of unbound substrate N/A
N Averaged intracellular concentration of bound substrate N/A
Table 6.1: Variables used in our multiscale model along with their respective units.
Parameter Description Estimate Units
k1 Transcription Rate of ramR mRNA 10 nMmin
−1
m1 Translation Rate of RamR 1 min
−1
k2 Transcription Rate of ramA mRNA 10 nMmin
−1
m2 Translation Rate of RamA 1 min
−1
k3 Transcription Rate of acrR mRNA 10 nMmin
−1
m3 Translation Rate of AcrR 1 min
−1
k4 Transcription Rate of acrAB mRNA 10 nMmin
−1
m4 Translation Rate of AcrAB 1 min
−1
k5 Transcription Rate of envR mRNA 10 nMmin
−1
m5 Translation Rate of EnvR 1 min
−1
k6 Transcription Rate of acrEF mRNA 10 nMmin
−1
m6 Translation Rate of AcrEF 1 min
−1
δm Degradation Rate of mRNA 1 min
−1
δp Degradation Rate of proteins 0.05 min
−1
d1L Degradation caused by Lon Protease 0.37 min
−1
KR Dissociation Constant of RamR 6.58 nM
KA1 Dissociation Constant of RamA with ramA and acrAB 2 nM
KA2 Dissociation Constant of RamA with acrR 2 nM
KA3 Dissociation Constant of RamA with acrEF 60 nM
KC Dissociation Constant of AcrR 20.2 nM
KE1 Dissociation Constant of EnvR with acrEF 20.2 nM
KE2 Dissociation Constant of EnvR with acrAB 20.2 nM
KI Saturation Constant of Substrate 0.3 nM
KH Dissociation Constant of H-NS 1 nM
µ Mutation Coefficient 0 or 1 N/A
P Permeability Mass Transfer Coefficient 0.01 µmmin−1
XC Efflux Conversion Constant 500 nMminµm
−1
DB Diffusion Coefficient Of Bound Substrate 0 µm
2min−1
DI Diffusion Coefficient Of Unbound Intracellular Substrate 2.30 or 1 µm
2min−1
DE Diffusion Coefficient Of Unbound Extracellular Substrate 1.01 µm
2min−1
RM Membrane Radius 2 µm
RB Outer Boundary Radius 4 µm
α Unbinding Rate Of Bound Substrate 0.22 min−1
β Binding Rate Of Unbound Substrate 0.09 min−1
φST Increase In MdsAB And MdtAB Efflux Rate 1.57× 10−4 µmmin−1
δST Decrease In MdsAB And MdtAB Efflux Rate 2.94× 10−2 µmmin−1
Table 6.2: Parameters used in our multiscale model with their estimated values and units.
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tained the fitted spatial parameters from Chapter 5. We opt not to compare against the
data of the remaining strains: AST (AcrAB, MdsAB and MdtAB), AET (AcrAB, AcrEF
and MdtAB), AES (AcrAB, AcrEF and MdsAB), ST (MdsAB and MdtAB). We do not
use this data as the first three strains (which have AcrAB active) do not hugely differ in
dynamics to the wild-type strain. Furthermore for the last strain, the genes that govern
MdsAB and MdtAB do not feature within our GRN. For comparing against the data for
the EST strain, we have knocked out acrAB in the GRN by setting k4,m4 = 0. Although
we do not have the data for any RamR mutant strain, we will run simulations to predict
the behaviour of the strain by mutating RamR in the GRN, setting µ = 0. Recall that
this mutation is known for causing the strain to confer MDR. In total we simulate four
strains: wild-type, EST knockout, RamR mutant and EST RamR mutant, detailing them
in Table 6.3.
Strain Name Active Efflux Pumps Mutations
Wild-type AcrAB, AcrEF, MdsAB, MdtAB N/A
EST AcrEF, MdsAB, MdtAB N/A
RamR Mutant AcrAB, AcrEF, MdsAB, MdtAB RamR
EST RamR mutant AcrEF, MdsAB, MdtAB RamR
Table 6.3: A summary of the strains involved in this section. We list each strain’s active
efflux pumps and any mutations to their GRNs.
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For the following simulations, we set down-regulated initial conditions for the repressor
mRNAs and proteins (Gm0 = G0 = 0.01nM) and set the initial condition for the efflux
rate of MdsAB and MdtAB from the parameter fitting results (XST0 = 2.12× 10−4nM).
For the mRNAs and proteins of the remaining genes ramA, acrAB and acrEF, their initial
conditions will vary depending on the strain we are modelling. To choose these initial
conditions, we first run a simulation for each strain with down-regulated initial conditions
for all mRNAs and proteins (Am0 = A0 = Bm0 = B0 = Fm0 = F0 = 0.01nM). For the
wild-type and RamR mutant strains, we expect acrEF expression to be down-regulated
as acrAB is active, so we maintain the initial conditions Fm0 = F0 = 0.01nM. For the
EST and EST RamR mutant strains, the gene acrAB is knocked out entirely so we set
Bm0 = B0 = 0. For the remaining variables, in the wild-type and EST strains, we choose
the initial condition of the variables to be half of the maximum value over the full time
course in the down-regulated simulation i.e. the system has had a short period of time
to react from a down-regulated state. For the RamR mutant and EST RamR mutant
strains, we choose the initial condition of the variables to be the steady state values in
the down-regulated simulation i.e. with RamR mutated there is always high expression of
ramA and acrAB or acrEF. In addition, as RamR is mutated in the latter two strains, we
set the initial condition of RamR protein R(0) = 0nM. We display these initial conditions
in Table 6.4. We produce simulations using these initial conditions in Figures 6.3-6.6
for the wild-type strain, EST (AcrAB knockout) strain, RamR mutant strain and EST
RamR mutant strain respectively.
Strain Name Am0 (nM) A0 (nM) Bm0 (nM) B0 (nM) Fm0 (nM) F0 (nM) G0 (nM) R(0) (nM)
Wild-type 3.6256 12.1458 3.1665 36.9524 0.01 0.01 0.01 0.01
EST 3.5985 12.2401 0 0 0.4798 3.5434 0.01 0.01
RamR Mutant 10 25.3726 5.0964 102.0014 0.01 0.01 0.01 0
EST RamR mutant 10 33.5428 0 0 0.3297 6.7758 0.01 0
Table 6.4: Initial condition values for strains involved in this section.
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For the wild-type strain mRNAs (Figure 6.3 (a)) and proteins (Figure 6.3(b)), at early
time we see low concentrations of ramR mRNA and RamR as the gene is inactive in the
presence of a high internal substrate concentration. This in turn allows fast expression
of ramA, resulting in large concentrations of RamA protein, activating the expression of
the efflux pump gene acrAB. Since the local efflux repressor acrR is inhibited by a large
concentration of RamA, we see higher expression of acrAB. This leads to an increase in
efflux rate (Figure 6.3(d)) and resulting expulsion of substrate from within the cell (Figure
6.3(c)). Once the intracellular bound substrate concentration is sufficiently low, we see
increased activation of ramR expression resulting in inhibition of the expression of the
network’s main activator ramA. The local efflux repressor acrR is able to express at a
faster rate due to a lower concentration of RamA. The lower concentration of RamA and
larger AcrR concentration result in less acrAB expression both indirectly and directly
respectively. This results in a decrease in efflux rate and results in an equilibrium be-
tween the transfer of intracellular and extracellular substrate. We note that the model
comparison to the data (Figure 6.3(c)) is not perfect, with mid time dynamics appear-
ing outside the standard error of the data. However, we have opted not to largely differ
our GRN parameter choices from Chapter 2 by manually editing parameters as little as
possible. Alternatively, we could run new parameter fitting exercises including the GRN
parameters, however due to the high number of parameters within the network compared
to the available data, there will likely be many non identifiable parameters.
We show the simulation of the EST strain in Figure 6.4. For (a) and (b), we note
that for all time there is no expression of acrAB due to the gene being knocked out in
this strain. Without the presence of AcrAB in this strain, there is no activation of H-NS
meaning that both envR and acrEF can be expressed freely. Thus at early time, similar
to the wild-type strain, with low concentrations of ramR mRNA and RamR due to a high
internal substrate concentration, we see activation of ramA expression, with RamA this
time activating expression of acrEF. Due to the difference in the dissociation constants of
RamA with acrEF and acrAB, we see less acrEF expression compared to the expression
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of acrAB in the wild-type strain (Figure 6.3(a) and (b)). The expression of acrEF is also
reduced by the constitutive expression of envR and hence we see a lower efflux rate (Figure
6.4 (d)) than in the wild-type strain (Figure 6.3 (d)). Thus substrate is expelled from the
intracellular space at a slower rate (Figure 6.4 (c)). There is also less expression of ramR
due to a higher intracellular substrate concentration, which reaches an equilibrium steady
state with the extracellular substrate at a higher concentration than that of the wild-type
strain. We note that we have achieved a good model fit to the data in this case (Figure
6.4 (c)), with almost all of the model fitting within the standard error of the data.
We show the simulation of the RamR mutant strain in Figure 6.5, exhibited against
the simulation of the wild-type strain in 6.5 (c) as a comparison (recall that there is
no experimental data for this strain). Following from Chapter 2, we have assumed that
RamR protein is mutated and thus there is no functional RamR in the system (Figure 6.5
(a) and (b)). This means that there is no inhibition of ramA expression, resulting in large
concentrations of RamA activating acrAB expression. This results in a large efflux rate
(Figure 6.5 (d)), comparatively larger than the wild-type strain (Figure 6.3 (d)). As the
intracellular bound concentration of substrate decreases (Figure 6.5 (c)), we see increased
degradation of RamA caused by an increased concentration of Lon Protease. At long
time we see both concentrations of RamA and AcrAB reach steady state, with almost all
substrate expelled from the intracellular space. Compared to the wild-type strain (Figure
6.5 (c)), we can see that there is less feedback from the internal substrate concentration
within the GRN on mid and long time. Mainly, the intracellular bound substrate reaches
a steady state that is below the concentration shown by the wild-type, clearly exhibiting
the strains ability to display MDR.
We show the simulation of the RamR mutant EST strain in Figure 6.6, exhibited
against the EST strain simulation for comparison in Figure 6.6 (c). Similar to the previous
strain there is no restriction upon expression of ramA due to no presence of RamR (Figure
6.6 (a) and (b)). However in this strain as acrAB is knocked out, we see RamA activating
acrEF expression. Whilst early time does not hugely differ from the normal EST strain,
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we see that with a higher RamA concentration, the concentration of AcrEF achieves a
higher steady state. This results in an efflux rate (Figure 6.6 (d)) similar to the wild-type
case (Figure 6.3 (d)) and a steady state of intracellular bound substrate concentration
(Figure 6.6 (c)) lower than the normal EST strain (Figure 6.4 (c)) i.e. this strain is


















Figure 6.3: Our multiscale model of the wild-type strain, run for the time course of the
wild-type data. In (a) we show the concentration of mRNAs over time, (b) we show
the concentration of proteins. In (c) we exhibit the substrate concentration over time
against the experimental data and (d) the corresponding efflux rate X, with efflux rate




















Figure 6.4: Our multiscale model of the EST strain (acrAB knockout,
k4,m4, Bm(0), B(0) = 0), run for the time course of the EST data. In (a) we show
the concentration of mRNAs over time, (b) we show the concentration of proteins. In
(c) we exhibit the substrate concentration over time against the experimental data and
(d) the corresponding efflux rate X, with efflux rate contributed by AcrAB (AB), AcrEF




















Figure 6.5: Our multiscale model showing a RamR mutant strain (µ,R(0) = 0), run
for the time course of the wild-type data. In (a) we show the concentration of mRNAs
over time, (b) we show the concentration of proteins. In (c) we exhibit the substrate
concentration over time compared against the simulation from the wild-type strain and
(d) the corresponding efflux rate X, with efflux rate contributed by AcrAB (AB), AcrEF


















Figure 6.6: Our multiscale model showing the RamR mutant EST strain (k4,m4, Bm(0),
B(0), µ, R(0) = 0), run for the time course of the EST data. In (a) we show the con-
centration of mRNAs over time, (b) we show the concentration of proteins. In (c) we
exhibit the substrate concentration over time compared against the simulation from the
EST case and (d) the corresponding efflux rate X, with efflux rate contributed by AcrAB
(AB), AcrEF (EF) and the sum of MdsAB and MdtAB (ST).
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Finally, in Figure 6.7, we compare the substrate expulsion of all strains. In (a) we plot
all time dependent simulations of the strains on one plot. In (b) we use the trapezium
rule (function “trapz” in MATLAB) to approximate the area under the curve (AUC) of
each strain simulated in (a). The AUC shows us the overall relative substrate exposure
over the simulated time course [90]. Immediately we can clearly see the benefits of the
RamR mutation for both strains as there is a clear reduction in substrate over all time for
strains with this mutation over their counterparts (Figure 6.7(b)). It is also interesting
to note that at steady state the EST RamR mutant achieves a similar value to that of
the wild-type strain (Figure 6.7(a)). This shows that even with acrAB knocked out, the
strain (which has mutated RamR) is able to compensate by using the secondary pump
system acrEF to achieve similar efflux in the long term to that of the wild-type. Finally
we note that, initially, the wild-type strain and RamR mutant display similar levels of
efflux (albeit the RamR mutant exhibiting slightly faster expulsion). However in the long
term, the RamR mutant maintains high levels of efflux, almost eliminating all substrate
from the intracellular space. This clearly shows the advantages of the RamR mutation,
the strain is able to prevent large concentrations of intracellular substrate and this is a
huge contributor to its ability to exhibit MDR.





























Figure 6.7: Our multi scale model showing the intracellular bound substrate concentration
over time for all strains. In (a) we show time dependent plots of all strains, in (b) we
approximate the AUC of the strains in (a) using the trapezium rule, to show the overall
relative substrate exposure. The wild-type strain is simulated using all parameters values
in Table 6.2, the EST case has k4,m4 = 0, RamR mutant µ = 0, and EST RamR mutant
k4,m4, µ = 0.
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6.4 Parameter Sensitivity
Similar to analysis in previous chapters, we conduct a sensitivity analysis of the parameters





where δĪ represents the change of bound intracellular substrate concentration steady state
for the simulated strain, and δP represents the change of the parameter being varied. If
we define P ∗ to be the default parameter value for the current parameter being varied,
we then vary the parameter in the space [0, 10P ∗]. By using a Latin hypercube method
of sampling, we choose 10000 points in the parameter space and apply these to each
individual parameter, finding the relative sensitivity for each point. We choose to omit
the parameters primarily involved in the spatial distribution of substrate, only varying
parameters involved in the GRN, since this is the mechanism we wish to target. We also
choose to omit the degradation parameters, since these are mostly universal to all of the
genes. Hence varying these parameters would involve targeting all genes simultaneously
which is not only an unrealistic target but will exhibit similar behaviour to preventing
the whole network from being expressed.
6.4.1 Wild-type strain
We exhibit the parameter sensitivity results using the steady state for the wild-type strain
with box plots in Figure 6.8. In (a) we denote the dissociation and saturation constants
involved in the model, we can immediately see that the dissociation constant related to
RamR (KR) is the most sensitive. By varying this parameter we should see direct effects
on the activation of ramA transcription. It is interesting to note that the sensitivity of
this parameter is larger than that of any of the dissociations constants related to RamA
(KAi). Thus in this strain, targeting ramA expression via a repressor to reduce the genes
expression may be a more effective method than targeting the RamA binding process to
the promoter regions of various other genes in the network. However, we must note that
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the sensitivity of all RamA dissociation constants are still significant, with the dissociation
with ramA and acrAB (KA1) showing more sensitivity than the dissociation with acrR
(KA2) and acrEF (KA3). This is expected, as in this wild-type strain we have normal
levels of acrAB expression, so we should expect lower expression of acrEF and hence a
smaller sensitivity upon parameters related to it. We note that the other two parameters
with notable significance, are related to AcrR (KC) and substrate (KI). The first of
these is expected due to direct inhibition of expression of the efflux pump gene acrAB.
Regarding KI , we do not know the full mechanisms behind how the substrate interacts
with the network, but this could provide insight for potential further research. We show
transcription and translation rates in (b). We note that for each individual gene the
transcription rates show similar sensitivity to the translation rates. Thus when targeting
gene expression, both transcription and translation seem to be feasible targets. It is clear
that the wild-type system is the most sensitive to the expression of four genes, namely
ramR and ramA, acrR and acrAB. This gives us clear insights into the most important
genes to target when inhibiting efflux in a wild-type strain. The other genes are envR
and acrEF, with the strain exhibiting little sensitivity to either. This again is expected,
as with no major restrictions upon acrAB expression we expect H-NS to be prevalent and







Figure 6.8: Box plots showing the relative sensitivity of parameters involved in the GRN
for the wild-type strain, varying parameters in the region [0, 10P ∗], where P ∗ is the default
parameter value. In (a) we depict the dissociation and saturation constants, in (b) we
depict the various transcription and translation rates related to mRNAs and proteins.
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6.4.2 EST strain
We exhibit the parameter sensitivity results using the steady state for the EST strain in
Figure 6.9. As expected due to the gene being knocked out, we can immediately see that
all parameters involved with acrAB have lost all sensitivity. In (a) the most sensitive
parameter is the dissociation of RamA with acrEF (KA3). This is expected as AcrEF is
the only active efflux pump in this strain. Compared to the wild-type strain (Figure 6.8),
we can see decreased sensitivity to the dissociation of RamR (KR). This could be due
to RamA having a smaller activation effect on acrEF expression than acrAB expression,
thus inhibition of ramA expression from RamR would have less of an effect. We also
see increased sensitivity of the dissociation of EnvR from acrAB and acrEF. With envR
being constitutively expressed in this case, we should expect higher sensitivity from this
local repressor. In (b) we note the most sensitive parameters are related to the expression
of ramR, ramA, envR and acrEF. The strain shows similar sensitivities to all of these
genes and thus targeting any of their expressions should be a viable target for inhibiting
efflux. Notably however, the strain is most sensitive to envR and acrEF, leading us to
believe that repressing acrEF expression directly or via envR may be a more effective









Figure 6.9: Box plots showing the relative sensitivity of parameters involved in the GRN
for the EST strain, varying parameters in the region [0, 10P ∗], where P ∗ is the default
parameter value. In (a) we depict the dissociation and saturation constants, in (b) we
depict the various transcription and translation rates related to mRNAs and proteins.
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6.4.3 RamR mutant strain
We exhibit the parameter sensitivity results using the steady state for the RamR mutant
strain in Figure 6.10. Immediately, compared to the wild-type strain (Figure 6.8) we can
see that all of the parameters relating to ramR (KR, k1 and m1) all have no sensitivity
due to the mutations of RamR. Additionally the sensitivity of the desaturation constant
relating to substrate (KI) is reduced, which could be due to the substrate only now having
an effect on Lon Protease concentration due to the mutations of RamR. In (a) we can see
that the dissociation of RamA with acrR (KA2) is the most sensitive, this is interesting
to note as our time dependent asymptotic analysis uncovered this link as one of the
key mechanisms for activating efflux in this mutant strain. The other RamA dissociation
parameters range of sensitivity are both decreased compared to the wild-type strain, which
could be due to the higher concentration of RamA in this strain, such that large activation
will occur regardless of the dissociation constant. We note the sensitivity of dissociation
related to acrEF (KA3) is minimal, which is expected due to high acrAB expression in this
strain. We also see an increase in the dissociation of H-NS (KH), which could be due to a
higher concentration of RamA. If H-NS does not inhibit acrEF expression so strongly, we
would see higher activation of acrEF expression through large concentrations of RamA. In
(b), we can see that the most sensitive parameters are related to the expression of ramA,
acrR and acrAB. The strain is most sensitive to acrAB expression, which we would expect
as it is direct expression of one of the efflux pumps, which is over-expressed in this strain.
Interestingly, there is increased sensitivity to changes in envR expression compared to the
wild-type (Figure 6.8). Whilst we have hardly any expression of envR in this strain, the
sensitivity increase here could be due to the overexpression of acrAB. We note that both
RamR mutant and wild-type strains exhibit similar sensitivity to changes in ramA and
















Figure 6.10: Box plots showing the relative sensitivity of parameters involved in the GRN
for the RamR mutant strain, varying parameters in the region [0, 10P ∗], where P ∗ is the
default parameter value. In (a) we depict the dissociation and saturation constants, in (b)
we depict the various transcription and translation rates related to mRNAs and proteins.
6.4.4 EST RamR mutant strain
We exhibit the parameter sensitivity results using the steady state for the EST RamR
mutant strain in Figure 6.11. As there are multiple manipulations to the genes in this
network, we can see that the amount of parameters that exhibit sensitivity has decreased
compared to the wild-type strain. As expected, all parameters relating to acrAB and
ramR are fully insensitive. Compared to the EST strain (6.9), we can see in (a) that the
most sensitive parameter is the dissociation constant of EnvR from acrEF and acrAB
(KE). This could be due to the overexpression of acrEF in this strain and hence the
local repressor would be likely to exhibit higher sensitivity. We note that the dissociation
of RamA with acrEF (KA3) has reduced in this strain, which could be due to a higher
concentration of RamA in the system and hence large activation is likely to occur regard-
less of the dissociation constant. In (b) we can see that the parameters related to the
expression of all genes have become much more sensitive compared to the EST strain,
with the strain most sensitive to changes in envR and acrEF expression. Again, this
leads us to believe that repressing acrEF expression may be a more effective target than








Figure 6.11: Box plots showing the relative sensitivity of parameters involved in the GRN
for the EST RamR mutant strain, varying parameters in the region [0, 10P ∗], where P ∗ is
the default parameter value. In (a) we depict the dissociation and saturation constants,
in (b) we depict the various transcription and translation rates related to mRNAs and
proteins.
6.5 Network Manipulation
While the parameter sensitivity analysis has given us insight into the sensitivity of the
substrate at steady state, it is important to note that we do not know the effects caused
by manipulating parameters through the rest of the timecourse. Therefore we take the
parameters to which the model is most sensitive in the above analysis and plot relevant
time dependent simulations. As we would like to repress efflux expression for all strains,
we omit parameters relating to ramR expression, as RamR is not present in our mutant
strains. In addition we also omit direct acrAB and acrEF expression through transcrip-
tion and translation, due to them both being trivial targets to vary efflux expression. For
each parameter, we either multiply or divide the original parameter by a factor of ten, in
order to exhibit a proportionally sizeable manipulation from the original parameter value.
To exhibit our manipulations, for each strain we plot a simulation with default parameter
values against a simulation with manipulated parameter values. We find the AUC for
both of these simulations using the trapezium rule (function “trapz” in MATLAB) and
plot the difference between AUC for both default and manipulated simulations.
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Firstly, we show the effects of varying gene expression through transcription, demon-
strated by Figures 6.12-6.14. In Figure 6.12, we can see the effects of decreasing expression
of ramA. We note that a decrease in efflux is universal between all strains i.e. the intra-
cellular substrate increases. This is further highlighted in Figure 6.12 (e) as the change
in overall substrate exposure is large for all strains. However, we note that when it comes
to the EST strain (Figure 6.12 (b)), the steady state is hardly altered compared to the
normal simulation. This highlights the importance of time dependent simulations as there
is a sizeable difference in mid time dynamics which is missed by the parameter sensitivity
analysis.
In Figure 6.13, we can see the effects of increasing expression of acrR. Notably we see
no effects in either of the EST strains (Figure 6.13 (b), (d) and (e)). This is expected as
AcrR is the local repressor of acrAB, which is not present in these strains. Noticeable
differences to efflux dynamics is however shown in the wild-type and RamR mutant strains,
with an increase in intracellular substrate concentration over all time.
In Figure 6.14, we can see the effects of increasing expression of envR. Similar to
ramA, we can see notable differences to the efflux dynamics in all strains, shown by
notable differences to the substrate exposure (Figure 6.14 (e)). However, barring the EST
RamR mutant strain (Figure 6.14 (d)), there is very little difference to the steady states of
all manipulated strains. This clearly differs from the early and mid time dynamics, with
sizeable differences compared to the default simulations. Thus, this may give us insights
into how envR expression effects the long term dynamics: the analysis leads us to believe
that there are only large changes to the steady state of substrate concentration when a
large concentration of AcrEF is present. In comparison between all three manipulations
(Figures 6.12-6.14), acrR expression is only a viable target for inhibiting efflux in strains
with acrAB expression. We can see that varying ramA expression has the largest effect
upon the long term dynamics of substrate concentration in the majority of the strains,
whereas interestingly varying envR expression has the largest effect on the early and mid
time dynamics of substrate concentration.
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Figure 6.12: Plots exhibiting the effects of varying ramA expression (default parameter
value k2 = 10) on the intracellular bound substrate over time. In (a) we have the wild-
type strain, (b) the EST strain, (c) the RamR mutant strain and (d) the EST RamR
mutant strain. Finally in (e) we exhibit the difference in AUC between the manipulated
parameter value simulation to the default parameter value simulation for each strain.
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Figure 6.13: Plots exhibiting the effects of varying acrR expression (default parameter
value k3 = 10) on the intracellular bound substrate over time. In (a) we have the wild-
type strain, (b) the EST strain, (c) the RamR mutant strain and (d) the EST RamR
mutant strain. Finally in (e) we exhibit the difference in AUC between the manipulated
parameter value simulation to the default parameter value simulation for each strain.
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Figure 6.14: Plots exhibiting the effects of varying envR expression (default parameter
value k5 = 10) on the intracellular bound substrate over time. In (a) we have the wild-
type strain, (b) the EST strain, (c) the RamR mutant strain and (d) the EST RamR
mutant strain. Finally in (e) we exhibit the difference in AUC between the manipulated
parameter value simulation to the default parameter value simulation for each strain.
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In regards to the dissociation and saturation constants, we only vary the parameters
KA1 , KE, KH and KI since these parameters are connected to multiple genes. With
dissociation constants that are connected to singular genes, we should expect similar
results to directly varying the target gene’s expression as per the previous manipulations.
In Figure 6.15, we can see the effects of varying RamA dissociation from ramA and acrAB.
Interestingly whilst this manipulation has changed the dynamics of the wild-type strain
(Figure 6.15(a)), the RamR mutant strain (Figure 6.15(b)) has only very small reductions
in efflux over all time periods (further shown by total exposure in Figure 6.15(e)). This
could be due to the overexpression of ramA in this strain meaning there is plenty of RamA
to activate acrAB expression regardless of the dissociation constant. When it comes to
the EST strains (Figure 6.15(b) and (d)), we note that there is only a minute difference in
dynamics to the normal simulations. Whilst this is expected for the activation of acrAB
expression (since the gene is not present), this gives us insight into the self activating
nature of ramA expression. These results suggest that the effect of this is minimal and
does not play a huge part in the network.
In Figure 6.16, we can see the effects of varying EnvR dissociation from acrAB and
acrEF. Notably, the manipulations to all strains do not differ hugely from varying the
direct expression of envR in Figure 6.14, again exhibiting larger effects in the early time
dynamics. Thus targeting the expression of the gene and the protein produced appear to
be viable targets.
In Figure 6.17, we can see the effects of varying H-NS dissociation from envR and
acrEF. For the EST strains (Figure 6.17 (b) and (d)), we can clearly see no effect upon
the efflux over time, further shown by the total substrate exposure (Figure 6.17 (e)).
This is expected as with no AcrAB in the system we should expect fully inactive H-NS
regardless of its dissociation constant. In regards to the wild-type and RamR strains
(Figure 6.17 (a) and (c)), we can see a minimal effect on efflux. Since increasing the
dissociation of H-NS alleviates the inhibition of acrEF expression, this agrees with the
view that if acrAB is active, then the expression of acrEF has little effect upon the overall
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efflux, matching experimental results.
In Figure 6.18, we can see the effects of varying the saturation of substrate with ramR
and ramA (via Lon Protease degradation). Whilst it is clear there are differences in all
strains, the effect upon efflux and substrate exposure (Figure 6.17 (e)) is minimal. Notably
both RamR mutant strains (6.18 (c) and (d)) provide a smaller difference in efflux to their
counterparts (Figure 6.18 (a) and (b)). This is most likely due to mutated RamR in these
strains, such that there is less feedback from intracellular concentration upon the GRN.
Comparatively between all manipulations, we can see that the dissociation constants
relating to ramA and envR are the most sensitive for affecting substrate concentration,
and thus have the most potential for inhibiting efflux.
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Figure 6.15: Plots exhibiting the effects of varying RamA dissociation with ramA and
acrAB (default parameter value KA1 = 2) on the intracellular bound substrate over time.
In (a) we have the wild-type strain, (b) the EST strain, (c) the RamR mutant strain and
(d) the EST RamR mutant strain. Finally in (e) we exhibit the difference in AUC between
the manipulated parameter value simulation to the default parameter value simulation
for each strain.
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Figure 6.16: Plots exhibiting the effects of varying EnvR dissociation with acrAB and
acrEF (default parameter value KE = 20.2) on the substrate over time. In (a) we have the
wild-type strain, (b) the EST strain, (c) the RamR mutant strain and (d) the EST RamR
mutant strain. Finally in (e) we exhibit the difference in AUC between the manipulated
parameter value simulation to the default parameter value simulation for each strain.
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Figure 6.17: Plots exhibiting the effects of varying H-NS dissociation with envR and
acrEF (default parameter value KH = 1) on the substrate over time. In (a) we have the
wild-type strain, (b) the EST strain, (c) the RamR mutant strain and (d) the EST RamR
mutant strain. Finally in (e) we exhibit the difference in AUC between the manipulated
parameter value simulation to the default parameter value simulation for each strain.
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Figure 6.18: Plots exhibiting the effects of varying substrate desaturation with ramR and
ramA (via Lon Protease) (default parameter value KI = 0.3) on the substrate over time.
In (a) we have the wild-type strain, (b) the EST strain, (c) the RamR mutant strain and
(d) the EST RamR mutant strain. Finally in (e) we exhibit the difference in AUC between
the manipulated parameter value simulation to the default parameter value simulation
for each strain.
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Whilst manipulating one parameter did provide notable changes to the efflux dynamics
of the strains, our results show that in order to provide broader changes, further manipu-
lations are needed. It was shown from varying the dissociation constants of proteins that
the results did not hugely differ from varying the expression of genes that produce these
proteins. In addition the only expression of genes that had notable change to all strains
were the expression of ramA and envR. In Figure 6.19, we show the effects of varying
both ramA expression and envR expression. The combination of manipulations has clear
effects on the dynamics in all strains, although the EST strains (Figure 6.19 (b) and (d))
do show a lesser change in dynamics to the wild-type and RamR mutant strains (Figure
6.19 (a) and (c)). In addition, the total substrate exposure (6.19 (e)) has similar dif-
ferences in exposure for one manipulation in all strains, however multiple manipulations
have larger effects to the wild-type and RamR mutant strains than the EST and EST
RamR mutant strains. These differences are likely due to there being one efflux pump
already inactive in the latter strains. In both RamR mutant strains (Figure 6.19 (c) and
(d)) however, we see much larger changes to the dynamics compared to their non mutant
counterparts (Figure 6.19 (a) and (b)). This is a useful insight as the RamR mutation
has been proven to cause MDR. We note that in all strains there is a notable difference in
the mid time dynamics, with the efflux rate of substrate slowed. Thus, in regards to an
antibiotic substrate, the slowing of efflux time may be crucial. If cells within the culture
cannot expel enough antibiotic at a fast enough rate, the antibiotic may have already
caused irreversible damage to the cells and hence the cells may die even if they are able to
pump out enough antibiotic to a low enough concentration that would normally be under
a killing threshold, thus preventing MDR in the strain.
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Figure 6.19: Plots exhibiting the effects of varying ramA and envR expression (default
parameter values k2 = 10, k5 = 10) on the bound intracellular substrate over time. In (a)
we have the wild-type strain, (b) the EST strain, (c) the RamR mutant strain and (d)
the EST RamR mutant strain. Finally in (e) we exhibit the difference in AUC between
the each of the manipulated parameter value simulations to the default parameter value
simulation for the strains.
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6.6 Discussion
By combining our two previous models of a GRN and substrate efflux, we have created
a multi scale model that better encapsulates the behaviour of how a Salmonella culture
expresses genes in order to react to a substrate stressor. Firstly, by using information
from further studies into the network as well as insights from the asymptotic analysis
in Chapter 3, we have adapted and simplified our GRN model from Chapter 2. Using
this updated GRN model, we combine the model with our spatial model on substrate
efflux from Chapter 5 to create a multi scale model. We have achieved this by linking
the concentration of efflux pumps with the efflux rate in our spatial model, as well as the
substrate having effects upon expression of ramR and degradation of RamA. By keeping
our parameters as similar as possible to our previous GRN model simulations, we have
recreated the efflux dynamics fitted to our spatial model for the wild-type and EST strains.
This has enabled us to run simulations of the model, in order to exhibit the effect of the
substrate upon the expression and behaviour of genes within the GRN. In addition to the
wild-type and EST strains, we have also simulated potential RamR mutant counterparts
in order to see the effect of mutations in the GRN to the spatial dynamics of substrate.
Similar to previous chapters, we have produced a parameter sensitivity analysis on
parameters in the GRN using the steady state of the intracellular substrate. We have
completed sensitivity analysis for all four simulated strains, in order for us to identify
targets for inhibiting efflux for each strain. By taking these parameters forward, we have
produced time dependent simulations in order for us to show the effect of varying these
parameters on the full time course. Whilst the long term behaviour was expected from
the parameter sensitivity analysis, we gained important insights with certain genes having
a larger effect upon short and mid time efflux behaviour. Comparing the manipulations
on all strains, we have identified the genes ramA and envR as the most viable targets
for inhibiting efflux. This is due to the strains displaying the most sensitivity to the
parameters linked with these genes. We have exhibited the effects of manipulating both
genes across all strains, with sizeable effects shown to the efflux dynamics. Thus, by
243
creating this multi scale model, it has enabled us to identify the potentially most important
genes in the network to inhibit efflux and combat MDR.
In summary, whilst our GRN model in Chapter 2, gave us insight into the interplay
of genes that govern efflux, it did not give us insights into how the expression of these
genes affect the Salmonella cell and population. In addition, the spatial model in 5 gave
us insights into how a Salmonella population expels substrate, however it did not give
us insights into how the cells activate mechanisms in order to react to the substrate. By
combining these two models we can manipulate any part of the GRN and find the resulting
larger scale effect upon substrate dynamics. Conversely, we can alter the spatial dynamics
of substrate surrounding and within a population and find the smaller scale reaction of
cells by gene expression. This model provides a useful tool for achieving new hypotheses
on new and existing strains, enabling us to identify new biological experiments to help




With the ever growing threat of antibiotic resistance, MDR Salmonella strains have been
listed as a high priority for where new treatment methods are required [100]. One of the
main defensive mechanisms used by Salmonella is efflux pumps that can expel multiple
different antibiotics from the cytoplasm of the cell. The AcrAB-TolC and the AcrEF-TolC
systems have been identified as major efflux pumps that contribute to MDR [10]. Inhibi-
tion of these efflux pump systems is a potential method to combat antibiotic resistance in
bacteria, preventing the bacteria from being able to expel antibiotics via active transport
[68]. However, inhibition of these efflux pumps is a complex process, as the regulation
of these efflux pumps are governed by complex gene regulation networks and inhibition
of one efflux pump system can cause up regulation of another efflux pump system [12].
These GRNs contain multiple different genes and proteins that interact with each other’s
expression, ultimately leading to the expression of the genes that produce structural ef-
flux pump proteins when the cell is under stress. The genes within these networks vary in
expression between different strains, with overexpression of efflux pump genes being com-
mon in mutant MDR strains [97]. In this thesis, we have produced multiple mathematical
models to investigate strains of Salmonella, including wild-type and MDR strains. These
models have ranged from the cellular scale of gene regulation to the population scale
of antibiotic distribution within bacterial strains and their environments. By modelling
these strains on multiple scales, we have gained many insights into the role of efflux in
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causing MDR.
Our first model in Chapter 2 models the intracellular processes of gene regulation
governing the expression of the efflux pump genes acrAB and acrEF. For this model, we
consider two strains: a wild-type strain and a mutant strain. Both of these strains consist
of the same genes governing efflux pump expression, however the latter has non-functional
RamR protein which indirectly causes overexpression of efflux pump genes. Thus in order
for an inhibition adjuvant to antibiotic treatment to be developed, the GRN processes
must be fully understood. For the inhibition to be effective, it must be able to repress the
efflux pump systems in multiple different strains. We produce simulations of this model,
starting from a down regulated state. Whilst this model gave us basic insights into how a
cell reacts to a constant stressor via gene expression, the combination of a large number
of parameters and multiple indistinct parameter values meant we were unable to draw
firm conclusions from the model simulations.
In Chapter 3, we have applied asymptotic techniques to reduce the need for specific
parameter values for the model in Chapter 2. This approach enabled us to complete
a series of time dependent asymptotic analyses upon the wild-type and mutant cases,
revealing nine and ten timescales respectively. We see mRNA transcription being domi-
nant on the early timescales, with protein translation closely following for those mRNAs.
As protein levels increase, inhibition of relevant transcription begins, decreasing certain
mRNA concentrations. Finally, degradation comes into effect bringing all variables to
steady state. By doing this process, we have broken down our nondimensional model
(which does not have a full set of analytical solutions) into a step by step model of each
dominant process. Thus, we are left with simplified models of our system, only taking
into effect the dominant behaviours that control the GRN.
By performing this asymptotic analysis, we have also achieved asymptotic approxima-
tions to the steady states of the system, which were not analytically solvable in our full
model. On most timescales we have full analytical solutions for each variable’s behaviour,
enabling us to see the full breakdown of how each variable acts and how step by step
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the system evolves over time. By performing parameter variations upon the steady state
values, we have been able to identify certain parameter groupings that have the most
effect on the expression of efflux genes in both the wild-type and mutant case. For both
cases, it was shown that both η and ξ relating to the binding affinity of EnvR to the two
efflux pump genes and envR expression exhibited some of the strongest sensitivities, thus
showing evidence for the gene envR to be a potential inhibition target. This is biologically
plausible as envR is the local repressor of the efflux gene acrEF but also can repress the
gene acrAB. As this gene affects both pumps directly, by targeting envR we may be able
to maximise inhibition of both efflux pumps. Notably however, the processes of EnvR
repression on the efflux pump genes were only dominant on the latter timescales. On early
timescales these repression processes did not appear at leading order. This may show the
limitations of envR as an inhibition target, with the gene more likely to affect the long
term behaviour only.
Most other parameters exhibited a reasonable relative sensitivity, providing evidence
that multiple genes could provide realistic inhibitory targets. Perhaps more importantly
however, was the sensitivity of ω relating to the link between the concentration of AcrAB
and the activation / repression of acrEF. Notably, this link appeared as a dominant
process in both strains on the latter timescales. Whilst we do not currently know the full
biological details of this link, the sensitivity of this parameter grouping suggests that it
could provide a possible efflux inhibition target. This provides a strong case to delve into
and further understand the mechanisms linking the various efflux pumps, as they could
provide the key to inhibiting efflux.
Whilst exploring the steady state analysis has provided plentiful insights into efflux
inhibition targets at the system’s long term behaviour, it is important to note that this
does not fully encompass the system’s earlier behaviour. By summarising the asymptotic
analysis showing the dominant behaviour on all timescales, we are able to exhibit a step
by step breakdown of the system. With this summary, we were able to distinguish easier
the differences of behaviour between the wild-type and mutant cases. In particular we
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noted the importance of ramA in the mutant case, with direct and indirect activation of
acrAB through RamA. Whilst at steady state the indirect activation (via AcrR) is still
prevalent, at leading order in the mathematical analysis the direct activation is not and
appears to be an important factor in early activation of acrAB expression. This has given
us reasonable grounds to consider ramA as a potential inhibition target, targeting acrAB
expression directly at early time, and indirectly at long time. Although this gene may not
be one of the most sensitive targets at long term behaviour, the step by step breakdown
shows that the early interactions of the gene are of huge significance. Thus by targeting
ramA, we may provide a method for inhibiting early efflux expression enough so that an
antibiotic can kill the bacteria before its efflux pumps become fully active. The analysis
has therefore also revealed the possible importance of effective timing of efflux inhibition
and how this may vary between targets.
Although this model gave us insight into how genes interplay starting from a down-
regulated state, it did not consider how a change in antibiotic concentration could itself
affect the network. In Chapters 4 and 5, we produce models of the distribution of an
antibiotic concentration within and surrounding a Salmonella population. In these models
we consider an antibiotic that is a substrate of four efflux pumps: AcrAB, AcrEF, MdsAB
and MdtAB. Notably two of these efflux pumps are apparent in our GRN model in
Chapter 2. We produced these models in order to replicate experimental data of ethidium
bromide efflux assays. This data consists of experiments taken upon a wild-type strain of
Salmonella and various efflux pump knockout strains. By replicating this data, we hoped
to achieve insights into the dynamics of the four efflux pump systems.
We started with a simplistic model in Chapter 4, formulating a PDE model of sub-
strate concentration of a spherical cell and surrounding extracellular space. We produced
numerical simulations of the model by discretising the domain using finite difference meth-
ods. By then using parameter fitting techniques, we were able to fit the model to each of
the Salmonella strains by varying the efflux parameter X. Initially, we proposed differing
outer boundary conditions for the model (zero far field and no flux). Whilst the parameter
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fitting results for this model did not show strong alignment to the data for both boundary
conditions, it was shown that for the long time behaviour, having a no flux boundary con-
dition produced fits that aligned better to the data. This gave us reason to believe that
in the experiments, the extracellular space is limited enough such that expelled substrate
(via either efflux or diffusion) is constantly diffusing back into the strains. In addition, it
was interesting to note the disparity between the reasonable fits to the AEST knockout
strain (all efflux pumps knockout) against the substandard fits to any strain with efflux
active. Furthermore, in fits to all strains, the model could not replicate the early time
dynamics that were shown by the data. These results made it clear that the current
model was missing essential dynamics and thus needed adaptation to fully encapsulate
the behaviour exhibited by the strains.
In Chapter 5, we formulated a model improving on the model in Chapter 4. As the
early dynamics of the strain were not present in the previous model, we firstly introduced
binding dynamics of the substrate. Ethidium bromide is a DNA-intercalating agent that
fluoresces when bound to DNA and thus is found within the cell in two states (bound and
unbound), by including these binding dynamics the model was expanded into a system
of PDEs. Parameter fitting techniques immediately displayed the improvements to the
model, with the model being able to replicate early and intermediate time behaviours,
producing a near perfect fit of data of the AEST strain. The model showed improvements
on the wild-type strain compared to the previous model. However it was clear that the
constant efflux parameter was incapable of encapsulating the behaviour of strains that
had active efflux. Therefore we adapted our efflux parameter to be variable, defined by a
simple formation and deformation ODE. Parameter fitting results showed the model better
replicated the dynamics of the wild-type strain with strong alignment to the experimental
data on all time scales. However, the efflux variable now showed unrealistic behaviour,
with the efflux depleting very quickly and only present for a short period of the experiment.
By making the increase of efflux dependent on the intracellular substrate concentration,
not only did we achieve more realistic efflux dynamics, we achieved fits with stronger
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alignment to the data. This lead us to believe that the strains have some feedback
mechanism involving the rate of efflux and the internal substrate concentration.
By using the optimal parameters for the most extreme cases: AEST (no active efflux)
and wild-type (full efflux), we were able to produce fits for the efflux pump knockout
strains. This enabled us to produce efflux profiles for each strain, which after making
assumptions we used to estimate the efflux profile of each individual efflux pump system.
We noted that these efflux profiles displayed similarities to the behaviour of our efflux
pump variables in our model in Chapter 2. This gave us good reason to believe that the
feedback mechanism between the internal substrate concentration and efflux could be the
result of the regulation of genes within a GRN.
In Chapter 6, we produced a multiscale model, linking the models in Chapters 2
and 5 to simulate a GRN feedback mechanism. By using new knowledge from further
studies into the network, we were able to adapt our GRN model from Chapter 2. In
addition, by using insights gained from the asymptotic analysis in Chapter 3, we further
adapted the GRN, simplifying the model by removing elements that were not influential
in the dominant processes revealed by the asymptotic analysis. Lastly, by linking the
intracellular substrate to certain mechanisms of the GRN (repressing ramR expression
and Lon Protease degradation), we were able to combine our ODE and PDE models, using
similar finite difference methods from Chapter 5 to produce numerical simulations. For
this model, we compared wild-type, EST (AcrAB knockout) strains and respective RamR
mutant counterparts. By using the final fitted parameters in Chapter 5, we compare our
model to the data of the wild-type and EST strains, maintaining as many parameter
values as possible from Chapter 2. We then simulated the RamR mutant counterparts
strains by manipulating the GRN, enabling us to predict how these strains behave in the
presence of a substrate stressor.
Similar to our asymptotic analysis in Chapter 3, we performed parameter sensitiv-
ity analysis varying GRN parameters, this time however measuring the difference to the
steady state of the intracellular substrate concentration. Taking forwards the most sen-
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sitive parameters for all of the strains from this analysis, we performed time dependent
simulations showing the effects of manipulating these parameters. These simulations en-
abled us to exhibit the effects on the dynamics of substrate efflux throughout the full time
course of the simulations. It was shown that the genes ramA and envR were the most
viable targets for inhibiting efflux in all strains, which aligned with our results from the
asymptotic analysis in Chapter 3. Therefore experimenting with an inhibition adjuvant
that targets processes involving these genes could prove useful to inhibiting efflux.
We have only displayed some of the many capabilities that this multiscale model
provides in Chapter 6. By creating this model we have provided a basis for understanding
MDR in Salmonella with multiple opportunities for further research. The model provides
the ability to target or manipulate any area of the GRN or cell spatial structure to
achieve new hypotheses on how the culture will react to the substrate. Manipulations
could be achieved by the addition of new variables into the model, such as including the
dynamics of an adjuvant that targets the GRN, or a synthetic molecule that slows efflux
activity or alters membrane permeability. In addition to this further research, another
clear extension to this thesis would be extending the time dependent asymptotic analysis
from Chapter 3 to incorporate all elements of the multiscale model. By breaking down
the GRN model to multiple different timescales, we demonstrated the increased volume
of information we were able to obtain from the analysis. If we were to apply this method
to the multiscale model, we would be able to obtain more in depth information of the
workings of the bacteria, with the ability to determine which genes are the most influential
on the expulsion of substrate at various different timescales.
There are of course many other areas where we could expand this model, one of these
being the inclusion of stochastic events. This could be incorporated through multiple
processes in the model, for example: gene expression, degradation, binding dynamics and
substrate diffusion. Specifically for gene expression, we could consider the effects caused
by intrinsic (process that affect singular genes) and extrinsic noise (global processes that
could affect multiple genes). As the concentration for specific genes within our GRN are
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low, we therefore have a low copy number of mRNAs and proteins. These concentrations
are therefore susceptible to intrinsic noise as the fluctuations in the processes affecting
these molecules can not be assumed as negligible (which is the case in larger concentra-
tions). In regards to extrinsic noise we have not considered cell growth, death and changes
to the physical environment in our models, which could have effects on the gene expression
of all or individual cells within the population [88]. In addition, cell growth and death
could be linked to the expression of efflux pump genes. Not only through their link to
the antibiotic concentration, the production of the efflux pump proteins could be costly
to the population and prevent or reduce the ability for cells to produce other essential
survival mechanisms.
We believe that this work has provided useful insights into the mechanisms behind
MDR in Salmonella. In the multiscale model, we have created a basis with positive capa-
bilities for future research, we hope that the success of this model will inspire the creation
of other GRN and efflux models for different bacterial species. With the hypotheses we
have generated on potential inhibitory targets and pathways, this should provide evidence
for further investigation of certain areas of the network. We hope the analysis will also
inspire potential therapies to be tested experimentally in order to produce new strategies
against efflux related MDR bacteria.
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